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Abstract 
Positron Emission Tomography (PET) is a non-invasive imaging method which enables 
to obtain both molecular and biochemical information of physiological processes in 
vivo, which means that PET imaging shows the chemical functioning of organs and 
tissues in a living subject. In recent years microfluidic lab-on-a-chip devices have been 
explored as a promising alternative for radiotracer synthesis due to benefits such as (i) 
superior control over reaction conditions leading to high yields and conversion rates, (ii) 
reduced reagent consumption and radioactive waste production as well as (iii) potential 
for automation with minimised shielding requirement. That said, most devices presented 
so far have focused on the synthesis of the radiotracer, with relatively little emphasis on 
the integrated devices that perform activation, synthesis and purification steps in an 
automated fashion. FDG (fluorodeoxyglucose) is one of the most widely used 
radiopharmaceuticals in Positron Emission Tomography (PET). Moreover the 
availability of several other PET radionuclides makes fluorine-18 (
18
F) the most 
predominant in the fields of oncology and neuroscience. 
The aim of the Radiochemistry on chip (ROC) project was to develop such an 
integrated lab-on-chip device and, in particular, here results for on-chip pre-
concentration of fluoride, together with some preliminary results on the removal of 
Kryptofix (K2.2.2) and the purification of fluoroethyl-dimethyl-2-hydroxy-
ethylammonium (FECH) are presented. Here in, three microfluidic modules for fluoride 
pre-concentration are described, the first employs a dam structure, the second and the 
third magnetic forces. In the final part of the thesis, preliminary results on the 
purification of fluoroethylcholine (FECH) and a suitable detection method for Kryptofix 
(K2.2.2) are reported. 
  Abstract     bjbk 
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Firstly, the design, fabrication and implementation of a glass microfluidic device for 
recovery of [
18
F] and [
19
F]fluoride ions is described. The device was initially tested with 
non radioactive [
19
F]fluoride ions and shown to repeatedly trap and elute > 95% fluoride 
over 40 successive experimental runs with no decrease in efficiency. The same device 
was then tested for the trapping and release of [
18
F]fluoride ions, again over 20 
experiments were executed with no measurable decrease in performance. Finally, the 
[
18
F]fluoride ions were eluted as a K
18
F/K2.2.2 complex, dried by repeated dissolution 
in acetonitrile and evaporation of residual water, and reacted with EtDT leading to the 
formation of the desired product ([
18
F]fluoroethyltosylate) with 96 ± 3 % yield (RCY). 
The overall time needed for conditioning, trapping, elution and regeneration was less 
than 6 minutes. This approach will be of great benefit towards an integrated platform 
able to perform faster and safer radiochemical synthesis on the micro-scale. 
In the following chapter, magnetic microparticles are described as a method for the 
trapping and elution of [
18/19
F]fluoride ions via formation of a magnetic plug inside a 
glass microdevice. Even though the method was found to be not as fast and efficient as 
the packed bed of microparticles (Chapter 3), and still requires several manual steps 
which are time and labour consuming, the proof of principle illustrates an alternative 
process not yet reported in the literature, with potential for future on-chip pre-
concentration of fluoride. The results showed that by employing positively charged 
magnetic particles, fluoride could be trapped in yield of > 50 % and elution achieved 
with approximately 90 % recovery of fluoride. A subsequent method for reducing the 
inefficiencies of the plug of magnetic particles is described where a multilaminar flow 
microreactor was investigated in which functionalised magnetic particles can be 
deflected through streams of reagents with the final aim to perform trapping and elution 
of fluoride in continuous flow. In the final chapter preliminary studies into the detection 
  Abstract     bjbk 
16 
 
and removal of K2.2.2 and FECH are described. Two detection methods for K2.2.2 
analysis and detection of K2.2.2 in FDG are proposed and assessed towards real 
sampling of FDG. Also a suitable detection method for FECH and DMAE and 
TBAHCO3 was also optimised, with separation of the three analytes achieved with an 
isocratic IC method. Trapping of FECH was also achieved with cation exchange 
material trapped in micro-chamber, and the capacity of the material was found to be 5.5 
µg mg
-1
. 
In a final study the integration of different micro-chambers modules was assessed for 
potential towards FECH purification to establish an alternative method whereby all the 
by-products are trapped and only FECH is released; results on this study showed that it 
was not possible to completely purify FECH due to DMAE presence found in the 
purified solution in high trace (only 30 % was trapped and the rest released together 
with FECH). 
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1 Introduction 
1.1 Positron Emission Tomography (PET) 
Positron Emission Tomography (PET) is a molecular in vivo imaging technique with 
very high resolution and sensitivity compared to single photon imaging (planar and 
single photon emission computed tomography (SPECT))[1] which requires the labeling 
with positron emitting radioisotopes, also referred to as radiotracers. It covers a wide 
range of applications in the fields of oncology, cardiology and neurology. PET scans 
can be applied for diagnosis of malignancy, grading of malignancy, staging of diseases, 
detection of residual disease, detection of recurrence, measuring the response to therapy 
and identification of the site of disease. The reason why PET is so successful compared 
to other techniques, such as X-rays and MRI scan and single photon imaging compared 
to single photon imaging (planar and single photon emission computed tomography 
(SPECT))[1], is that PET not only shows the anatomy of the body, but also the chemical 
and metabolic aspect of any eventual disease with the added benefit of sensitivity and 
specificity. Furthermore, specificity and sensitivity can be increased when combined 
with computed tomography (PET CT SCAN) as shown in Figure 1 where CT and PET 
images are taken sequentially showing the anatomy and metabolic aspect within the 
same image [2]. The development of positron emission tomography illustrates how 
advances in basic science translate into benefits for human beings. In 1930 Ernest 
Lawrence and co-workers [3, 4] realised the first cyclotron. By 1938 Lawrence and 
Livingston [4] had designed a "medical cyclotron". In the mid-1950, while looking for a 
method to examine the oxygenation of tumors, Ter-Pogossian and Powers investigated 
C-11, N-13, O-15, and F-18 and found many uses in medical and physiological research 
[5]. These early experiments stimulated interest in the use of short-lived radioactive 
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gases, and led, in 1955 to the construction of the first medical cyclotron, located on the 
grounds of the Hammersmith Hospital in London. The introduction of 
fluorodeoxyglucose (FDG) represented another major step towards practical clinical use 
of positron-emitting tracers. In 1977, after a decade of development, Sokoloff et al. 
described in a classical paper the use of carbon-14 deoxyglucose for measurement of 
local cerebral glucose utilization [6]. Shortly afterwards Reivichv et al. extended the 
carbon-14 radiographic method to measurements of regional glucose utilization with 
fluorine-18 deoxyglucose [7], a tracer developed by Ido and colleagues [8]. It was a 
significant accomplishment not only the development of this tracer but also the 
modeling of its use to reveal regional cerebral glucose utilization, which gave birth to 
functional mapping of the human brain[9]. 
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Figure 1 (a) CT scan showing the anatomy of the brain (left), on the right PET scan showing the 
metabolic process of the brain. b) Fusion of CT and PET scan increasing sensitivity and specificity. 
1.2 Basic principles of PET imaging 
Several steps are required in the PET process, from the selection of a suitable molecular 
probe labelled with a positron emitting radionuclide, administration either by injecting 
into the vein, swallowing or inhaling, to imaging the distribution in the patient. Positron 
emitters are isotopes, which are neutron-deficient and reach their stability by conversion 
of a proton to a neutron. Figure 2 is a schematic representation of the positron emitted 
from the nucleus and the subsequent formation of two photons or gamma rays. 
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Figure 2 Schematic representation of positron emission and formation of 2 photons (gamma rays). 
Once the positron is emitted, energy in form of β+ radiation is given off. Once the 
radionuclide is emitted, annihilation process takes place, which is the energy produced 
between positron-electron and is produced outside the nucleus which takes place outside 
the positron emitting atom and gives rise to two photons or gamma rays (γ). Each of 
them has an energy of 0.511 MeV, given off at 180  opposite directions in order to 
maintain their momentum. This is the crucial phenomenon of the detection in PET 
where two photons are detected simultaneously by a circular array of detector in the 
PET scanner. The process of positron emission is described in more details below. 
There are two ways to produce a positron, by pair production and by nuclear 
transmutation. The general equation in positron decay is shown in equation 1: 
Z
AX Z 1
A Y 1
0 Q( e )    Equation 1 
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Where Q is energy, the atom X is a proton rich and achieves stability by converting a 
proton to a neutron [10]. The positive charge is carried away with the positron and to 
balance the charge an electron is ejected from the outer orbital (internal conversion); 
initially the positron has energy similar to the 
-
 decay, but it loses its kinetic energy by 
interaction with the surrounding matter via four types of interactions: 
 Inelastic collisions with atomic electrons. 
 Elastic scattering with atomic electrons, where positron is deflected but 
maintains energy and momentum. 
 Inelastic scattering with a nucleus, positron deflected emission of radiation. 
 Elastic scattering with a nucleus where positron is deflected but not transfer any 
energy to the nucleus. 
When a positron and electron combine and annihilate giving off electromagnetic 
radiation in the form of two photons as described above, in some cases three photons 
can be emitted (< 1% probability) [2, 11]. 
Once the positron is ejected from the nucleus, it loses energy by collision with other 
atoms and combines with another extra nuclear electron so the total mass of β+ + e- is 
converted to energy according to Einstein equation (2): [11] 
Total mass of β++e- =18.219x10-31 kg 
Speed of light =2.998x10
8
 ms
-1
 
E=mc
2
 =1.6375x10
-13
 kg m
2 
s
-2
 (J)   Equation 2 
19
13
106022.1
106375.1
x
x
eV
 
= 1.022x 10
6 
eV = 1.022 MeV 
 Examples of isotopes which undergo decay via positron emission are shown in Table 
1:  
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Table 1 Properties of commonly used positron emitting radioisotopes [12]. 
Isotope Half-life 
(min) 
Maximum 
positron 
energy 
(MeV) 
Positron range in 
water (mm) 
Decay 
product 
Production 
method 
11
C 20.3  0.96 1.1 
11
B Cyclotron 
13
N 9.97  1.19 1.4 
13
C Cyclotron 
15
O 2.03 1.70 1.5 
15
N Cyclotron 
18
F 109.8 0.64 1.0 
18
O Cyclotron 
68
Ga 67.8 1.89 1.7 
68
Zn Generator 
64
Cu 762 3.15 1.7 
64
Ni Cyclotron 
 
1.3 Radiation detector 
Radiation detectors measure the energy lost or deposited by ionizing radiation when 
they pass the detector, typically they convert the energy into an electrical or charge 
signal. They are generally divided into three categories: gas chambers, semi-conductors 
and scintillation detectors. The latter one is the most used and successful for the 
detection of 511 KeV photons in PET imaging. They consist of an inorganic crystal 
(scintillator) which emits visible (scintillation) light photons after the interactions of the 
photons with the detector, a photo detector measures the number of scintillation photons 
during the interactions which is proportional to the energy deposited within the crystal 
[13]. 
1.4  Fluorine, 18F and its production 
The non radioactive 
19
F
-
 isotope is a group p-block element (electron configuration: 
[He] 2s
2
 2p
5
) has natural abundance of 100% and reacts readily with almost every 
element and compound when present in its gaseous form. This basically means that 
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neither any radioactive fluorine isotope nor gaseous fluorine will be found in nature. 
Fluorine is the most electronegative element present with a Sanderson electronegativity 
of 4.0. The most common oxidation number is -1. 
[
18
F]Fluorine itself is one of many known radioactive isotopes, and it consists of 9 
protons and 9 neutrons with a half life between 109.8 – 109.7 min. All other known 
radioactive positron emitting fluorine isotopes (there are three) have short half-lives for 
in vivo imaging purposes (e.g 
17
F, t1/2= 64.8 s) and their production is of relatively of 
little interest [14]. 
1.5 [18F]Fluorine radiopharmaceuticals 
[
18
F]Fluorine as part of the radiohalides is becoming increasingly the radionuclide of 
choice not only due to its physical and nuclear characteristics as described earlier but 
also due to the successful use in clinical oncology of 2-[
18
F]fluoro-2-deoxy-D-glucose 
[
18
F]FDG, which is currently the most widely used PET radiopharmaceutical. 
[
18
F]fluorine it decays in 97% of the cases by positron emission and 3% by electron 
capture to the stable isotope 
18
O [15]. In general it can react either as electrophile or 
nucleophile but due to its reactivity in the electrophile reaction, regioselectivity which 
makes the nucleophilic reaction of [
18
F]fluoride the preferred method. The most 
common method to produce nucleophilic [
18
F
-
]fluoride is the 
18
O (p, n) 
18
F nuclear 
reaction, i.e. the reaction of an accelerated proton with 
18
O to produce a neutron and 
18
F
-
. A variety of chemical reactions are available for 
18
F
-
, but they can be divided mainly in 
two categories; SN2-type (nucleophilic substitution bimolecular) reactions with the 
substrate containing a leaving group, and aromatic nucleophilic substitution reactions, 
which utilise an activated aromatic group. Its relative longer half-life makes it 
18
F
-
 a 
suitable candidate both on synthesis time and longer imaging applications [16]. 
Nucleophilic substitution with no-carrier-added (N.C.A) [
18
F]fluoride is still the only 
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way to obtain products with high specific activity which denotes the ratio of the 
radiotracer in question to the total amount of compound both labelled and unlabelled is 
expressed in GBq µmol
-1
 or mCi mmol
-1
. Several developments in the synthesis of 
18
F-
tracers have been achieved, with some of the common radiotracers used in PET shown 
in Table 2; peptide synthesis via prosthetic group labeling [
18
F]SFB, click chemistry 
formation of triazole between an azide and an acetylene, enzyme fluorination of 
adenosylmethionine but the three main methods of fluorination procedures are namely; 
i) direct fluorination (one step) [
18
F] such as flumazenil ii) direct fluorination followed 
by cleavage either basic/acid hydrolysis or oxidative cleavage such as FDG, iii) 
synthesis of a 
18
F-synthon (prosthetic group) either 2 or 3 steps such as FECH [15]. 
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Table 2 Common 
18
F radiotracers for PET with their application and structure [17-21]. 
Radiotracer Applications Structure References 
[
18
F]Fluoroethylcholine 
(FECH) 
Prostate, brain 
tumors 
 
 
[17] 
 
[
18
F]Fluoromisonidazole 
(FMISO) 
Hypoxia 
 
 
[18] 
[
18
F]Fluorothymidine 
(FLT) 
Cellular 
proliferation 
 
 
[19] 
[
18
F]2-Deoxy-2-fluoro-D-
glucose (FDG) 
Glucose 
metabolism 
and tumors  
 
[20] 
[
18
F]Fluorodopa (FDopa) Parkinson’s 
disease  
 
 
[21] 
 
1.6 [18F-]Fluorine radiochemistry systems for synthesis  
Currently the synthesis of radiocompounds is performed in a variety of formats 
depending on the type of chemistry and their requirements, commonly these platforms 
are referred to as radiosynthesisers or radiochemistry systems. Radiochemistry systems 
are able to perform a number of operations such as chemical reactions, neutralisation, 
purification and dilution. These are mainly used to synthesise radiopharmaceuticals, 
where due to the large amount required for clinical purposes, automation is an essential 
requirement in order to minimise handling of these high energy emitters which would 
be dangerous for the operators. There are many commercially available systems, a 
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classification of these will be presented below, but it will be restricted to systems for 
[
18
F
-
] labeling. 
Radiochemistry systems can be divided in three main categories: 
 Systems to be charged with reagents (1.6.1), 
 Systems with disposable cassettes (1.6.2), 
 ‘Modular’ systems (1.6.3), 
Functionality also varies between systems depending of their use; single dose FDG, and 
multi-dose where both nucleophilic substitutions and electrophilic reactions can be 
performed on the same system. Depending on the chemistry performed, the system can 
also be divided in two further categories; substitution in a reactor or in a loop as well as 
whether acid or basic hydrolysis is performed on reactor or on cartridges. 
From a technical point of view, they differ depending on the number of reactors 
available, their detector functions, and if they integrate a HPLC – preparative for their 
purifications [22]. 
1.6.1 Radiochemistry systems to be charged with reagents 
The first group of system are characterised by the fact that reagents and products are 
loaded onto reactor vessels either manually or in some cases by robotic arms. Common 
materials for vessels are plastic, glass or glassy carbon, with volumes reagents from 1 
mL to 10 mL. Reaction temperature are controlled by electrical resistance (25 – 250 °C) 
or via Peltier technology (-180 – 300 °C). In the next paragraphs some of the 
commercially available systems are described. 
Three synthesisers are available from GE (GE Healthcare, United Kingdom) under the 
name of TracerLab as shown in Figure 3: the “FX-FDG double” for FDG synthesis 
(Figure 3a) with a 60 % radiochemical yield (R.C.Y.) is able to perform two 
independent runs and it comes with three radiation detectors. The “FX-FN” or “FX-FE” 
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(Figure 3b), for both nucleophillic and electrophilic substitution which features built-in 
preparative radio / UV HPLC and the “FX-Dopa” (Figure 3c) which enable the 
synthesis of Fluoro-Dopa with a 20 % radiochemical yield in less than 40 min with 99% 
enantiomeric purity. 
 
Figure 3 a) GE Tracer Lab FX-FDG for synthesis of FDG which allows two consecutive runs 
without opening the hot-cell [23]. b) The TracerLab FX-FN/FE a versatile system for multiple 
18
F 
radio compounds[23, 24]. c) The TracerLab FX-DOPA for fully automated synthesis of [
18
F]F-
Dopa [25].  
 
Raytest (Raytest GmbH, Germany) also produce a series of synthesisers under the name 
of “Synchrom” as shown in Figure 4; for single run FDG synthesis as shown in Figure 
4(a) as well as a system for general radiosynthesis with an HPLC purification system 
built in as shown in Figure 4(c). 
 
Figure 4 Images of different modular systems from Raytest a) the “Synchrom FDG”, b) “Synchrom 
F2” and c) “Synchrom R&D” [26].  
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Furthermore there are Synthra synthesisers (Synthra GmbH, Germany) for FDG and F-
Dopa as shown in Figure 5(a-b) both with integrated heating / cooling systems and three 
radiation detectors as well as a system with built-in preparative Radio / HPLC 
purification. 
 
Figure 5 (a) The “Synthra FDGtwo” a fully automated system for FDG synthesis[27]. (b) the synthra 
F-Dopa for routine production of 6-[
18
F]fluoro-L-Dopa[27].  
(c) The “Synthra RNplus” a completely automated radio synthesis system for routine production of a 
wide variety of [18F]fluorine labelled compounds by nucleophilic substitution[27].  
 
1.6.2 Radiochemistry systems with disposable kits 
Another category of radiochemistry synthesisers consists of systems with disposable 
cassettes where chemicals, cartridges and solvents are already included and loaded into 
the cassette, thus allowing multiple back-to-back production runs for 
18
F-FDG, as well 
with the advantages of reducing maintenance and cross-contamination. 
 
Figure 6 Image of a disposable cassette system with reagents and chemicals already loaded the 
image shows a cassette system for the GE “FastLab” [28]. 
Two systems are available from GE Healthcare (GE HealthCare, United Kingdom), the 
“MX Tracer Lab” as shown in Figure 7(a) for synthesis of FDG in 60 % radiochemical 
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yield in less than 27 min as well as the “Fast Lab” which allows different cassette 
systems to be used (FDG, 
18
F-NaF) with a 70 % radiochemical yield for FDG in less 
than 23 min. 
 
Figure 7 (a) The “GE MX Tracer Lab” for FDG synthesis[29].(b) The “GE Fast Lab” a more 
versatile system for multiple synthesis of radiocompounds including FDG, FLT, FMISO [25].  
Cassette systems are also produced by IBA (IBA Solutions, Belgium) with the 
“Synthera” family for both FDG and FLT as shown in Figure 8. The “Synthera FDG” in 
Figure 8(a) enables FDG synthesis with a yield of 55 % and an automatic ejecting of the 
cassette. The “Synthera FLT” (Figure 8(b)) allows synthesis of FLT in a 20% yield in 
less than 40 min also available with the “Synthera HPLC” for on-line purification. 
 
Figure 8 Images of two types of “Synthera” produced by IBA. (a) The “Synthera FDG” for 
synthesis of FDG and (b) the “Synthera FLT” for synthesis of FLT [30]. 
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Also belonging to the category of the cassette systems is the Siemens “Explora” 
(Siemens Healthcare, Germany) with three different synthesisers; the “Explora FDG4” 
for synthesis of FDG with a non d.c.y. of 65 % in 45 min which allows up to four 
sequential runs of FDG and includes up to five radiodetectors. In the same product 
family is the “Explora FM+LC” for synthesis of FLT which allows for reagents 
measurements and integrates a semi-preparative HPLC. This instrument supports two 
batches of automated synthesis before cleaning is needed. 
 
Figure 9 (a) The “Explora FDG4“ a disposable system for FDG synthesis[31]. (b) The “Explora 
GN” for multiple synthesis of FDG[32]. (c) The “Explora FM+LC”, a fully automated system with 
built-in a semi-preparative LC system for purification [33].  
Bioscan which has recently been acquired by Eckert and Ziegler (Bioscan Europe Ltd., 
France), offers two synthesisers one for FDG synthesis with a yield of 55% as shown in 
Figure 10(a) as well as an automated loop system for synthesis of 
18
F-Choline and other 
alkylation syntheses like 
18
F-FBrEt or 
18
F-FBrMe which allows direct injection into the 
HPLC system. 
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Figure 10 (a) The “FDG-Plus” synthesizer for multiple runs of FDG production[34].(b) “Autoloop” 
Module, a system that takes advantages of the ‘loop technique’ developed by Dr. Alan Wilson at the 
centre for Addiction and Mental Health in Toronto, where the reaction happen at room 
temperature in the closed loop [35]. 
1.6.3 Modular radiochemistry systems 
This category of synthesisers consists of small, sealed, stainless steel modules stacked 
and connected by tubing and by a single electrical cable. The use of multiple, 
replaceable modules allow the system to be applied for various isotopes and many types 
of reactions. Due to its multifunctionality these systems can replace several single-
purpose devices, which significantly reduce cost and lab space. Currently there are two 
companies that produce such systems. The first is by Eckert & Ziegler (Eckert & 
Ziegler Strahlen- und Medizintechnik AG, Germany) (Figure 11) where different 
modules (Figure 11(b)) can be assembled together for a custom synthesis process. Each 
individual modules are quite small (13 x 13 x 8 cm
3
) in Figure 12(a-b) both the 
modular–Lab for FDG and FECH are shown which allow synthesis of FDG in less than 
30 minutes and can produce up to four sequential FDG batches. 
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Figure 11 (a) Eckert & Ziegler modular system assembled and interfaced to a PC, (b) The 
individual components [36]. 
 
Figure12 The E&Z Modular Lab F-FDG for synthesis of FDG [37]. The Modular-Lab F-FECH for 
synthesis of FECH [38]. 
Also of similar concept are the Scintomics modular synthesisers (SCINTOMICS 
GmbH, Germany) with an example shown in Figure 13. 
 
Figure 13 (a) The Scintomics modular system, (b) The “AutoFEC” modular systems for synthesis of 
FEC [39].  
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1.6.4 “Microfluidic” radiochemistry systems 
This category consists of modular, liquid-flow-based 
18
F microchemistry system with 
the ability to combine both microscale and macroscale process steps in PET synthesis. 
The main difference to the modular systems is the integration of a microfluidic loop, 
commonly glass capillaries, for reactions [40, 41]. Current the only available system of 
this category is the Advion NanoTek LF (Advion, USA) as shown in Figure 14 which 
consists of a liquid flow reactor system, an auxiliary pump module as well as a 
concentrator and evaporator module, thus allows for a fast synthesis and enable 
production of multiple biomarkers from a single 
18
F batch. It features lower reagent 
usage and can integrate a purification system. In Figure 14(b) the microfuidic reactor 
loop is shown which consists of a coiled fused silica capillary. 
 
Figure 14 (a) The microfluidic systems from Advion (Advion “Nanotek LF”) which consists of a 
reactor module, a concentrator module and an evaporator module. (b) The microfluidic loops for 
reaction situated in the Advion “NanoTek LF” system which consists of a coiled glass capillary 
(approximately 2 m in length with a diameter of 150 µm)connected to a heating system [42]. 
Radiochemistry systems sizes comparisons 
The paragraphs above show that there is an expansive line of radiochemistry modules 
for small to medium scale synthesis and production of different PET imaging 
biomarkers. In Figure 15 an image of the variety of the systems described above are 
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compared in terms of their size. In Table 3 few examples of each of the categories 
described above are compared in terms of their synthesis time and yield obtained 
 
Figure 15 Comparison of the different radiochemistry modules described above in term of their 
size.
                  Chapter 1 
35 
 
Table 3 some of the commercially available synthesisers compared in terms of their timing and synthesis yield  
System Company Radiopharmaceutical Time for synthesis 
(FDG) 
R.C.Y Advantages 
1) Charged: 
 
“TracerLab” 
“Synthra FDGTWO” 
 
 
GE Healthcare 
Synthra 
 
 
FDG, Fluoro Dopa 
FDG 
 
 
< 30 min 
< 28 min 
 
 
70 % 
98 % R.C.P 
 
 
Two production runs per 
loading  
High starting activity 
 (555 GBq) 
2) Disposable:  
 
“FastLab” 
“Explora FDG4” 
 
 
GE Healthcare 
Siemens 
 
 
FDG 
FDG  
 
 
25 min 
45 min 
 
 
74 % 
65 % 
 
 
Quick set-up (< 1 min) 
Automatic self-cleaning 
3) Modular: 
 
“Modular Lab 18F- 
FDG” 
 
 
Eckert & Ziegler 
 
 
FDG 
 
 
<30 min 
 
 
Not 
reported 
 
 
Four sequential syntheses 
without user interaction 
4) Microfluidic: 
 
“NantoTek LF” 
 
 
Advion 
 
 
FECH 
 
 
< 90 s 
 
 
60-85 % 
 
 
“Dose on demand” 
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1.7 Preparation of nucleophilic [18F-] for radiosynthesis 
In the following paragraphs an in depth description for the preparation of nucleophillic 
[
18
F
-
] radiotracers will be presented.  
All radiosynthetic nucleophilic substitutions, to introduce [
18
F
-
] into molecules, start 
with a drying step, because the fluoride is obtained as an aqueous solution. This means 
that its nucleophilic properties are weak due to hydrogen bonding with water molecules 
[22, 43]. Therefore, prior to performing any synthesis, [
18
F
-
]fluoride is dried 
azeotropically under reduced pressure in the presence of acetonitrile. This step is 
commonly achieved in automated synthesis module or manually with a drying apparatus 
as shown in Figure 16 [15]. The first step after passing the [
18
F]F
- 
through an activated 
ion exchange cartridge is to remove the excess H2
18
O water under vacuum with air or a 
gas such as helium or argon [44, 45]. Subsequently the [
18
F]F
-
 is eluted from the 
cartridge with a solution of K2.2.2 and K2CO3 in acetonitrile and collected in a second 
drying vial, the choice of acetonitrile is mainly due to its suitability to form an 
azeotropic mixture with water which facilitates the drying step [46]. Once the elution 
steps are complete, the drying vial is heated at about 90-95 °C with a constant flow of 
nitrogen (or helium or argon) under reduced pressure and stirring to help the 
evaporation of the azeotrope (water/acetonitrile); this drying step usually takes 3-5 min. 
As a small amount of water stays in the vial (about 10 - 20 μL), another portion of 
acetonitrile is added (about 0.5 – 1.0 mL) and the drying continued. After the second 
drying step (another 2 – 3 min) the complex is dried. Some researchers will add a third 
step to ensure complete drying of the complex, which finally leaves the [
18
F
-
] in the vial 
as a slightly yellowish film which is ready for use in the synthetic step. In the case of 
automated synthesis modules, the risk of contamination and the reduction of human 
errors make the drying procedure a convenient approach [47]. 
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Figure 16 Experimental setup to manually dry 
18
F
-
: 1) The 
18
F
-
 in H2
18
O water has to be passed 
through the QMA cartridge (ion-exchange), the 
18
F
-
 stays on the resin and the H2
18
O water passes 
through; 2) a mixture of Kryptofix 2.2.2 (10-15 mg), K2CO3 (10-15 µL of a 1.0 M K2CO3 solution), 
water (40 µL) and acetonitrile (300-900 mL) elutes the 
18
F
- 
from the resin into the drying (reaction) 
vessel. Adapted from [47] 
FDG Synthesis 
[
18
F]FDG is a glucose analogue in which the hydroxyl group on the 2-carbon of a 
glucose molecule is replaced by a fluoride atom. Brown et al. [48] showed that the 
uptake of glucose was related to the expression of glucose transporter-1 (GLUT-1). 
After the transport of FDG across the cell membrane, it is phosphorylated to become 
FDG-6-phosphate. This compound is trapped intracellular and is resistant to further 
metabolic processes that would normally occur to glucose-6-phosphate. It is the 
increased number of glucose transporters located on the tumour cell membrane which 
allows an increased uptake of FDG and the trapping of FDG-6-phosphate in cancerous 
   Chapter 2     bjbk 
38 
 
tissue. This gradual accumulation of FDG in the malignant cells, allows the tumour to 
be visualised [49]. 
 
Figure 17 Schematic synthesis of FDG step by step; Step 1 activation and isolation of fluoride. Step 
2 solvent exchange from water to acetonitrile. Step 3 fluorination with mannose triflate. Step 4 
hydrolysis. Step 5 product purification [50]. 
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The first synthesis of FDG was carried out in Brookhaven National Laboratory by Wolf 
et al. [51] in 1976 by electrophilic fluorination (Figure 18 (a) shows the electrophilic 
mechanism); however, the first FDG trial in humans had a low yield and the synthesis 
time was long (several hours). Several improvements were made subsequently to try to 
incorporate other sugar precursors, but the main limitation was that the only 50 % of 
radioactive fluorine atoms were incorporated during the electrophilic fluorination step. 
Only several years later was there a breakthrough by Hamacher et al. [16] who through 
a nucleophilic substitution, with the use of Kryptofix 2.2.2 as phase transfer catalyst 
(P.T.C.), increased the yield over 50 % and reduced the synthesis times to 50 min. 
 
Figure 18 a) Electrophilic fluorination. b) Nucleophilic substitution. 
In the synthesis, the F
-
 ion is the nucleophile and the precursor is mannose triflate in 
which the 1,3,4 and 6 positions are protected with an acetyl group and triflate is the 
leaving group at the second carbon (Figure 17). Since fluoride has high hydration 
energy, water is not a suitable solvent; hence a polar aprotic solvent like acetonitrile 
must be used to isolate the fluoride from the irradiated water. As previously discussed, 
this is achieved by anion exchange where the trapped fluoride is eluted with a solution 
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of ACN/K2CO3 and K2.2.2 [52]. The presence of the kryptand complexes the K
+
 cations 
preventing the formation of KF and enhancing the reactivity of the fluoride [53]. Once 
the fluoride has been activated and isolated, it is necessary to evaporate any residual 
water from the solution, normally achieved by azeotropic distillation as described in 
Section 1.7. Then the fluorination takes place with the addition of the sugar derivative, 
mannose triflate, with acetyl protecting groups at position 1,3,4 and 6 preventing 
fluorination at these sites. The next step is to remove the acetyl protecting groups via 
either acid or base hydrolysis; whit the latter one being faster and taking place at room 
temperature [54]. The final step involves purification of the toxic compound K2.2.2 
[55], removal of any unreacted fluoride and non-hydrolysed by-products or partially 
acetylated FDG. This is achieved using a series of SPE columns [56], where the by-
products are retained and the FDG released. By this approach, FDG radiochemical 
yields of over 95% can be achieved and FDG is produced routinely in automated 
synthesis modules (ASMs) consisting of disposable cassettes with required chemical 
reagents as discussed in section 1.6 an example which is shown in Figure 19[57]. 
 
Figure 19 GE “FastLab” synthesiser by GE healthcare for synthesis of FDG [28]. 
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1.8 Microfluidics and Micro Total Analysis System (μTAS) 
Microfluidic devices consist of a network of channels etched in a solid substrate, the 
channels typically have dimensions in the range of 10 – 1000 µm. Such lab-on-a-chip 
devices are nowadays emerging as useful technology for the intensification and 
miniaturization of chemical processes. Microfluidic devices have found applications in 
a range of different research areas due to the advantages they offer over many of the 
bench top systems. Table 4 lists some of the key advantages of micro-reactors [58]. 
Table 4 General properties of microreactors and their benefits. 
Property Characteristics and benefits 
Size 
Heat transfer, diffusion and mass transfer, are 
improved. Better control over temperature and 
concentration gradients. 
Volumes 
Volumes in the range of nL-µL,  
reduced reagent consumption,  
increased safety. 
High surface to volume ratio 
More efficient heat transfer, increased rate of 
chemical reactions. 
Short mixing time 
Diffusion based mixing is in the s to min 
range, reaction time also reduced. 
Mode of flow 
Laminar flow where mixing is diffusion based 
can be regulated with hydrodynamic or 
electrokinetic controls.  
Parallel process 
Can be adapted for high throughput or 
combinatorial synthesis. 
 
Several fabrication methods are available. Chips can be fabricated from polymers, 
metals, quartz, silicon or glass depending on the properties required for an application 
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such as the nature of the reaction, material cost and reliability. Glass is often the first 
choice because it is mechanically strong, compatible with a wide range of chemical 
solvents and is optically transparent. Alternatively polymer based devices especially 
PDMS give good flexibility in fabrication and valve control ability but are restricted to 
applications not involving organic solvents that cause swelling or damage [58]. 
With the development of MEMS (micro-electro-mechanical-system) technology and 
microfluidic systems, a number of groups have been working towards miniaturised PET 
radiosynthesis devices [59]. With the aim of offering exciting advantages such as low 
sample and reagent consumption, high reproducibility and automation. Furthermore, 
working with radioactivity requires special equipment such as lead-shielded cabinets 
(hot cells) and computerised systems. A few of the advantages of micro-PET tracer 
synthesis systems over conventional system are i) controlled transfer of small volumes 
of radioactive liquid, ii) increase in surface area which enhances heat and mass transfer 
(hence faster reaction), iii) better product selectivity, iv) reduced volume of reagents and 
v) reduced space requirement and easy shielding [60]. Overall, microfluidic reactors 
seem to be suitable for performing rapid radiolabeling reactions since they are ideally 
suited to handle small amounts of reagents (normally ng to µg), especially important 
when dealing with radiotracers where the supply can be limited. Some examples of 
radiolabeling in microfluidic device have been reported however most of them are only 
a proof of concept and few are discussed below. 
The first example of [
18
F]FDG synthesis in a glass based micro-reactor started with the 
conventional azeotropic method for drying aqueous [
18
F] fluoride ions [61] where the 
dried K
18
F with kryptofix was introduced into one micro-reactor through one of the two 
inlets and the precursor from the other inlet at a rate of 5-100 µL min
-1
. Then the 
product was fed into another micro-reactor where the hydrolysis took place, and the 
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RCY obtained was 24% [61]. In 2006 Gillies et a.l. [46, 62] reported the use of a 
polycarbonate microfluidic reactor for radiolabeling using 
18
F. Exploying two modules 
to achieve the synthesis of FDG, one for the fluorination of the triflate protected 
mannose in DMF, the second to carry out the deprotonation using sodium methanolate 
in methanol, but the result was incomplete deprotection of the mannose triflate 
precursor with a significant proportion of F
-
 unreacted (Figure 20). 
 
Figure 20 Schematic of the two microfluidic devices used by Gillies et al. Chip 1 radiolabelling of 
the mannose triflate, chip 2 base deprotonation [62]. 
A year later, Steel et al. [63] reported a two stage glass device for synthesis of FDG. 
This presented significant advantages over the previous devices in terms of total 
processing time, taking only 18 min compared to the 30-60 min of the previous systems. 
However so far, only a few of the five processing steps required for the synthesis of 
FDG were performed on a microfluidic device, mainly the fluorination and the acetyl 
deprotection. The first micro-reactor capable of performing the five chemical process 
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steps was reported by Lee et al. [64] in 2005 however the device only produced enough 
FDG to conduct micro PET scans on a mouse model (Figure 21). 
 
 
Figure 21 (a) Schematic representation of the microfluidic reactor circuit used for FDG production 
b) view of the device and optical micrograph from Lee et al.[64]. 
This was a PDMS device capable of performing the five steps with an integrated anion 
exchange column for pre-concentration of fluoride. The main limitation of the device 
was the PDMS elastomer and the poor resistance to chemicals and solvents. Recently, in 
2010, the same group optimised a 5 µL coin-shaped reactor to produce sufficient 
quantity of FDG to be validated by in vivo imaging; however, the complexity of the 
system which consist of pressure valves and vacuum assisted mechanisms makes it still 
a batch process that is not yet ready to produce multiple human doses [65]. Since then 
not much has been achieved in terms of complete microfluidic synthesis due to the 
complex nature of the chemistry involved however several groups have attempted a 
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different approach for the separation of [
18
F
-
]fluoride from water using EOF [66] and 
electrochemical separation [67, 68]. 
So far, all the process have not been united in one system capable of fulfilling the 
important requirements of a system that i) is fast and high yielding production of a 
broad range of biomarkers, ii) reducing reagent consumption, iii) is autonomous and 
self-shielding, iv) is located at the clinic, v) is reliable and capable of performing many 
cycles without involvement of technical help. The application of micro-reactors in 
radiochemistry is therefore still in its infancy with limited number of examples, most of 
them proof of principle studies or investigations [69] not yet ready to be transferred to a 
large scale production. Only two products using microfluidic flow reactors in some 
stages of radiosynthesis which have recently became available. Advion offers a system 
flow based system called “Nanotek LF”. ScintOmics sells components for 
radiosynthesis system. These are described in Section 1.7.3-1.7.4 [59]. Nevertheless 
these so called ‘microscale’ systems still suffer from main limitations such as size, 
where apart from the micro-reactor (e.g the fused silica used in the Advion system) the 
rest of the components (pump, detector, heating system) still require a significant 
amount of space, as well extra engineering complexity (e.g. setting-up and stabilisation 
of the pressure pump) which make them only available to a specific group of experts. 
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Table 5 FDG synthesis in micro reactors and overview of the evolution. 
Entry Implementation of steps  
on chip 
Micro reactor Reference Year 
1 Solvent exchange 
Hydrolysis 
Glass [23] 2003 
2 Fluorination 
Base deprotonation 
Polycarbonate [24] 2005 
3 Fluorination 
Base deprotonation 
Glass [25] 2007 
4 All five steps as batch 
process 
PDMS [15] 2005 
 
1.9 [18F]Fluoride ion activation on-chip 
In order to address the challenges associated with performing the five steps, the first 
part of the thesis describes an investigation into the activation/isolation of 
[
18/19
F]fluoride. Since the nucleophilic substitution was reported by Amacher et al.[16] 
two main advantages were reported i) the [
18
F]fluorine is obtained as a solution in the 
irradiated water and ii) [
18
F]fluorine is obtained “no-carrier-added” (NCA). This means 
the [
18
F]fluoride ions has very high specific radioactivity, i.e. the ratio of [
18
F] fluoride 
ions to mass of the carrier or total fluoride ion (
19
F + 
18
F). Highly specific radioactivity 
is essential for radiotracers, which are targeted at low density proteins, because low 
specific radioactivity (high carrier) would mean that non-radioactive tracers would 
annul any signal from radiotracer binding. Highly specific radioactivity also enables 
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radiotracers to be injected into human subjects in low mass doses (typically less than 1–
10 nmol) without toxic or pharmacological effects [70]. 
1.9.1 Ion exchange process 
The first step in many fluorine based radiosyntheses is the fluoride pre-concentration (as 
described in section 1.7) achieved via an anion exchange solid-phase extraction (SPE) 
process. In general Ion Exchange (IC) is a separation method based on an ion-exchange 
process occurring between the mobile phase and the ion exchange group bound to a 
solid material. The technique can be used for the separation of both organic and 
inorganic anions and cations, with the separation of anions accomplished either by a 
weak anion exchanger (NH2 group bonded to a solid support) or strong anion exchanger 
(quaternary ammonium groups attached to the support), whereas sulfonate or carboxylic 
acid functionalities are used for the separation of cations. The solid support or resins 
employed in ion exchange chromatography carry the functional group with a fixed 
charge, and the counter ions are located near the functional group rendering the whole 
entity electrically neutral. 
The anions in the mobile phase are exchanged for the counter anions in the stationary 
phase according to the reversible equilibrium process given by the Equation 3: 
XBNRCBXNRC 33   Equation 3 
The separation of the ions is determined by their different affinities toward the 
stationary phase; the constant determining the equilibrium process is the selectivity 
coefficient K and is defined as follows: 
ms
ms
XB
BX
K     Equation 4 
Where [X
-
]m,s is the concentration of the sample ion in the mobile (m) or the stationary 
phase (s) 
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[B
-
]s,m is the anion concentration in the mobile phase (m) or the stationary phase (s). 
Selectivity provides a means for determining the relative affinities of ion-exchangers for 
different ions [71]. 
Some general rules can be offered to assist in the prediction of the affinity order [72] 
based on a number of properties: 
I. The charge on the solute ion, 
II. The solvated size of the solute ion, 
III. The polarisability of the solute ion, 
IV. The ion exchange capacity of the ion-exchanger, 
V. The functional group on the ion exchanger, 
 
Figure 22 Example of a bound quaternary ammonium functional group with chloride as counter 
ion. 
The first step of the synthesis of FDG and many 
18
F based radiotracers is the pre-
concentration (activation or isolation) of fluoride, and this is achieved by an anion 
exchange process by means of a solid phase extraction technique (SPE). There are four 
main phases in SPE as shown in Table 6: 
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Table 6 Different retention behavior between compounds for solid phase technique. 
Name of 
Phase  
Type of phase  Type of interaction Application 
Reversed 
phase  
Polar liquid phase,  
non-polar modified 
solid phase 
Non-polar interactions 
Van der Waals forces. 
Process 
purification of 
active 
biomolecules, 
separation 
Normal phase 
 
Non-Polar liquid 
phase, polar modified 
solid phase 
Polar-polar interactions 
Hydrogen bonding 
Π- Π interactions 
Dipole-dipole interactions. 
Separation of 
small organic 
compounds with 
similar 
structures 
Ion exchange  Anionic and cationic 
phase 
Electrostatic attraction of 
charged group on the 
sorbent’s surface. 
Separation of 
charged 
compounds 
Adsorption  Interaction of 
compounds with 
unmodified materials 
Hydrophobic and 
hydrophilic interactions 
may applied depend on 
solid phase. 
Separation of a 
wide variety of 
organic vapours 
and several 
types of 
inorganic gases. 
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1.9.2 Anion Exchange process 
Ion exchange SPE can be used for compounds that are charged when in solution; the 
primary retention mechanism is mainly based on the electrostatic attraction of the 
charged functional group on the compound to the charged group that is bonded to the 
surface. For the purpose described herein anion exchange will be investigated. The 
material is comprised of an aliphatic quaternary amine group as illustrated in Figure 22. 
The pKa of such a quaternary amine is high (greater than 14) which renders the 
functional group charged at all pHs when in an aqueous solution making it ideal for the 
separation of [
18
F]fluoride from [
18
O]water. Several types of anion exchange support 
exist: 
 Polymer based on PS-DVB (polystyrene crosslinked with divinyl benzene) 
 Silica based 
 Membrane based 
 Monolith based 
Release is achieved using a stronger eluent like high ionic strength salt like potassium 
carbonate (CO3
2-
) in the presence of phase transfer catalyst and acetonitrile. Other 
methods to isolate fluoride ions have been used recently, for example electrochemical 
procedures where an electrochemical cell was designed to allow anodic deposition of 
N.C.A. fluoride and recovery of deposited fluoride achieved in the presence of an 
aprotic solvent containing a phase transfer catalyst.[43] The use of the particles has been 
more a common choice due to surface area and volume ratios. There are three 
possibilities for the implementation of SPE in microfluidic device namely; i) to fill a 
channel with particles that serve as the extraction material, ii) to coat the channel wall 
with the functionality to act as the extraction material, iii) to fill a channel with a 
polymeric rod (monolithic phase) [73](Table 7). 
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The first example of wall coating was reported in 2000 by Kutter et al. [74] where the 
wall of a glass device was coated with C18 for enrichment of coumarin C460 but the 
method suffered from capacity problem due to the limited surface area. The 
implementation of beads in microfluidic was firstly introduced in 1995 by Ocvirk et al. 
[75]. This was a novel concept for liquid chromatography where a packed column was 
integrated in a silicon chip; a disadvantage of this early work was that the packing 
material could not be easily exchanged. Five years later, in 2000, Harrison et al. [76] 
reported the combination of solid phase extraction (SPE) and capillary 
electrochromatography (CEC) which allowed facile exchange of packing material. 
Several improvements were made later with Ekstrom et al. [77] utilising a weir based 
silicon microextraction chip packed with reversed phase beads for the purification and 
enrichment of peptide mixtures. Subsequently Bergkvist et al. [78] improved the design 
and replaced the weir with a grid structure to contain the beads. In addition to beads, 
monolithic porous polymers prepared by photoinitiaton within the channel were 
reported by Yu et al. [79] in 2001, where an increase in concentration by a factor as 
high as 10
3
 was achieved. Solid phase extraction on the chip was also later applied for 
DNA purification and extraction in 2007 by Wen et al. [80]. Even though the chip-
based SPE method improved the sample treatment in terms of minimising sample loss 
and contamination problems, as well as reducing analysis time, the real benefit is in the 
development of an integrated system capable of miniaturising sample treatment, 
transportation, reaction, separation and detection provide the key to the success of 
microfluidic systems in chemical analysis and medical diagnosis. 
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Table 7 Different approaches for SPE technique and their evolution in the last decade. 
Year References Type of SPE Applications  Problems 
1995 Ocvirk et al. 
[76] 
Filled channel 
with particles 
Liquid chromatography Particles difficult to 
exchange 
2000 Kutter et al. 
[75] 
Coated channel 
wall with C18 
Enrichment of Coumarin 
C460 
Capacity problem due 
to limited surface area 
2001 Yu et al. [80] Photoinitiated 
monolith 
Digestion of protein  Reproducibility 
2002 Ekstrom et al. 
[78] 
Weir based 
particle retention  
Enrichment and 
purification of peptide 
mixtures 
Not a complete 
integration of two steps 
2003 Bergkvist et.al. 
[79] 
Grid structure to 
contain the 
beads 
Enrichment and 
purification 
Not good extraction 
efficiency 
2007 Wen et al. [48] Sol-gel method DNA extraction Extraction efficiency 
not uniform 
1.10 Product purification and analysis 
As FDG is by far the most used radiopharmaceutical for clinical PET investigation, 
particular attention will be given to the purification of FDG, taking into consideration 
that the preparation of many other 
18
F radiotracers is based on the same step by step 
approach. The potentially toxic chemical impurities resulting from the fluorination step 
and the hydrolysis step include: [
19
F]FDG and FDM, K2.2.2, acetonitrile, together with 
radiochemical impurities of [
18
F]FDM, [
18
F] unreacted and partially or fully acetylated 
FDG. With this in mind, there are several quality controls and demands for FDG 
described in the European Pharmacopoeia which requires analysis for FDG and FDM 
by HPLC, K2.2.2 by colour spot test, 
18
F by TLC and residual solvent by GC [81]. 
Based on these stringent guidelines, purification of FDG is performed on a series of 
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solid phase extraction cartridges including an anion exchanger cartridge for 
neutralisation of the acidic hydrolysis, alumina for removal of unreacted fluoride and a 
series of C18 cartridges for removal of starting materials or acetylated by products. An 
example of such a multifunctional cartridge is shown in Figure 23 [82]. The most 
widely used method for [
18
F]FDG synthesis utilises the aminopolyether (K2.2.2 
Kryptofix) as a phase transfer reagent to facilitate the nucleophilic [
18
F]fluoride 
displacement of the triflate leaving group. Because of the toxicity of Kryptofix [IV rat 
LD50 = 35 mg / kg][83, 84] different method were developed to minimize the carryover 
of this reagent into the final product [85-87]; nevertheless verification for absence of 
K2.2.2 is still a mandatory requirement for quality control. 
Thin-Layer Chromatography (TLC) is the most widely used quality control method for 
K2.2.2 in FDG injection. The method consists of spotting 2 µL samples of [
18
F]FDG 
and K2.2.2 standard solutions on a silica gel plate and developing in methanol:NH4OH 
(9:1). Following hot-air drying, the plates are exposed to iodine vapours for an 
additional 15 to 20 min for visualization [88]. Using an acidic iodoplatinate spray 
reagent Alexoff et al. [85] were able to increase the sensitivity of this method from 25 
µg mL
-1
 to 2.5 µg mL
-1
 by spotting 5 µL samples [1 volume concentration hydrochloric 
acid to 4 volume colour reagent]; however, this method still requires the use of 
calibrated micropipettes and approximately 15-20 min to develop. A more rapid and 
sensitive method was developed by Mock et al. [55] where a colour spot test was able to 
confirm the presence of K2.2.2 in less than 5 min and utilised pre-treated strips of 
plastic-backed silica saturated with iodoplatinate reagent. Over spotting with the final 
product [
18
F]FDG and Kryptofix standard solution, a blue-black circular spot is visible 
at K2.2.2 concentrations as low as 2 µg mL
-1
; however as iodoplatinate is not specific 
for K2.2.2, it reacts with tertiary amines in general [89]. There is the possibility of a 
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false positive. If a negative colour reaction is observed however, this proves that 
Kryptofix is absent. Aside from techniques such as TLC a number of other analytical 
methods have been developed for detection of Kryptofix namely Gas Chromatography 
(GC) with a nitrogen-selective detector [90], HPLC with a conductivity detector [91] 
and Liquid Chromatography-tandem mass spectrometry (LC/MS/MS) which benefits 
from selective reaction monitoring [92]. Whilst the limit of detection for GC and HPLC 
are in the low µg mL
-1
 range, LC-MS/MS can be used to quantitatively detect ppb levels 
of K2.2.2 in radiopharmaceutical formulations. 
 
Figure 23 Example of a solid phase extraction cartridge used for FDG purification from ABX, 
Germany. 
1.11 FECH synthesis and purification 
Another important radiotracer that is briefly discussed in Chapter 6 is 2-[
18
F]Fluoroethyl 
choline ([
18
F]FECH), a tracer used in oncology to image prostate cancer [93]. It 
represents one of the few examples of ionic radiotracers used in PET. Two synthetic 
approaches are currently employed and are as shown in Figure 24. In both methods 
18
F-
labelling can be carried out by 
18
F-fluoroalkylation via small prosthetic groups. The 
most important 
18
F-fluoroalkylating agent is 2-[
18
F]fluoroethyl tosylate ([
18
F]FETos), 
first introduced by Block et al. [94] [
18
F]FETos can be synthesised easily in a 
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reproducible manner and purified using HPLC. In comparison 1-bromo-2-
[
18
F]fluoroethane ([
18
F]BFE), synthesised by Chi et al. [95] is less commonly used 
because the synthetic route includes a final distillation step which makes the integration 
into an automated system difficult. The most common route is a two step approach 
which consists of the synthesis of the tosylated compound (EtDt) with subsequent 
addition of a large excess of N,N-dimethylaminoethanol (DMAE) to yield the desired 
final compound [
18
F]FECH. In 2010 a one step approach was reported by Asti et al. 
[96] where the EtDt was reacted at the same time with DMAE in presence of 
18
F
-
/TBAHCO3/ACN (after elution from the cartridge). 
Purification of the final compound can be achieved using two routes. The first, reported 
by Hara et al. [97] utilised a semi-preparative HPLC, in the second approach by Asti et 
al. [96], the vial containing FECH was first washed with water, and the solution filtered 
through two C18 (reversed phase) cartridges connected with two anion exchange 
cartridges; finally the purified FECH was passed through a cation exchange cartridge 
and eluted with a solution of 0.9 % NaCl. Radiochemical purity (RCP) was assessed by 
TLC and chemical purity using an HPLC system equipped with a cation column and 
three different detectors (conductimetric, radiometric and UV detection at 206 nm). A 
GC with an FID detector was used to determine the concentration of volatile products 
such as ACN, EtOH. In both methods RCP of 99% was obtained. 
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Figure 24 a) Two steps approaches for 2-[
18
F]fluoroethyl choline (FECH) synthesis. b) One step 
approach for the synthesis of FECH. Adapted from [98]. 
1.12 Magnetism and magnetic particles 
In this thesis two of the chapters are dedicated to the investigation of fluoride pre-
concentration using magnetic particles. Such particles offer all of the advantages of 
polymeric particles some of which were described in Section 1.9 (i.e. high surface-to-
volume ratio, variety of surface functional groups, range of sizes etc.), but with the 
added benefit of being easy to manipulate by the application of external magnets. 
Before describing these particles in more detail, it is worth discussing some of the 
relevant magnetic theory.  
When an external magnetic field (B) is placed in proximity of a magnetic dipole 
moment (md), the dipole moment experiences a force (torque), τ, (in N m, or J), as the B 
field tries to align the dipole such that the moment (md) aligns parallel with the flux 
density (Equation 5). 
     xBmd     Equation 5 
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The extent to which a medium responds to the magnetic field (H) depends on the 
permeability of the material, µ, (in Henry per metre, H m
-1
, corresponding to N A
-2
). 
The relationship between the H, B and µ terms is given by Equation 6 [98] 
     HB       Equation 6 
The field of magnetic flux density (B) consists of lines of magnetic flux, Φm (in Weber, 
Wb), within a unit area; hence a B field of 1 Tesla = 1 Wb m
-2
. A greater number of 
lines per unit area give a greater value of B, indicating a stronger magnetic field. The 
value of B decreases rapidly with increasing distance from the surface of a magnet as 
the flux density lines move further apart, as shown in Figure 25 for a typical rectangular 
(bar) magnet. 
 
Figure 25 Characteristics of a typical rectangular magnet, illustrating a) the magnetic flux density, 
B, in and around the magnet, and b) the decrease in B with increasing distance from the magnet 
surface in the x-direction. Adapted from [99]. 
Additionally, when two permanent magnets are placed in proximity, different results are 
observed depending on their relative orientation. Figure 26a shows two magnets placed 
with their opposite poles facing, where the black lines represent the magnetic flux 
density, the colour shown indicates the relative magnitude of B field (where purple 
shows the highest value of B and blue the lowest). In the case shown in Figure 26 (a) 
the lines of magnetic flux density pass from the north pole of one magnet to the south 
pole of the other creating loop from one magnet to another. The flux lines between the 
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magnets are concentrated into a small space, and the result is an attractive force between 
them as shown in Figure 26 (a) [100]. In the case shown in Figure 26 (b) the field lines 
cannot cross, and they instead “push” against each other, generating a repulsive force 
between the magnets 
 
Figure 26 Magnetic flux lines and their density (B field) between two permanent magnets. a) When 
the opposite poles of two magnets are facing, the B field flows from the north pole of one magnet to 
the south pole of the other, and there is a resultant attractive force between the magnets. b) When 
the like poles of two magnets are facing, the field lines cannot cross, and they instead “push” 
against each other, generating a repulsive force between the magnets. Additionally, an area of low 
field is created between the facing poles. Adapted from [99]. 
Superparamagnetism 
The main characteristic is that this materials exist as small, single domain nanoparticles 
[101, 102]. This means that all of the magnetic moments of the atoms in a particle align 
without the application of a magnetic field, forming a magnetic domain. However, due 
to the small size of the nanoparticles they are affected by thermal energy (kBT), with the 
thermal motion continuously causing the moment of the particle to randomly flip. 
Hence, without an applied magnetic field the dipole moment becomes zero. 
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Figure 27 Magnetisation (M-H) curve for a superparamagnetic nanoparticle. As the applied field 
increases, so too does the particle magnetisation, until it is saturated. material, there is no magnetic 
remanence, meaning that upon removal of the field the particle essentially becomes non-magnetic. 
When a magnetic field is applied, the moments of the particles align with the direction 
of the field, producing a magnetisation. However, when the field is removed, thermal 
energy is again able to affect the moments of the particles, returning them to their 
original state whereby they exhibit no magnetic moment. As a result, the particles lose 
their magnetisation and disperse back into the media they are present in. Hence, the 
particles act like paramagnets, except with very large magnetic susceptibilities and 
magnetic moments, and thus they are known as superparamagnetic particles. Figure 27 
shows a typical M-H curve of a superparamagnetic nanoparticle, reaching saturation as 
seen in ferromagnetic materials but without the hysteresis, hence having no magnetic 
remanence (i.e. no magnetic “memory”). 
 
1.12.1 Superparamagnetic particles 
Superparamagnetic particles can be fabricated or purchased in a range of sizes and with 
differing magnetic properties. The synthesis of superparamagnetic nanoparticles has 
been reviewed previously by Lu [103], Osaka [104], and Gijs [102, 105]. After the 
fabrication or synthesis of the magnetic particles, they can be coated with a layer of 
   Chapter 2     bjbk 
60 
 
material (such as a polymer, surfactant, silica, carbon, precious metal etc.) to 
prevent/reduce their agglomeration due to van der Waal’s, magnetic and electrostatic 
forces. As well as these protective coatings, the surface can also be functionalised with a 
range of chemical or biological species (as with the microparticles in Section 1.2), 
including antibodies, antigens, DNA and chemical functional groups. Regarding their 
use in biomedicine, Osaka et al. [104] For their application to bioassays, and Palacek 
and Fojta [106] for their use in electrochemical DNA and protein biosensing. 
Additionally, reviews by Saiyed et al. and Safarik et al. [107] detail the use of magnetic 
particles (both nanoparticles and microparticles) in drug delivery and biomedicine, and 
for the isolation and purification of proteins and peptides. A review by Wu et al. [108] 
also summarises the most recent applications of magnetic nanoparticles in biomedicine, 
while a review by Krishnan [109] details their use in imaging, diagnostics, and therapy. 
Some of these applications include hyperthermia, drug targeting, MRI (magnetic 
resonance imaging) contrast enhancement and cell/particle separations [101, 110]. 
Two important uses of magnetic particles (both nanometre and micrometre sized) are 
their application to bioassays and particle/cell separations. Monodisperse magnetic 
microparticles can be purchased commercially from a number of sources and the brand 
names include Dynabeads (Invitrogen, Paisley, UK), Micromer particles (Micromod 
Partikeltechnologie GmbH, Rostock, Germany), Compel (Bangs Laboratorie, Inc., 
Indiana, USA), MACS MicroBeads (Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany), Adembeads (Ademtech, Pessac, France), SiMAG (Chemicell, Berlin, 
Germany), as well as Seradyn and MagnaBind particles (Thermo Fisher Scientific Inc., 
Illinois, USA).  
Superparamagnetic microparticles (hereafter referred to simply as magnetic particles) 
are typically the same as polystyrene or silica microparticles, as described in Section 
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1.2, except that, crucially, they contain either a core of iron oxide (Figure 28a) or 
dispersion of iron oxide nanoparticles throughout the particle (Figure 28b). As well as 
polystyrene, various other polymer matrices can be used to fabricate the particles, and, 
in the case of SiMAG, a silicon matrix is also applied. The iron oxide core/nanoparticles 
are typically in the form of ferrimagnetic magnetite (Fe3O4) and maghemite (-Fe2O3), 
though sometimes other ferrites such as cobalt ferrite and manganese ferrite can be 
used. 
 
Figure 28 Cross-section of two types of superparamagnetic microparticle: a) an iron oxide core is 
encased in a polymer matrix, and b) iron oxide nanoparticles are dispersed throughout the polymer 
matrix, before being sealed inside with an extra layer of polymeric material. 
Due to the size of the iron oxide nanoparticles, the microparticle as a whole displays 
superparamagnetic behaviour. Is due to its properties that superparamagnetic particles 
are becoming popular as mobile solid supports that can be easily manipulated with 
magnetic fields. The wide variety of possible surface functionalities, as with 
conventional polystyrene microparticles allows for their use in any number of reaction 
and/or separation procedures. 
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Figure 29 A typical reaction or separation using magnetic particles, where (1) the particles are 
introduced into the sample or reagent solution, (2) they bind to the target analyte/reagent, (3) the 
particles are collected using an external magnet, (4) the supernatant is removed and (5) the 
particles are resuspended in fresh buffer solution. Steps 3-5 are repeated several times to ensure 
any unbound material is removed from the particle surfaces. Adapted from [99] 
A typical magnetic particle based bioassay or separation takes place in an Eppendorf 
tube or similar vessel, as shown in Figure 29. The tube contains the reagent or sample of 
interest into which the magnetic particles, featuring surface groups for binding specific 
targets, are introduced. The suspension is incubated with agitation, allowing the 
particles to bind to the target molecules, after which they are drawn to the side of the 
tube by application of an external magnetic field. The supernatant can then be removed, 
and fresh solution added. This washing step is repeated several times to ensure any 
unbound material are removed from the surface of the particles. Thus, the particles have 
successfully either removed the analyte of interest from the sample mixture, or been 
used to perform a bioassay or chemical reaction on their surface followed by their 
separation from the reagent solution.  
This type of magnetic particles have gained particular attention in the field of 
microfluidics.some of their applications will now be presented. 
The applications of magnetic particles in microfluidic devices have been reviewed in 
more detail by Pamme [111-113] and Gijs et al. [102] within a review of on-chip 
particle trapping methods by Nilsson et al. [114], and in reviews of on-chip continuous 
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flow particle separations by Pamme [115], Lenshof et al. [116], Gossett et al. [117], 
Kersaudy-Kerhoas et al. [118] and Tsutsui et al.[119]. 
 
1.12.2 On-chip magnetic trap and release procedures 
Microfluidic methods of performing magnetic particle-based processes often employ a 
‘trap and release’ technique (Figure 30). Here, functionalised particles are pumped 
through a micro-channel and trapped in a magnetic field, before having wash solutions 
or reagents flushed over them. A common use of the trap and release method is for the 
on-chip separation of magnetic particles that have been suitably functionalised to bind 
to a particular target analyte, from the original sample matrix. The particles are trapped 
and washed with buffer solution, which removes the unwanted non-magnetic material 
from the system and they are then released for collection or downstream analysis. Such 
processes have been achieved using permanent magnets [109, 120, 121] integrated 
micro-electromagnets [122, 123] external electromagnets [124, 125] and integrated 
metallic or microcircuit structures that are subsequently magnetised by an external 
applied field [126-128]. These set-ups have typically only been used to separate 
magnetic particles from their carrier fluid, but it has also been shown that different 
magnetic particle populations can be separated and trapped when combined with 
dielectrophoresis [121], along with the successful separation and detection of 
magnetically labelled dengue virus has been reported [120]. 
   Chapter 2     bjbk 
64 
 
 
Figure 30 Trap and release method of magnetic particle handling in microchannels. a) Magnetic 
particles are loaded into the channel and trapped in a magnetic field, b) a sample or reagent is 
flushed over the trapped particles, allowing reactions to occur on the particles surface, before being 
washed with buffer solution, c) the field is removed and the particles released for downstream 
detection or further processing. Adapted from [99]. 
Here, functionalised particles are trapped in the micro-channel by a magnetic field, and 
a reagent solution is flushed over them, allowing the reagent to bind to the particle 
surfaces. The reagent is replaced with buffer solution in order to wash the particles, 
which are then released from the magnetic field for downstream detection, or other 
reactions and assays i.e. streptavidin-biotin and protein [129, 130], purification and 
enrichment of dengue virus samples for RNA amplification and detection [131], mRNA 
isolation [132], DNA hybridization [133, 134], separation [135] and protein digestion 
[136, 137]. The above examples show a selection of microfluidic ‘trap and release’ 
methods however, the ‘trap and release’ is a batch method, and as such suffers from 
the same inefficiencies as off-chip methodologies in that they can be laborious and 
time-consuming due to the number of reaction and washing steps that must be 
performed. One method of reducing these inefficiencies is to perform the separations, 
reactions and assays in continuous flow. This offers the advantages of combining all of 
the reaction and washing steps into one single process, thereby decreasing the amount 
of time and labour required and user intervention required, rendering the procedure 
relatively automated once developed. 
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1.12.3 On-chip magnetic particles separation in continuous flow 
As previously mentioned continuous flow separations offer the potential to eliminate 
some of the inefficiencies associated with batch microfluidic methods, allowing 
continuous introduction and separation of the sample, as will be discussed in Section 
4.2; magnets produce magnetic field gradients with respect to the distance from their 
surface. When in proximity to a micro-channel (~ few mm), these gradients are 
sufficient to exercise a pN force on a particle. An immediately obvious advantage of a 
magnetic force over other forces is its simplicity. Sorting of magnetic material is readily 
achievable with a very basic fluidic and magnetic set-up. For example, Kim and Park 
[138] presented a device with two inlets, a single channel and two outlets. Using a 
simple permanent magnet placed adjacent to the channel they were able to isolate 
fluorescent particles agglomerated with magnetic nanoparticles via an immunoassay 
procedure from a sample stream. The magnetic field gradient across the channel could 
be varied by simply moving the magnet closer or further from the channel edge[139-
141]. 
 
Figure 31 A common microfluidic method for continuous magnetic particle separation, known as a 
H-filter. A particle mixture is introduced into a wide channel alongside a buffer stream, and a 
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magnet used to deflect the magnetic particles into the buffer stream while the non-magnetic 
particles remain unaffected. The two particle populations are thus separated via two outlets. 
Adapted from [138]. 
In order to fractionate out material according to magnetic properties, a chamber with 
multiple outlets is required. The development of free-flow magnetophoresis using a 
small permanent magnet was first developed by Pamme et al. [142] in which a 
separation chamber was fabricated in glass with multiple exits. Magnetic particles were 
introduced and deflected from flow by the application of a magnetic field on the 
opposite side of the chamber, perpendicular to flow, as shown in Figure 32. 
 
 
Figure 32 (a) Principle of on-chip free-flow magnetophoresis. A mixture of particles is introduced 
into a microfluidic chamber and deflected laterally by a magnetic field, allowing different particle 
types to exit the chip by different outlets [142]. (b) Experimental particle trajectories of 4.5 µm and 
2.0 µm magnetic particles, as well as non-magnetic particles, demonstrating their separation as they 
traverse the chamber. Adapted from [113]. 
The on-chip free-flow magnetophoresis microfluidic device featured a wide chamber 
into which a mixture of particles was introduced into the bottom corner (Figure 32). A 
series of inlets allow the introduction of a buffer stream parallel to the sample stream, 
with the two streams flowing side-by-side due to laminar flow, and a series of outlets 
provide a number of potential exit points for the particles; as well as allowing the 
removal of sample and buffer waste. An inhomogeneous magnetic field was generated 
across the chamber, perpendicular to the direction of laminar flow, via an external 
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permanent magnet. When a mixture of magnetic particles of different sizes and 
magnetic susceptibilities was introduced into the chamber, they were deflected from the 
direction of flow by the magnetic field, traversing the chamber diagonally until they 
exited via one of the outlets. However, the different particle types deflected towards the 
magnet to different extents, such that the two particle populations exited through 
different outlets, thus achieving a continuous, simultaneous separation of two types of 
magnetic particles. Later, Pamme and Wilhelm [111] also used the technique to separate 
magnetically labelled cells. Thus, the technique of on-chip free-flow magnetophoresis 
has been demonstrated for the simultaneous separation of different magnetic particle 
types, and for the deflection and separation of magnetically labelled cells. 
1.13 Aims of the project 
The aim of this project was to develop an integrated modular microfluidic platform for 
the pre-concentration of [
18
F]fluoride and purification of 
18
F fluorine based 
radiopharmaceuticals employed in Positron Emission Tomography (PET). Micro Total 
Analysis Systems (µTAS) have been applied to the synthetic pathways typical for 
radiotracers in order to improve the traditional approach in terms of efficiency and 
safety. The work of this thesis was part of a European Union Radiochemistry on Chip 
project (CP-FP 213803-2 ROC as part of the FP7 Theme 4-NMP/Nanosciences, 
Nanotechnologies, Material and new Production Technologies) which consisted of a 
collaboration of industrial and academic partners as shown in Figure 33. The objective 
of this work package (WP4) was to implement microfluidic modules for 
18
F pre-
concentration (the starting material for radiosynthesis) and the final product 
purification.  
The work performed throughout the PhD is split into different sections in this thesis. 
Firstly, the materials and methods used will be detailed in the Experimental Chapter. 
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This will be followed by several Results Chapters, which are divided into two main 
sections describing those experiments performed for the fluoride pre-concentration 
using magnetic and non-magnetic particles followed by the experiments on the 
investigation of the product purification. A Conclusions Chapter summarises the work 
performed along with recommendations for future of the work. References will then be 
listed, followed by an Appendix containing publications related to the work described 
here. 
 
Figure 33 Image showing the different work packages (WP) involved in the FP7 EU project, with 
their deliverable and task. 
2 Experimental 
This Chapter describes the experimental set-up and procedures utilised for work in this 
thesis, detailing (Section 2.1) the chemicals, particles and instrumentation employed, 
the design of the microfluidic chips, the chip set-up and the particle visualisation (2.2, 
2.3, 2.4), the off-chip fluoride pre-concentration experiments (2.5), on-chip fluoride pre-
concentration via dam-structure experiments (2.6), on-chip fluoride pre-concentration 
via plug of magnetic particles experiments (2.7), on-chip fluoride pre-concentration via 
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free flow magnetophoresis (2.8), Kryptofix 2.2.2 detection and removal (2.10), FECH 
detection and purification (2.11). 
2.1 Chemicals, particles and instrumentation 
Solvents and reagents were purchased from the distributors shown in Table 7. All 
chemicals were of analytical grade. Aqueous solutions were prepared in water with a 
resistivity of 18.2 MΩ cm at 25 °C, obtained from an ELGA Option 4 that fed into an 
ELGA UHG PS water purification system (both devices from ELGA Process Water, 
Marlow Buckinghamshire, UK), unless otherwise stated. Prepared solutions were 
filtered through 0.20 µm syringe filters (Whatman, VWR, Lutterworth, Leicestershire, 
UK) prior to introduction into microfluidic devices. 
Table 7 Chemicals, solvents and reagents used in the experiments described herein. 
Chemical Supplier 
Solvents 
Acetone 
 
 
Fisher Scientific, Leicestershire, UK 
Acetonitrile Fisher Scientific, Leicestershire, UK 
Chloroform Fisher Scientific, Leicestershire, UK 
Cycloexane Fisher Scientific, Leicestershire, UK 
Ethanol Fisher Scientific, Leicestershire, UK 
Hexadecane 
 
Fisher Scientific, Leicestershire, UK 
Methanol Fisher Scientific, Leicestershire, UK 
Propan-2-ol Fisher Scientific, Leicestershire, UK 
Toluene Fisher Scientific, Leicestershire, UK 
2,2,4-Trimethyl pentane (isooctane) Fisher Scientific, Leicestershire, UK 
Acids and Bases and buffers 
Hydrochloric acid (36%) 
Hydrochloric acid (36 
%) 
 
Fisher Scientific, Leicestershire, UK 
Methanesulfonic acid (MSA) Sigma-Aldrich, Dorset, UK 
Potassium carbonate Sigma-Aldrich, Dorset, UK 
Phosphate buffered saline tablets (PBS) Sigma-Aldrich, Dorset, UK 
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Potassium bicarbonate Sigma-Aldrich, Dorset, UK 
Potassium fluoride Sigma-Aldrich, Dorset, UK 
Potassium hydroxide Sigma-Aldrich, Dorset, UK 
Sulphuric acid (98%) Fisher Scientific, Leicestershire, UK 
Sodium fluoride Sigma-Aldrich, Dorset, UK 
Sodium hydroxide Sigma-Aldrich, Dorset, UK 
Sodium chloride Sigma-Aldrich, Dorset, UK 
Surface treatments and silanising agents 
Agarose (low melting point) Sigma-Aldrich, Dorset, UK 
(3-Aminopropyl)triethoxysilane 
(APTES) 
Sigma-Aldrich, Dorset, UK 
Dimethyloctadecyl[3-(trimethoxysilyl)-
propyl]ammonium chloride (42 % wt. in 
MeOH) (QAS) 
Sigma-Aldrich, Dorset, UK 
 
 
Octadecyltrichlorosilane (OTS) Sigma-Aldrich, Dorset, UK 
Trichloro(1H,1H, 2H,2H-
perfluorooctyl)silane (FDTS) 
Sigma-Aldrich, Dorset, UK 
Surfactants and additives 
Tween 20 (polysorbate 20) Sigma-Aldrich, Dorset, UK 
Sodium dodecyl sulphate (SDS) Sigma-Aldrich, Dorset, UK 
Fluoride pre-concentration 
Kryptofix 2.2.2 (K2.2.2) 
(4,7,13,16,21,24-hexaoxa-1,10-
diazabicyclo-[8.8.8]-hexacosane) 
Sigma-Aldrich, Dorset, UK 
12-Crown-4 (1,4,7,10- 
Tetraoxacyclododecane) 
Sigma-Aldrich, Dorset, UK 
Tetrabutyl ammonium bicarbonate 
(TBAHCO3) 
ABX, Radeberg, Germany 
FDG synthesis 
Mannose triflate, 1,3,4,6-tetra-O-acetyl-
2-O-trifluoro-methanesulfonyl-beta-D-
mannopyranose 
ABX, Radeberg, Germany 
2-Deoxy-2-fluoro-D-glucose (FDG) ABX, Radeberg, Germany 
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2-fluoro-2-deoxy-glucose tetraacetate 
(ACY- FDG) 
ABX, Radeberg, Germany 
2-Fluoro-2-deoxy-D-mannopyranose 
(FDM) 
ABX, Radeberg, Germany 
FECH synthesis 
1,2-Bis(tosyloxy)ethane (Ethylene 
glycol ditosylate) 
ABX, Radeberg, Germany 
N-(2-Fluoroethyl)-2-hydroxy-N,N-
dimethyl-chloride (FECH chloride) 
ABX, Radeberg, Germany 
2-(Dimethylamino)ethanol (DMAE)  Sigma-Aldrich, Dorset, UK 
 
2.1.1 SPE with non magnetic particles 
Several commercially available solid phase extraction (SPE) chromatography cartridges 
were investigated. The particle content was extracted from the cartridges; the specific 
details are reported in the Tables 8-11: 
The most popular method for the purification of proteins and other charged molecules is 
ion exchange chromatography as described in Section 1.10.1. In cation exchange 
chromatography, positively charged molecules are attracted to a negatively charged 
solid support. Conversely, in anion exchange chromatography, negatively charged 
molecules are attracted to a positively charged solid support. 
Anion exchange particles: 
For a comparative study, the following commercial anion exchange cartridges and 
resins, commonly used in the pre-concentration of fluoride during the FDG preparation, 
were obtained; QMA Sepak light particles, (Waters, Massachusetts, USA), Chromabond 
PS-HCO3 (Macherey-Nagel, Duren, Germany), Strata SAX particles (Phenomenex, 
Macclesfield, UK) and Source 15Q (GE Healthcare, Uppsala, Sweden) details of which 
are reported in Table 8. The cartridges were delivered in sealed packages except for the 
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source 15Q delivered as suspension of particles in 20% ethanol and 80% water. Before 
use, each cartridge was washed with purified water to remove any residual contaminants 
that may have been present. 
Table 8 Commercially available SPE cartridges for anion exchange chromatography used in this 
work. 
Cartridge / 
Particles type 
Application 
Particle 
diameter / 
µm  
Functional 
group and 
counterion 
Protein 
Binding 
capacity*  
(mg g
-1
) 
Matrix 
core 
material 
Sep-Pak 
Accell Plus 
QMA 
(Waters UK) 
Strong anion 
exchanger 
60 Quaternary 
ammonium 
(Cl-) 
222 Silica 
Chromabond 
PS-HCO3 
(Macherey–
Nagel) 
Strong basic 
anion 
exchanger 
100 Quaternary 
ammonium 
(HCO3
-
) 
0.90 PS-DVB 
Chromabond 
PS-OH
-
 
(Macherey–
Nagel) 
Strong basic 
anion 
exchanger 
100 Quaternary 
ammonium 
(OH
-
) 
0.53 PS-DVB 
Strata SAX 
(Phenomenex) 
Strong anion 
exchanger 
57 Quaternary 
ammonium 
(Cl
-
) 
30 Silica 
Source 15Q 
(GE 
Healthcare) 
Strong anion 
exchanger 
15 Quaternary 
ammonium 
(Cl
-
) 
40 PS-DVB 
* As reported from the manufacturers MSDS 
Reversed phase particles 
Separation via reversed phase chromatography arises from the adsorption of 
hydrophobic molecules onto a hydrophobic solid support in a polar mobile phase. 
Decreasing the mobile phase polarity, using organic solvents, reduces the hydrophobic 
interaction between the solute and the solid support resulting in desorption. The more 
hydrophobic the molecule the more avidly it will adsorb onto the solid support. This 
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requires a higher concentration of organic solvent to promote desorption. Reversed 
phased cartridges were therefore investigated for removal of K2.2.2 (Table 9). 
Table 9 Reversed phase chromatography cartridges investigated during the removal of K222. 
Particles Type Application 
Particle 
diameter 
/ µm 
Functional 
group 
Binding 
capacity* 
/ mg g
-1
 
Matrix 
core 
material 
Chromabond 
HR-P 
(Macherey–Nagel) 
 
Reverse phase 
chromatography 
85 
Octadecyl 
carbon 
chain 
300 ± 100 
(caffeine) 
PS-DVB 
Strata-X 33u 
Polymeric 
reversed  
phase 
(Phenomenex) 
Reverse phase 
chromatography 
33 
Octadecyl 
carbon 
chain 
Not 
reported 
Polymer 
SEP-PAK C18 
(Waters UK) 
Reverse phase 
chromatography 
55-104 
Octadecyl 
mono 
functional 
silane 
Not 
reported 
Silica 
* As reported from the manufacturers MSDS 
Cation exchange particles 
Table 10 Commercially available SPE cartridges for cation exchange chromatography. 
Particles type Application 
Particles 
diameter 
/ µm 
Functional 
group 
Binding 
capacity* 
/ mg g
-1
 
Matrix 
core 
materia
l 
SEP-Pak Accell 
Plus CM 
(Waters UK) 
Strong cation 
exchanger 
53 Sulfonic acid 201 Silica 
Chromabond 
PS-H 
(Macherey- 
Nagel) 
Strong acid 
cation 
exchanger 
100 Sulfonic acid 0.35 PS-DVB 
* As reported from the manufacturers MSDS 
Normal Phase particles 
Neutral aluminum particles were also used for removal of fluoride during the 
purification step in the FDG synthesis (Table 11). 
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Table 11 Commercially available SPE cartridge for unreacted fluoride removal during purification 
of [
18
F
-
]fluorine based radiocompounds. 
Particle 
name 
Application 
Particle 
diameter 
/ µm 
Functional 
group 
Binding 
capacity*/ 
mg g
-1
 
Matrix 
core 
material 
ALOX-N 
Macherey- 
Nagel 
Normal 
phase 
100 
Aluminum 
oxide 
0.29[143] 
Aluminium 
oxide 
2.1.2 Magnetic particles 
Dynabeads superparamagnetic particles of 1 µm and 2.8 µm diameter were purchased 
from Invitrogen (Paisley, UK) and featured a variety of surface functionalities, as 
detailed in Table 12, and were supplied in a buffer suspension. Others particles were 
purchased from Chemicell (Chemicell, Germany). Table 12 lists the magnetic particles 
used during the work in this thesis with their characteristics and specifications. 
Table 12 List of superparamagnetic particles employed in this work. Details are given of particle 
sizes, surface groups, number of particles, all as stated by the manufacturer. 
Particle Type Application 
Particles 
diameter 
/ µm 
Surface 
group 
 
Particles 
concentratio
n / particles 
g
-1
 
Matrix 
core 
materi
al 
Dynabeads 
SAX 
(Invitrogen) 
Strong anion 
exchanger 
1.0 
Quaternary 
amine 
(Cl
-
) 
1.8 x 10
12
 PS 
Dynabeads 
M-270 Amine  
(Invitrogen) 
Weak anion 
exchanger 
2.8 
Amine  
(-NH2) 
2 x 10
9
 PS 
Dynabeads 
MyOne 
Carboxylic 
Acid 
(Invitrogen) 
Weak anion 
exchanger 
1.05 
Carboxylic 
acid  
(-COOH) 
7 - 12 x 109 PS 
SiMAG –Q 
(Chemicell) 
Strong anion 
exchanger 
1.0 
Quaternary 
ammonium  
(Cl
-
) 
1.8 x 10
12 
 Silica 
SiMAG –Q 
(Chemicell) 
Strong anion 
exchanger 
3.0 
Quaternary 
ammonium  
(Cl
- 
counter 
ion) 
6.8 x 10
10
  Silica 
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Dynabeads 
RPC 18  
(Invitrogen) 
Reversed phase 
chromatography 
1.0 
Octadecyl 
carbon 
chain 
2.3 x 10
10*
 PS 
SiMAG-
DEAE 
(Chemicell) 
Weak anion 
exchanger 
1.0 
Diethylamin
oethyl 
1.8 x 10
12
 Silica 
SiMAG- 
Carboxyl 
(Chemicell) 
Weak cation 
exchanger 
1.0 
Sodium 
carboxylate 
1.8 x 10
12
 Silica 
SiMAG- 
Phosphonate 
(Chemicell) 
Weak cation 
exchanger 
1.0 
Sodium 
phosphonate 
1.8 x 10
12
 Silica 
SiMAG- 
Sulfon 
(Chemicell) 
Strong cation 
exchanger 
1.0 
Sodium 
sulfonate 
1.8 x 10
12
 Silica 
 
*the only value given by the particles supplier was 12.5 mg beads mL
-1
, since the exact 
density of  the particles is not known, an assumption can be made in which the density 
is an approximate to that of polystyrene particles, so the following calculation was 
performed to obtain the number of particles per mL: 
3
3
4
rV       Equation 7 
Density of polystyrene particles approximate 1.07 g mL
-1
, hence by knowing the 
volume and the density the number of particles was calculated. 
 
2.1.3 Detection instruments 
In this paragraph a detailed list of several detection methods for some of the common 
analytes used in the synthesis of FDG reported in the literature are presented (Table 13). 
It is worth noting that not all of the below instrumentations were used or described in 
more detail by the author of this thesis, but it should give a general overview to the 
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reader in understanding the variety of detection methods available with a 
comprehensive list of their detection limit when reported. 
 
Table 13 Methods applied to the detection of product and impurities after the synthesis of 2-
[
18
F]fluoro-2-deoxy-D-glucose. 
Analyte Detection method 
Limit of 
detection 
[
19
F]Fluoride 
IC with conductivity detector [144]  
Fluoride selective electrode [145] 
0.05 g mL
-1
 
1.9 g mL
-1
 
[
18
F]fluoride Radio-TLC* Not reported 
[
19
F]FDG 
HPLC-PAD (IC-PAD or HPAEC-PAD)* [56, 82, 85, 
146]  
HPLC-RID[20] 
GC [147] 
GC-MS [64] 
HPLC-UV (after derivatisation with 2-CA) (276 nm) 
[148]  
HPLC-UV (after derivatisation with PMP) (210 nm) 
[149]  
Not reported 
Not reported 
Not reported 
0.31 g mL
-1
 
0.02 g mL
-1 
Not reported 
 
Not reported 
[
18
F]FDG 
Radio-TLC* [16, 22, 62, 65, 67, 85, 150, 151]  
Radio-HPLC* [20, 50, 82, 152] 
Not reported 
Not reported 
Kryptofix 
2.2.2 
Colour spot test on TLC plate* [22, 55, 57, 82, 153] 
TLC [85, 86, 88] 
GC with nitrogen selective detector [90]  
LC-MS-MS [154] 
Titration with lead (II) perchlorate [155]  
2 g mL
-1
 
25 g mL
-1
 
0.25 g mL
-1
 
1 ng mL
-1
 
1 x 10
-5
 M 
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UV-Vis (after forming a lead (II) complex) (250 nm) 
[156]  
HPLC-UV (210 nm)[149]  
NMR [157] 
IR [157] 
< 10 g mL
-1
 
 
0.5 g mL
-1
 
Not reported 
Not reported 
Acetonitrile 
GC-FID* [22, 151, 158]  
GC-MS [159] 
HPLC-RID [20] 
0.1 g mL
-1
 
< 10 g mL
-1
 
< 30 g mL
-1
 
* Denotes recommended method of analysis according to the European Pharmacopeia 
[160]. 
 
2.1.4 Detection of [19F]Fluoride ions 
For detection of cold fluoride [
19
F] three systems were compared namely; ion selective 
electrodes (ISE), Colourimetric detection and ion chromatography (IC). 
In the first part of the project the fluoride ion detection was investigated using an ion 
selective electrode (Jenway 924-305 Fluoride (F
-
), Jenway, Dunmow, Essex, UK). This 
is the most commonly used ion-electrode, responding to a wide range of fluoride 
concentration with little interference. The sensor is a crystal of lanthanum fluoride, 
whose surface potential changes when placed in solutions of different concentrations. 
The experiment was carried out to evaluate the dynamic range of fluoride concentration. 
The relationship between potential and fluoride concentration is given in the modified 
Nernst equation. 
 FFF aEE log0591.0*   [145]   Equation 8 
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Where: EF
- 
is a constant. A change in electrode potential of 59.16 mV will be associated 
with a ten-fold change in fluoride concentration. 
A calibration graph of potential (mV) vs. log [F
-
] could be plotted from which the 
concentration of the unknown could be determined.  
The mV-reader was a Horiba pH/COND Meter D-54 (Horiba, Japan). A magnetic hot 
plate stirrer was used to stir the solutions before taking the measurement and to keep the 
temperature constant (20 ± 3 ºC). All the solutions were placed in a plastic beaker 
before the measurement. The electrode was clamped in a vertical position so that the 
sensor was immersed in a beaker and was washed and dried when transferring between 
solutions. The electrode was immersed in the solutions for 7 min to obtain a steady 
reading. Due to its sensitivity, the electrode was immersed in the most dilute standard 
first.  
For the colorimetric detection of fluoride, two different spectrophotometers were 
employed: i) Perkin-Elmer UV/vis Spectrometer Lamba Bio 10 (Perkin-Elmer, 
Cambridge, UK) with UV win lab software and ii) Camspec M508 UV/vis 
Spectrophotometer (Camspec Analytical Instrument Ltd., Leeds, UK). The first was 
used to scan the wavelength range between 200 – 800 nm and the second for single 
wavelength calibration experiments. Optically transparent polystyrene disposable 
cuvettes (Fisher, UK) of 1000 µL volume and 10 mm pathlength were used for 
wavelength below 400 nm.  
Later on an ion exchange chromatograph was set-up and used for detection of fluoride. 
The system employed was an ICS 2000 (Dionex, USA) with a conductivity detector and 
a self-regenerating suppressor AS11-HC column (250 mm column length, 2.5 mm 
diameter, 0.25 mL min
-1
 flow rate, 15 mM KOH as eluent) which was employed to 
quantify the trapping and elution of fluoride and was used in isocratic mode. Due to the 
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interferences of carbonate ions with the IC detector only concentrations lower than 
0.001 M (mol L
-1
) were employed to elute the fluoride 
 
2.1.5 Detection of K2.2.2 
All experiments for the detection of Kryptofix by HPLC-MS were performed with a 
Varian MS 500 (Varian, USA) quadruple ion trap mass spectrometer equipped with an 
atmospheric pressure ionization interface of electrospray ionization and dual gradient 
pump with an autosampler (Varian, USA). Electrospray ionization was performed in 
positive ion mode and the data were processed using Xcalibur software. HPLC analysis 
was performed on an analytical column HS C18, 150 mm x 2.1 mm, 3 µm particles, 
(Supelco, UK), with an isocratic mobile phase consisting of 50% water, 50% 
acetonitrile at a flow rate of 0.4 mL min
-1
 and an injection volume of 10 µL. Under 
these conditions the total run time was 10 min and the retention time of Kryptofix was 
1.46 min. For the colorimetric detection of Kryptofix, two different spectrophotometers 
were employed; i) Perkin-Elmer UV/vis Spectrometer Lamba Bio 10 (Perkin-Elmer, 
Cambridge, UK) with UV win lab software, ii) Camspec M508 UV/vis 
Spectrophotometer (Camspec Analytical Instrument Ltd., Leeds, UK). The first to scan 
the wavelength range between 200 – 800 nm and the second for single wavelength 
calibration experiments. Optically transparent polystyrene disposable cuvettes (Fisher, 
UK) of 1000 µL volume and 10 mm pathlength were used. 
2.1.6 Radioactive detection instrumentation 
18
F Fluoride was produced at a cyclotron in Pisa (PETrace, GE, USA) by proton 
bombardment (Ep = 16.7 MeV, 5-10 min at 20-25 µA) of a 1.3 mL 
18
O-water 
(enrichment >98 %) silver target. Radio HPLC was performed on a Waters Delta 600 
pump system equipped with a RaytestGabi Star Gamma detector connected in series to 
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a Waters 996 Photo Diode Array (PDA) detector and a Synergi Fusion-RP C-18 column 
(4 x 150 mm) (Phenomenex, UK). 
Radioactive tests and labeling reactions were conducted using an Advion Nanotek 
system (Advion, USA) as shown in Figure 34. The chips were connected to the system 
by modifying the standard plumbing whereby the inlet of the chip was interfaced to a 
port of an 8-way bridged valve bearing a 0.5 mL high pressure syringe. Three radiation 
detectors were integrated in the system in order to follow the distribution of the 
radioactive species during the experiments. 
The operation for trapping and elution was software controlled, minimising direct 
intervention of the user. Solutions employed were; i) for conditioning 1.0 M NaHCO3; 
ii) for trapping and release of irradiated target water containing the fluoride, Kryptofix 
2.2.2 10 mg in 1 mL acetonitrile and 80 µL of 5 % w/v K2CO3. Trapping of fluoride 
took place at 500 µL min
-1
 and elution of fluoride at 250 µL min
-1
. 
 
Figure 34 Image of the modular, liquid-flow-based “NanoTek LF” microfluidic synthesis system 
[42]. 
2.1.6.1 [19F]Fluoride pre-concentration 
All chemicals were of analytical grade and used without further purification. Ultrapure 
water (18 MΩ cm-1) was employed unless otherwise stated. A solution of [19F-] (1 µg 
mL
-1
) prepared from sodium fluoride was used as a reference standard. The elution 
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solution consisted of 10 mg of Kryptofix 2.2.2 (K2.2.2) dissolved in 900 µL anhydrous 
acetonitrile (MeCN) and 100 µL of 0.01 M aqueous potassium carbonate (K2CO3). 
Required amount of fluoride: The amount of [
19
F]fluoride ions used for experiments and 
the amount of ion exchange packing used in the device were chosen according to the 
amount of [
18
F]fluoride ion routinely used for FDG tracer synthesis. The radioactivity of 
1-2 mL “hot water” used for FDG production can be as high as 150 GBq. Considering a 
specific activity between 300 GBq µmol
-1
 and 43,000 GBq µmol
-1
 (maximum 
theoretical activity = 63,000 GBq µmol
-1
), it was calculated that the maximum amount 
of [
18
F]fluoride ions present in cyclotron irradiated water should not exceed 9.5 µg, with 
a typical average of 0.5 µg [156, 161, 162]. The experiments with the radioactive 
fluoride isotope were carried out with hot water as would routinely be used for FDG 
synthesis. Experiments involving standard solutions of fluoride were carried out with 1 
µg of fluoride ions. 
On-chip procedure: The on-chip particle bed was activated prior to trapping by flushing 
with 2 mL ethanol and 2 mL purified water at a flow rate of 1000 µL min
-1
. For 
trapping, 1 mL of fluoride standard solution was pumped through the particle packing at 
a flow rate of 500 - 1800 µL min
-1
, this was followed by flushing with 1 mL water. The 
trapped fluoride was subsequently eluted with the K2.2.2/acetonitrile/K2CO3 solution at 
a flow rate of 500 µL min
-1
. The particle bed was then regenerated by flushing the chip 
with 2 mL of 1.0 M KHCO3, followed by 3 mL of purified water at 1000 µL min
-1
. 
Fluoride detection: Eluted solutions were collected after both the trapping and elution 
steps for the quantification of fluoride. 25 µL of each collected solution was injected 
into an ion chromatography system (ICS-2000, Dionex, USA) equipped with an AS-
11HC analytical anion exchange column and a conductivity detector. The flow rate was 
0.25 mL min
-1
 and 15 mM potassium hydroxide was used as the eluent. 
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2.1.6.2 [18F]Fluoride pre-concentration 
Chemicals and solutions: High-purity solvents were stored on molecular sieves and 
vented through a sodalime molecular sieve trap during radiochemical experiments.
 
[
18
F]Fluoride ion was produced at a cyclotron (PETtrace, GE, USA) by proton 
bombardment (Ep = 16.7 MeV, 5-10 min at 20-25 µA) of 1.3 mL 
18
O-water 
(enrichment > 98%) using a 1.5 mL silver target-holder. The produced target water with 
a starting activity of 5-7 GBq was diluted with pure water to a volume of 4 mL. Ethyl 
ditosylate (EtDT) was synthesized as published [93, 163]. 
Fluorination mixture analysis: HPLC with radioactivity detection was performed using 
a Delta 600 pump (Waters, USA) equipped with a Synergi Fusion-RP C-18 column 
(Phenomenex, UK) (4 m, 3 mm x 150 mm) and a Gabi Star gamma detector (Raytest, 
Germany) connected in series to a 996 Photo Diode Array detector (Waters, USA). 
Microfluidic chip set-up for fluoride trapping test: The microfluidic chips were 
connected to an Advion Nanotek radiotracer synthesis system (Advion, USA) by 
modifying the standard connections (Fig. 35). The inlet of the chip was interfaced to a 
port of an 8-way bridged valve bearing a 0.5 mL syringe on the common port and was 
operated under negative or positive pressure as required. The remaining vials were 
connected to vials containing (i) a solution of aqueous 1.0 M sodium bicarbonate 
(NaHCO3) or H2O, (ii) (K2.2.2) solution which was prepared by adding a solution of 10 
mg K2.2.2 in 1 mL acetonitrile to 80 µL aqueous K2CO3 (5% w/v), (iii) air for drying 
the particle bed and (iv) irradiated target water. The remaining ports on the valve were 
blocked off. The chip outlet was connected to software controlled solenoid valve (SV) 
to direct the fluids towards either a waste or a collection vial. 
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Figure 35 Schematic representation of the microfluidic chip integrated with the Advion synthesis 
system, showing the 8 way valve connected to a driving syringe, vials with target water (containing 
aqueous radioactive [
18
F]fluoride ions), aqueous carbonate solution or water, K2.2.2/acetonitrile 
elution solution, air and finally the microfluidic anion-exchange chip. The chip outlet was 
connected to a solenoid valve (SV) which could direct liquid either to a waste vial or a collection 
vial. Radioactivity detectors were placed on the anion-exchange chip, next to the waste vial and 
next to the collection vial. 
 
Figure 36 Image of the microchip device (packed bed microchip) integrated with the Advion 
Nanotek LF, showing the microchamber glass device and one of the three radiodetector probes 
placed on top the device for real time monitoring of the radioactivity. 
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Procedure for trapping and releasing of fluoride: A flow rate of 500 µL min
-1 
was 
employed for all steps. 0.5 mL of target irradiated water (activity ranging from 620-875 
MBq) was delivered into the microfluidic chip packed with Chromabond PS-HCO3 
particles followed by 1 mL of air to dry the particles. The solenoid valve was then 
turned off/on to direct liquid to the collection vial. 0.5 mL of K2.2.2 solution was 
pumped through the chip followed by 1 mL of air to ensure recovery of the [
18
F]fluoride 
complexed solution. The solenoid valve was turned back to direct liquid to the waste 
vial and additional 0.5 mL of pure H2O was delivered to waste. The entire procedure 
took 6 min. 
Procedure for regeneration of the ion-exchange particles: The packed chip was rinsed 
with 2 mL of NaHCO3 and subsequently with 2 mL of H2O, both at a flow rate of 500 
µL min
-1
, the reconditioning procedure lasted 4 min. 
Three radiation probes were employed for continuous on-line count rate monitoring at 
different locations of the hardware; one was placed on top of the microfluidic chamber 
(Figure 36) to measure the radiation in the particle bed, the second for measuring 
radioactivity in the waste vessel and the third for measuring radioactivity in the 
collection vessel. The hardware operations for the trapping and releasing of 
[
18
F]fluoride ions, as well as regeneration of the particle bed, were programmed using 
Advion’s software (Version 1.4) in order to minimise direct intervention of the operator. 
At the end of each trap, release and reconditioning cycle, the waste vials and collection 
vials were counted and replaced with empty ones. The cycles were repeated for as long 
as target water was available; a maximum of eight consecutive runs was possible from 
the same batch of [
18
F]fluoride ion solution.  
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2.1.6.3 Fluoride labeling reaction 
When the fluoride solution was used for labeling reactions, the whole volume of target 
water (1.5 mL), containing [
18
F]fluoride ion,
 
was trapped in the chip and the elution step 
was performed at a slower flow rate, thus allowing the delivery of 100 µL drops directly 
into  separate 3 mL V-vials (preheated at 110 °C) while applying nitrogen flow (1.2 bar) 
and a vacuum to aid evaporation. Azeotropic evaporation of the excess water was 
achieved by dropwise addition of 0.5 mL acetonitrile under the same nitrogen flow, 
leading to a bubble-free evaporation. This last step was done alternating the recovery of 
a 100 µL drop in the collecting vial to a 20 s pause allowing evaporation; this confined 
the entire radioactivity to the bottom of the V-shaped vial. The dry residue was then 
reconstituted with 0.5 mL of acetonitrile, and the labeling medium was charged into a 
403 µL storage loop. A solution of EtDT (25 mg mL
-1
 in acetonitrile) was pumped into 
a second 429 µL storage loop. Finally, several labeling reactions were conducted by 
employing 10 µL aliquots of both reactants dispensed at 20 µL min
-1
, each into a 15.7 
µL fused silica reactor preheated to 150 °C. The fluidic scheme for this procedure is 
shown in Figure 37. 
 
Figure 37 Schematic representation of the EtDT labeling reaction process within the Advion 
automated system after drying of excess of water has been performed. The precursor solution was 
pumped into the loop of pump 1 (P1) while the labeling solution was introduced into the sample 
loop of pump 3 (P3). (a) In the reaction step, fluoride complex and precursor solution aliquots were 
delivered into the capillary micro-reactor (MR) preheated at a temperature 150 °C from the 
storage loops by pushing with pure solvent (acetonitrile); in this phase the fluids moved through the 
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lines indicated in bold. (b) In the sweep step, the micro-reactor system was rinsed with pure solvent 
through the lines indicated in bold and prepared for a further reaction with other aliquots of 
reagents. 
2.2 Microchip designs 
Several chip designs were used throughout the experiments described here; 1) a dam 
structure chip design for fluoride pre-concentration, K2.2.2 removal and FECH 
purification, 2) four different glass devices with parallel channels for the pre-
concentration of fluoride via plug of magnetic particles and 3) two different devices one 
with four inlets and four outlets the second with five inlets and five outlets for the 
magnetophoresis experiments. 
2.2.1 Parallel channel chip  
Four different chip designs were investigated (Figures 38-39) the difference between 
them was the number of parallel channels and the width of each individual channel. All 
of them were fabricated in glass with a depth between 20-30 µm. Preliminary 
experiments as described in Section 4.3 were carried out using the designs in Figure 38 
featuring 16 parallel channels (PC16) of 200 µm width and 32 parallel channels (PC32) 
with a width of 100 µm each. The 64 channels (PC64) had a width of 200 µm for each 
individual channel whilst the 128 channels (PC128) had a width of 100 µm each 
channel.  
 
Figure 38 Schematic view of chips design for investigation on magnetic plug left device featuring a) 
PC16 and b) PC32. 
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Figure 39 Schematic of chips design, featuring a) 64 parallel channels (PC64) and b) 128 channels 
(PC128). 
2.2.2 Dam structure device 
The chips design were patterned onto glass wafers using the photolithography technique 
and wet etching method of chip fabrication [164]. For the dam structure a double etched 
design was used to obtain 2 different depths to allow particles trapping, 3 mm glass 
wafers coated with chromium layer and photoresist layer were used (B270 glass, Telic, 
Valencia, CA, USA). The top plate was etched to a depth of 50 µm and the bottom 250 
µm for a total depth of 300 µm. Particles were introduced via the larger hole (1.5 mm 
diameter) which was also the inlet for introduction of fluid. The outlet hole was drilled 
at 400 µm diameter. A schematic view as well as a photo of the empty chamber are 
shown in Figure 40. 
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Figure 40 Schematic view of the dam structure chip device. a) 3D view, b) top view featuring 
dimension of the chamber and holes, c) cross sectional view featuring the depth of the double 
etched plates and d) a photo of the empty glass chip. 
2.2.3 Free-flow magnetophoresis chip 
Two different devices (FL1 and FL2) were used for the investigation of the free-flow 
magnetophoresis experiments. Both were fabricated in 1 mm thick B-270 glass to a 
depth of 20 µm. FL1 featured an 8 mm x 3 mm reaction chamber with a depth of 20 µm 
with a symmetrical inlet and outlet system of five channels (Figure 41). Each of the 
inlet and outlet channels was 240 µm wide, before branching into two 120 µm wide 
channels prior to the reaction chamber. Inlet 1 was used for the introduction of particles 
into the chamber, with inlets 2 to 5 used as reagent and buffer inlet channels, depending 
on the experiment being performed. 
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Figure 41 Schematic of chip design FL1, featuring an 8 mm x 3 mm reaction chamber, five inlets, 
and five outlets. 
 
Figure 42 Schematic of chip design FL2, featuring a 6 mm x 4 mm reaction chamber, four inlets, 
and four outlets. 
FL2 featured a reaction chamber of 4 x 6 mm etched at a depth of 20 µm with a 
symmetrical inlet and outlet system of four channels with a width of 200 µm. 
2.3 Chip setup and interfacing 
Chip designs FL1 and FL2 were utilised for the on-chip free-flow magnetophoresis 
experiments. Before the use of the pressure pump, glue was used for fixing capillaries 
into the inlets and outlets of the microchip. For most of the experiments described here, 
fused silica capillaries (150 µm i.d., 363 µm o.d., Polymicro Technologies LLC, 
Composite Metal Services Ltd., UK) were inserted into the inlet / outlets holes and 
glued in place using Araldite Rapid Glass & Ceramic epoxy resin. For the dam structure 
device where the inlet hole was 1.5 mm in diameter  a piece of PTFE (0.3 mm i.d., 1.58 
mm o.d., Supelco, UK) tubing was used and at the outlet a piece of poly ether ether 
ketone tubing (PEEK, 150 µm i.d., 360 µm o.d., Cole-Parmer Instrument Co., UK) was 
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glued using Araldite Rapid Glass & Ceramic epoxy resin, into the inlets and outlets 
holes of the chip and interfaced to a 5 mL syringe (Henke-Sass Wolf (HSW) 
polypropylene syringe, VWR), via Tygon tubing (1.0 mm i.d., 1.8 mm o.d., Cole-
Parmer). A syringe infuse rate between 400 µL h
-1
 to 1.7 mL min
-1
 was applied using a 
syringe pump (Pump 11 Plus, Harvard Apparatus, UK). 
Microfluidic chip interfacing with chip holder 
Later in the project to avoid gluing issues with blocked channels when glue seeped into 
the inlet or outlet holes, a chip holder was used where chips could be fixed in place and 
the capillaries introduced and sealed without the need for glue. The chip holder was 
prepared in-house by the Engineering Workshop in the Department of Chemistry, and 
was fabricated from aluminium. The holder was built in two identical sections, each 
consisting of a bottom plate, onto which the chip was placed, with a top plate placed 
over the inlet holes of the chip and screwed into the lower plate (Figure 43). The top 
plate featured a matrix of holes, each 5 mm apart, such that the access holes of the chip 
could be aligned to allow capillaries to be connected to the chip.  
 
Figure 43 Photographs of the chip holders fabricated in-house, and the nuts used to connect the 
capillaries to the chip. a) Chip holder design, consisting of sliding sections to accommodate different 
sized chips. b) Schematic demonstrating the interfacing of capillaries to a microfluidic device when 
using a chip holder. The capillary is held by a ferrule that covers the inlet hole of the chip, and the 
ferrule is sealed against the chip by a PEEK nut that screws directly into the chip holder. The top 
and bottom plate are made of Aluminium and are held together in place by eight screws (four for 
the inlets side and four for the outlets). Adapted from [99]. 
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Whether the capillaries were glued into a chip or a holder was used for the connections, 
the subsequent steps remained the same for each setup. Tygon tubing (0.254 mm i.d., 
0.762 mm o.d., Cole-Parmer) was attached to each of the outlet capillaries and fed into a 
sample vial for waste collection. Tefzel ferrules (1/16 inch, Anachem Ltd., UK), with a 
sleeve of poly(tetrafluoroethylene) tubing (PTFE, 0.3 mm i.d., 1.58 mm o.d., Supelco, 
UK) inside them, and PEEK nuts (1/16 inch, Anachem Ltd.) were attached to the ends 
of each inlet capillary by inserting the capillary into the PTFE sleeve, and the chips then 
underwent a washing procedure. The washing solutions varied depending on the 
experiment. A PEEK syringe adaptor (1/4-28 Female to Female Luer adaptor, Anachem 
Ltd.) was screwed onto the nut of one of the capillaries, and the first washing solution 
was pumped through the chip via a 1 mL syringe (BD Plastipak, Becton Dickinson UK 
Ltd., UK). Positive pressure was used for all the experiments, syringes with the 
appropriate particle suspension and reagents were loaded onto a syringe pump with a 
multi-syringe rack (PHD 22/2000, Harvard Apparatus). The syringe pump was activated 
to start pumping the particle suspensions, reagents and buffers through the chip if using 
positive pressure. Flow rate between 10-30 µL h
-1
 were employed unless the pressure 
pump was used. 
2.4 Particle visualization 
Chips were placed onto the stage of a Nikon Ti inverted fluorescence microscope 
(Nikon Instruments Europe B.V., Surrey, UK), equipped with 2x, 4x, 10x, 20x, and 40x 
objectives (Figure 56). Videos and images were captured using colour CCD camera 
(MTV-63V1N, Mintron Enterprise, Taiwan) and WinDVD Creator 2 software 
(InterVideo (Corel UK Ltd.), Berkshire, UK). 
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2.5 [19F]Fluoride pre-concentration off-chip 
Initial investigations into non-radioactive fluoride pre-concentration were performed off 
chip in order to gain familiarity with the new detection methods and to optimize a 
suitable method for quantification of fluoride during the trapping and elution steps.  
2.5.1 Preparation of anion standards for fluoride calibration 
Seven anion standards were used to aid the analysis of fluoride by ion chromatography 
(IC) and to help identify the different peaks and their retention times. The standard was 
prepared by the dissolution of high purity salts in the concentration range between 10 -
100 ppm in high purity deionised water. 
2.5.2 Preparation of stock solutions 
A stock solution of NaF was prepared by dissolving 2.21 g of sodium fluoride (Sigma 
Aldrich, UK) in 1 L of water which gave 1000 ppm of F
-
 (1000 µg mL
-1
).  Fluoride 
standard solutions were prepared in the range 0.1 – 100 ppm by serial dilution of the 
stock and stored in plastic beakers. A solution of 0.25 M K2CO3 (Sigma Aldrich, UK) 
was prepared by dissolving 6.9105 g in 200 mL water. A solution of 1.0 M KHCO3 
(Sigma Aldrich, UK) was prepared by dissolving 10.012g of potassium bicarbonate in 
100 mL water. 
2.5.3 Off-chip pre-concentration via non magnetic particles 
The experiments were carried out by pumping solutions through the different cartridges 
listed in Table 8 using a syringe pump (Harvard apparatus 11 plus and Harvard 
apparatus PHD 2000, USA) with a disposable 1 mL plastic syringe (BD Plastipak, UK). 
Figure 44 shows the schematic procedures for trapping and elution of fluoride which 
includes the five steps cycle needed for the pre-concentration of fluoride; i) 
conditioning, ii) washing, iii) trapping, iv) elution, and v) regeneration. 
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conditioning
excess
X-
pH 9-11
trapping
1 mL  fluoride 
solution
F-elution
200 µL K2CO3 
(0.01M) solution
CO3
2-
Resin beads
X-
pH 5-7
 
Figure 44 Schematic representation of fluoride activation; first conditioning of the resin, washing 
with water to neutralise the resin, trapping, elution and regeneration. 
2.5.4 Off-chip pre-concentration via magnetic particles 
Two different superparamagnetic particles, 1 and 3 µm diameter, featuring quaternary 
ammonium groups in the chloride form were tested during the off chip experiment to 
identify the binding efficiency of the particles to the fluoride ion in an aqueous 
environment. The particle suspension was vortexed for 20 s and the particles collected 
at one side of the Eppendorf tube (1.5 mL, VWR, UK) via an external magnet. The 
supernatant was removed and fresh water was added; the process was repeated twice. 
When loading of the counter ions was performed the last wash was replaced with a 
solution of NaCl (1.0 M). A schematic representation of the steps used during the 
magnetic approach for fluoride pre-concentration is shown in Figure 45. 
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Figure 45 Steps by steps trapping of fluoride and elution. Step 1 fluoride solution was introduces 
into the Eppendorf containing the magnetic particles. Step 2 the adsorption of fluoride onto the 
particles surface takes place. Step 3 an external magnet is applied on the side of the Eppendorf and 
the particles with the fluoride ions collected on the side, a further washing step is sometimes 
performed with fresh buffer solution. Step 4 the carbonate anions in solution (less volume then the 
original solution is then introduced and the exchange between fluoride and carbonate takes place. 
2.6 Fluoride pre-concentration on-chip (dam structure) 
The first part of the experiment was the preparation of the microchamber (described in 
2.2.2) this was achieved by deconstructing the available cartridge and filling the 
chamber with the particles. For the pre-concentration of fluoride, the chamber was filled 
with commercially available anion exchange particles, (PS-HCO3 or Sep-Pak Light Plus 
QMA) as described in Section 2.1.2. The particles were introduced as a dry powder 
from the larger hole by using a micro spatula and constantly tapping the device in a 
vertical position to obtain a homogenous packing, as shown in Figure 46 a). 20-30 mg 
of ion exchange particles could be trapped in the chamber. It has to be noted that during 
the gluing of the inlet tubing the tube was insert into the inlet hole (in top plate) in such 
a way that it will be in contact with the chamber (bottom plate) in order to ensure that 
when solution was pumped through the particles bed was fully wet. The on-chip particle 
bed was activated prior to trapping by flushing with 2 mL ethanol and 2 mL purified 
water at a flow rate of 1000 µL min
-1
. For trapping, 1 mL of fluoride standard solution 
was pumped through the particle packing at a flow rate of 500 - 1800 µL min
-1
, 
followed by flushing with 1 mL water. The trapped fluoride was subsequently eluted 
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with the K2.2.2/acetonitrile/K2CO3 solution at a flow rate of 500 µL min
-1
. The particle 
bed was then regenerated by flushing the chip with 2 mL of 1.0 M (KHCO3) followed 
by 3 mL of purified water at 1000 µL min
-1
. 
 
Figure 46 Pre-concentration of fluoride on trapped anion exchange particles, including (a) loading 
of the particles into a microfluidic device, (b) trapping of fluoride from solution and (c) elution of 
fluoride. 
 
Figure 47 SPE cartridges commercially available. Silica based QMA from Water (50 µm average 
particles diameter), Chromabond polystyrene cross linked with divinyl benzene (100 µm average 
particles diameter) and silica based Strata SAX (60 µm average particles diameter). 
 
Figure 48 Dam structure device filled with two different anion exchange particles namely; silica (Si) 
and polystyrene (PS). 
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2.6.1 Pressure measurement on dam structure chip 
Investigation on the maximum flow rate and pressure exerted on the dam structure chip 
were performed using a pressure meter DPG 120 (OMEGA Engineering INC., US) 
connected with PEEK tubing to the inlet of the chip allowing correlation of the pressure 
with the flow rate from the syringe pump; the experimental set-up for this study is 
shown in Figure 49. 
 
 
Figure 49 Set-up used to measure the pressure within the chamber of the packed bed device. 
2.7 Fluoride pre-concentration on-chip via plug of magnetic particles 
Magnetic microparticles can be captured on-chip with external magnets. As described in 
Section 1.13.2, fluoride can be trapped and subsequently eluted from the particle bed. 
The schematic representation for the pre-concentration of fluoride via magnetic plug 
trapping is shown in Figure 50, with the loading of the magnetic particles first and the 
trapping and release of the fluoride in the same device. 
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Figure 50 Schematic of the magnetic capture approach. Magnetic microparticles can be captured 
on-chip with external magnet; fluoride can be trapped and subsequently eluted from the particle 
bed. 
Microchip pre-treatment 
Before each experiment, the microchip was flushed with water to remove any air from 
the chamber and the channels by manual pumping. The microchip was then flushed 
with 100 mM NaOH using the syringe pump at a rate of 100 μL h-1 for 3 min. The 
NaOH was flushed out of the microchip with water, and EtOH was pumped through for 
another 3 min.  
2.7.1 On-chip plug formation 
1 µm and 3 µm Simag-Q superparamagnetic particles functionalised with a quaternary 
ammonium group in the chloride form were purchased from Chemicell (Berlin, 
Germany). The particles were received as a concentrated suspension (4.2 x10
10
 particles 
mL
-1
 for the 1 µm i.d. and 1.57 x 10
9
 particles mL
-1
 for the 3 µm i.d. particles); the stock 
suspensions was stored in a refrigerator at 6° C. 
Fused silica capillary of ~ 8 cm length (100 µm i.d., 360 µm o.d., Polymicro 
Technologies LLC, Composite Metal Services Ltd, UK) was used. The polyimide 
coating was partly removed using a flame from a lighter to allow observation under the 
microscope. The capillary was then mounted onto a glass slide; tygon tubing (254 µm 
i.d., 762 µm o.d., Cole Parmer, UK) was pushed over the ends of the capillary. One end 
was dipped into the Eppendorf tube (1.5 ml VWR, UK) the other end the tubing was 
pushed over a 25G syringe needle (Terumo, Surrey, UK) which was luer locked to a 1 
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mL glass syringe (SGE Analytical Science, Australia). The sample was pulled from the 
sample tube through the capillary by application of negative pressure with a pump 
(Harvard Apparatus 11plus, Harvard application, USA). NdFeB magnets of 5 mm 
length and 2 mm diameter were purchased from Magnet Sales (Swindon, UK). A pair of 
magnets was glued to a glass support such that the opposite poles were facing each 
other over a 5 mm gap. The magnet holder was placed on the capillary support such that 
the capillary ran through the gap of the poles. Blu tac adhesive was used to fix the 
magnet holder. The whole set-up was placed on the stage of an inverted microscope 
(Nikon) with images captured and recorded with a CCD camera (PV10, Olympus, 
Japan) and Image pro capture software (Open source software 
http:\\rsb.info.nih.gov/ij.index.html). An image of the experimental set-up is shown in 
Figure 51. 
 
Figure 51 (a) Set-up of the glass capillary and the magnet pairs positioned on a glass slide, (b) Set-
up of the microfluidic device under the microscope. 
2.7.2 Magnet set-up for parallel channels experiment 
For parallel channels experiments most commonly, a 10 x 10 x 5 mm
3
 rectangular 
NdFeB magnet (Magnet Sales, UK) was placed on top of the chip, in the case when 128 
or 256 parallel channels chip was used three magnets facing opposite poles were used.  
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Figure 51 Image showing the device PC128 filled with red ink for visualization and the position and 
orientation of the NdFeB magnets.  
2.8 Fluoride pre-concentration on-chip via free-flow magnetophoresis 
This section describes the experimental parameters, chemicals, particles and set-up 
employed for the study of magnetic particle deflection behaviour in a microfluidic 
chamber with the aim of achieving the pre-concentration of fluoride via free-flow 
magnetophoresis. 
 
Figure 52 Schematic of the set-up of chip design for performing fluoride trapping  in continuous 
flow. Magnetic particles were pumped into inlet 1, and fluoride ion in solution in inlet 2-3. 
Dynabeads SAX particles (1 µm diameter), as described in Section 2.1.3, were 
purchased from Invitrogen and prepared as per the manufacturer’s instructions. ~ 2 x 
10
6
 particles) were dispersed in 1 mL of PBS buffer in a 1.5 mL Eppendorf tube and 
underwent the following particle washing procedure; the suspension was vortexed for 
20 s, the particles were collected at the side of the tube via an external magnet and the 
supernatant removed prior to the addition of fresh PBS. This washing process was 
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repeated twice more and once the supernatant had been removed for the last time the 
particles were resuspended in fresh PBS. 
When a magnet was placed next to the deflection chamber, magnetic particles in the 
chamber experienced not only an attractive force in the y-direction but also upwards, in 
the z-direction, which could result in particles becoming stuck against the top surface of 
the chamber. Therefore, by positioning a magnet in the same horizontal plane as the 
particles, they would experience no upwards force and so should flow through the 
chamber without being pulled against the chip surfaces, thus helping to reduce 
‘sticking’. With this in mind, some of the chips had a section of glass cut out next to the 
chamber so that the magnet could be placed in line with the chamber. An example of a 
chip with a section of glass cut out is shown in the chip holder in Figure 53. 
 
Figure 53 Glass chip featuring a box magnet 20 x 10 x 5 mm
3
 within the glass cut out. 
 
Figure 54 Chip design with the 4 x 4 x 5 mm
3 
 NdFeB magnet placed on top of the chip, next to the 
reaction chamber. 
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2.8.1 Pressure pump  
In some experiment the syringe pump was replaced with a pressure control pump and 
the interface between the glass device and the tubing was substituted with a chip holder 
fabricated in house, the set-up of which is shown in Figure 56. The MicroFluidic 
Control System (MFCS) (Fluigent, France) is a high precision pneumatic pressure 
controller designed to handle fluid in microfluidics systems. It allows a stable and 
pulsation free flow with short response time (100 ms) and a stabilisation time a low as 1 
s. With the MFCS it is also possible to control several independent channels at the same 
time as shown in Figure 55 thanks to the individually controlled vials. The user friendly 
software allows you to create scripts for complex flow patterns or dynamic coupling for 
user-controlled dependence between channels. 
 
Figure 55 a) Schematic of the Fluigent pressure pump with the fluiwell + the reservoirs, b-c) image 
showing the front and back of the fluiwell (vials rack), d) showing the principle of the flow of the 
liquid via pressurized gas [165]. 
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Figure 56 Full system set-up comprising of pressure pump connected to the chip and microscope 
for visualization. 
2.8.2 Magnet setup for magnetophoresis experiment 
Most commonly, a 4 x 4 x 5 mm
3 
rectangular NdFeB magnet (Magnet Sales UK) was 
placed on top of the chip, next to the chamber, as shown in Fig 54. When a magnet was 
placed onto the chip surface, magnetic particles in the chamber experienced not only an 
attractive force in the y-direction but also upwards, in the z-direction, which could result 
in particles being drawn towards the top of the chamber and becoming stuck against the 
surface of the chamber. Therefore, by positioning a magnet in the same horizontal plane 
as the particles they would experience no upwards force, and so should flow through the 
chamber without being pulled against the chip surfaces, thus helping to reduce sticking. 
With this in mind, some of the FL2 design chips had a section of glass cut out next to 
the chamber so that the magnet could be placed in line with the chamber. An example of 
a chip with a section of glass cut out is shown in the chip holder in Figure 57. When this 
setup was used, a 20 x 10 x 5 mm
3
 NdFeB rectangular magnet was placed in this 
position rather than the smaller magnet used above. 
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Figure 57 Chip holder featuring a glass device with cut out for magnet. 
 
2.9 Surface treatment 
In an effort to reduce the sticking of particles to the glass surfaces of the microfluidic 
channels, several treatments were performed to modify the glass. Initial attempts to 
perform surface treatments involved the introduction of chemicals through fused silica 
capillaries. However, it was found that this also treated the capillaries themselves, and 
always resulted in increased back pressure and difficulties in introducing particles into 
the chips. It was hypothesised that this was due to the presence of water (possibly from 
moisture in the air) that reacted with the silanising agent to form residues that partially 
blocked the capillaries. Silanisation of a glass surface requires a small amount of water 
to be present, but too much water will cause the formation of powdery residues, and 
were typically only used for 2 – 3 weeks after being opened. Due to the suspected 
blocking of the capillaries, subsequent attempts to treat the chips involved pumping the 
required solutions directly into the chip via one of the following methods.  
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Table 14 Silanising agents and their properties. References show where the application methods for 
each agent were adapted from. 
Silanising agent  Abbrev. 
Leaving 
group 
Solvent 
Effect on the 
glass surface 
Octadecyltrichlorosilan
e [166, 167] 
OTS  - Cl 
4:1 
Hexadecane: 
Chloroform  
Hydrophobic 
uncharged  
Trichloro(1H,1H,2H,2
H-perfluorooctyl)silane 
[168, 169] 
FDTS  - Cl 
Isooctane 
(2,4,4-
trimethyl-
pentane 
Hydrophobic
; 
fluorophilic; 
lyophobic; 
uncharged 
2-[Methoxy 
(polyethyleneoxy)propy
l] [170] 
PEG-silane  - OMe Toluene  
Hydrophilic; 
uncharged  
(3-aminopropyl) 
triethoxysilane [171] 
APTES  - OEt Ethanol  
Positively 
charged at 
low pH  
Dimethyloctadecyl[3-
(trimethoxysilyl)propyl] 
ammonium chloride 
[172] 
QAS 
(quaternar
y 
ammonium 
silane)  
 
- OMe 
 
 
Methanol  
Positively 
charged  
 
A chip, having been cleaned via a furnace (500 °C for 6 h) and/or in piranha (80:20 
H2SO4:H2O2) solution, and with no tubing attached, was flushed with acetone by 
placing a syringe directly over one of the inlet holes, then a syringe filled with air used 
to remove the acetone. The chips were placed in a 60 °C oven overnight to ensure that 
the surfaces were dry. These steps were to ensure that no water was present in the chips 
ahead of silanisation treatments, where the presence of water can produce unwanted by-
products and cause blockages. For the silanisation procedure, solutions were prepared 
by dissolving the silanising agent in an appropriate solvent to a concentration of 1 % v/v 
(Table 14). 
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Table 15 Chemical structures of the silanising agents. 
Silanising Agent Chemical Structure 
OTS 
 
FDTS 
 
PEG - Silane 
 
APTES 
 
QAS 
 
 
The chips were flushed first with the pure solvent via a syringe, before filling them with 
the silanisation solution list of the different surface treatment compounds is reported in 
Table 14 and leaving it to react for 10 min. Finally, the chips were flushed with the 
solvent again, followed by acetone and then water, leaving the chip ready for use in 
experiments. The silanising agents were used to render the glass chip surfaces 
hydrophobic, hydrophilic (more so than native glass), or positively charged, depending 
on the type of agent used. Each agent featured a silane group with four substituents, one 
of which was the group (-R) responsible for conferring the desired physical effect on the 
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system, and the other three of which were hydrolysable leaving groups of either 
methoxy (-OMe), ethoxy (-OEt) or chlorine (-Cl), used to link the silane to the glass 
surface. Table 14 shows the different silanising agents used in this work, together with 
their abbreviations, the effect on the glass surface, the leaving group, and the solvents 
used to prepare the 1 % v/v solutions. Table 15 shows the chemical structures of each of 
the silanising agents. Figure 58 shows the mechanism by which silane modification 
takes place on a surface featuring hydroxyl groups (-OH), such as the surface groups on 
glass [173, 174]. Firstly, the alkoxy (methoxy, -OMe, or ethoxy, -OEt) leaving groups 
of the silane are hydrolysed by water to form silanols. Hence, a small amount of water 
is typically required in the system to perform the surface treatment, and may come from 
the atmosphere or be present in small quantities on the surface of the glass. For those 
silanising agents featuring chlorine leaving groups, anhydrous alcohols are usually used 
as the solvent, and the chlorosilane reacts with the alcohol to produce an alkoxysilane 
and hydrochloric acid. Some of the hydrochloric acid then reacts with the alcohol to 
produce small quantities of alkyl halide and water, the latter of which causes the 
formation of silanol groups from the alkoxysilanes. Thus, whether an alkoxysilane (with 
methoxy or ethoxy groups) or a chlorosilane (with chlorine groups) is used as the 
starting material, both become silanols as a result of hydrolysis, albeit by slightly 
different mechanisms. In general, the reactivity of the silanising agents with the 
hydroxylated groups of the substrate surface is greater for the chlorosilanes than the 
alkoxysilanes, but nevertheless the latter type are the most widely used due to the non-
corrosive and volatile byproducts, and for the methoxysilanes there is the advantage that 
they are able to modify surfaces under dry condition. 
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Figure 58 The deposition of silanising agents onto a glass substrate. The example shows an 
alkoxysilane featuring three hydrolysable methoxy groups. 
Once hydrolysis of the silanes has been performed, the silanols produced undergo 
condensation to form oligomers, which in turn hydrogen bond with the hydroxyl groups 
of the substrate. Finally, a covalent bond is formed with the substrate due to loss of 
water by drying or curing, securing the silane and the properties of its R group to the 
glass surface. These steps are described sequentially, but can actually occur 
simultaneously after the hydrolysis step. Chips silanised with a hydrophobic treatment 
were tested by examining the water-air interface in a channel to observe the contact 
angle, where it was found that hydrophobic surfaces gave a contact angle of around 90 
while untreated surfaces exhibited contact angles of < 30. 
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2.10 Kryptofix detection and removal 
This section describes the experimental parameters, chemicals, particles, and set-up for 
the study of detection and removal of K2.2.2 in a microfluidic chamber. 
2.10.1 Preparation of stock solution 
Kryptofix standards were prepared in water by serial dilution of 1.0 mg mL
-1
 in 
acetonitrile. Kryptofix standards between 1 – 100 µg mL-1 were used in this study. 
 
Figure 59 The chemical structure of Kryptofix K2.2.2 when complexes with K
+
 ion. 
2.10.2 TLC silica for detection of K2.2.2 
Thin Layer Chromatography (TLC) is the most widely used quality control method for 
K2.2.2 in FDG injection. The method consists of spotting 2 µL samples of [
18
F]FDG 
and K2.2.2 standards solution on silica gel plate and developing in methanol:NH4OH 
(9:1). Following hot-air drying, the plates are exposed to iodine vapors for an additional 
15 to 20 min for visualization [88]. When the Alexoff et al. [85] method was used an 
acidic iodoplatinate solution was prepared as described in Section 2.10 and the stock 
solution was applied to strips of plastic-backed silica gel 60 thin-layer chromatographic 
plates (Sigma-Aldrich, UK). 
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2.10.3 Colourimetric test for Kryptofix detection 
4,7,13,16,21,24-Hexaoxa-1,10-diazabicyclo [8.8.8]-hexacosane, Kryptofix (98%), 
chloroplatinic acid 6 hydrate, potassium iodide and hydrochloric acid 36 %  were 
purchased from Sigma Aldrich, UK.  
Following the published method [55], stock iodoplatinate reagent was prepared by 
mixing 5 mL of 5% chloroplatinic acid in water with 45 mL 10% potassium iodide in 
water and diluting with an additional 100 mL of water. Acidic iodoplatinate was 
prepared by mixing 1 part conc. HCL with 10 part stock reagent. 
 
Figure 60 Image of the setup for of the colour change reaction between K2.2.2 and iodoplatinate 
reagent. 
2.10.4 HPLC–MS for Kryptofix detection 
Owing to its increased sensitivity, an HPLC-MS-MS method was investigated which 
enabled quantitative experiments for the purification steps to be performed such as the 
amount of resin needed to remove the Kryptofix. The method of Ma et al. [92] was 
slightly modified as the use of ammonium acetate as mobile phase was found to be 
detrimental for the LC pump causing several stalling and blockages; consequently 
ammonium acetate was replaced with water (50:50 water: acetonitrile). The standard 
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stock solution of K2.2.2 was prepared in acetonitrile, from which the working solution 
of K2.2.2 was diluted to give a range of concentrations from 1.0 –100 ng mL-1, all 
solutions were stored in a refrigerator. 
2.11 FECH detection and on-chip removal 
For the detection and analysis of FECH experiments, starting materials and by-products 
were purchased; EtDt, [
19
F]Fluororethylcholine (FECH) was delivered in 20 mg vials 
and prepared from a stock solution by serial dilution in the concentration range 1-100 
ppm in water, DMAE, dry acetonitrile (ACN) and tetrabutylammoniumbicarbonate 
delivered as liquid (TBAHCO3). Kryptofix 2.2.2/K2CO3 solutions were prepared in the 
same concentration as used during the pre-concentration of fluoride experiments 
described in the experimental chapter Section 2.1.5.1. The microchamber glass device 
was prepared in the same way as described in Section 2.6 with the difference being the 
type of particles introduced in this case both CM cation exchange particles, as well as 
reversed phase particles were used. The on-chip particle bed was activated prior to 
trapping of FECH and K2.2.2 by flushing with 2 mL ethanol for the reversed phase 
particles and NaCl 0.1 M solution for the CM cation particles and subsequently washed 
with 2 mL purified water at a flow rate of 1000 µL min
-1
. For trapping of FECH, 1 mL 
of FECH (10 µg mL
-1
) standard solution was pumped through the particle packing at a 
flow rate of 500 - 1000 µL min
-1
. This was followed by flushing with 1 mL water. The 
particle bed was then regenerated by flushing the chip with 2 mL of 1.0 M NaCl, 
followed by 3 mL of purified water at 1000 µL min
-1
.  
FECH and by-products detection: Solutions of DMAE, FECH and TBAHCO3 were 
analysed by IC. Different mixtures at different concentrations between 1-100ppm were 
injected into the ion chromatography system (ICS-2000, Dionex, USA) equipped with a 
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CS18 IonPAC analytical cation exchange column and a conductivity detector. The flow 
rate was 0.25 mL min
-1
 and 20 mM potassium hydroxide (KOH) was used as the eluent. 
   Chapter 3     bjbk 
112 
 
3 On-chip pre-concentration of [18/19F]fluoride via regenerable 
anion exchange resin  
This Chapter describes the on-chip pre-concentration of fluoride with both 
[
18/19
F]fluoride via a packed bed of anion exchange chromatography resin, this work has 
been published in the Journal of Chromatography A [1]. 
3.1 Introduction 
As previously reported in Section 1.5 the most common reaction with radioactive 
fluoride is the nucleophilic substitution. When this reaction was described by Amacher 
et al. [16] two main advantages were reported i) the [
18
F]fluorine is obtained as a 
solution in the irradiated water and ii) [
18
F]fluorine is obtained “no-carrier-added” 
(NCA). This means the [
18
F] fluoride ion has very high specific radioactivity (i.e., ratio 
of [
18
F] fluoride ion to its mass of carrier or total fluoride ion 
19
F + 
18
F). The 
nucleophilic substitution is achieved in the presence of a phase transfer catalyst, in this 
case K2.2.2, in Figure 46 and 61 the mechanism of the pre-concentration and activation 
of the [
18/19
F]fluoride ions in the presence of K2.2.2 via a packed bed of anion exchange 
chromatography particles is described. 
 
 
Figure 61 Principle of anion exchange process after the production of 
18
F
-
 from proton 
bombardment of 
18
O water in a cyclotron. The fluoride ions are exchanged with the counter anions 
(CO3
2-
) and subsequently eluted with high ionic strength salt (K2CO3) in the  presence of 
acetonitrile and Kryptofix as phase transfer catalyst, to obtain the activated fluoride. 
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In Figure 62 is shown the schematic of the chip design already described in Section 
1.2.2 as well as a photo of a glass device filled with two different types on AE particles. 
The amount of particles contained in the individual chamber was between 20-30 mg. 
 
 
 
Figure 62 (a) Schematic representation of the chip design. The bottom plate features two chambers 
(3 cm long, 5 mm wide, 250 µm deep). The top plate, etched to a depth of 50 µm, also featured two 
chambers (3 cm long, 5 mm wide). This top plate also featured a triangular section (2.5 mm long), 
leading to a channel of 100 µm width that formed a shallow section for bead trapping when the top 
and bottom plates were thermally bonded. On the inlets side, 1.5 mm diameter holes were drilled 
into the top plates, while on the outlets, 400 µm diameter holes were drilled for the outlets. (b) 
Photograph of the glass device. One chamber was filled with polystyrene (Chromabond PS-HCO3) 
particles and the lower chamber filled with silica (Sep-Pak Light Plus QMA) particles. 
3.2 Non-radioactive [19F]fluoride ion detection methods 
The first part of the work was dedicated to the investigation and optimisation of a low 
limit of detection method for non-radioactive fluoride, [
19
F]fluoride. Three methods 
were investigated namely, (i) ion selective electrode, (ii) spectrophotometric detection 
and (iii) ion exchange chromatography with conductivity detector.  
3.2.1 Ion Selective Electrode (ISE) 
The fluoride electrode (described in 2.1.5) was first tested due to its ready availability 
and ease of use. The aim of this experiment was to prepare a series of standards in the 
range 1 x 10
-2 
M to 1 x 10
-7 
M of [
19
F]fluoride and plot a calibration graph to measure 
the concentration of fluoride in an unknown solution.  
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Figure 63 Calibration graph of Potential/mV versus the logarithm of [F
-
]. 
Table 16 Table showing the values of the potential /mV and the concentration of fluoride. 
[Fluoride] /M 
Potential /mV 
(mean n=3) 
Log [F
-
] 
0.000001 -238 -6 
0.00001 -292 -5 
0.0001 -334 -4 
0.001 -397 -3 
0.01 -458 -2 
0.1 -513 -1 
 
From the results shown in Figure 63 it can be seen that there was a linear response. 
However, the working range was limited between 1 x 10 
-2
 to 1x 10 
-6
 M. The volume 
required for the measurement was around 200 µL and the error found while measuring 
the potential was found to be ±15 mV possibly due to factors such as temperature, time 
needed to take the reading, differences in volume and dilution factor. Owing to the limit 
of detection of only 1 x 10
-6
 M (19 µg mL
-1
 of fluoride), as well as the amount of 
volume required for analysis, >200 µL, the method was not optimised further.  
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3.2.2 Spectrophotometric detections: Alizarin fluorine blue 
A spectrophotometric method was also considered with the intent to use it as a 
continuous on-line method for fluoride detection as described in experimental section 
2.1.5. UV-vis spectra were obtained for each standard of fluoride in the range 10-50 
ppm as shown in Figure 64. The maximum absorbance was at λ = 625 nm. As shown in 
Figure 65 a linear response was obtained, and it also shows that the absorbance was 
proportional to the concentration. Preliminary results obtained showed that the method 
had good sensitivity in the microgram range for the detection of fluoride. So was 
decided to carry out a further optimisation both for sensitivity and interferences. 
Table 17 Mass of fluoride versus absorbance at 625 nm. 
Mass  
[
19
F]fluoride/( g/ 
mL) = ppm 
Absorbance 
At 625nm 
(mean n=3) 
40 
30 
20 
10 
1.1654 
1.1071 
0.9504 
0.8362 
 
Results of the concentration of [
19
F]fluoride versus the absorbance found at λ= 625 nm 
are shown in Table 17. The spectra of a range of [
19
F]fluoride concentrations are shown 
in Figure 64 and a calibration graph of the mass of fluoride versus the absorbance is 
plotted in Figure 65. 
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Figure 64 Absorption spectra at 625 nm of different fluoride concentrations (10-40 ppm). 
 
Figure 65 Calibration graph of absorbance vs concentration of fluoride. 
A further test was performed to identify the effect of carbonate anions since pre-
concentration of fluoride for radiosynthesis is performed in the presence of carbonate 
anions, introduced during the elution step as described in Chapter 1 Section 1.8. The 
results are shown in Table 18 and the graph plotted in Figure 67. The method was the 
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same as outlined previously. The only addition was a known amount of potassium 
carbonate in each of standards, and the absorbance was measured at 625 nm. 
Table 18 Effect of K2CO3 in the absorbance at 625 nm. 
Concentration  
of [
19
F]fluoride g mL
-1
 
Volume of 
K2CO3(0.25 M) / ml 
Absorbance 
At 625nm 
40 2 0.1433 
30 2 0.5221 
20 2 0.5710 
10 2 0.8045 
 
As shown in Figure 66 there is no linearity between the peaks and the maximum 
absorbance recorded, as compared with the spectra in Figure 64. 
 
 
Figure 66 Absorption spectra of fluoride (10-40 ppm) and K2CO3 (0.25 M) at 625 nm. 
When potassium carbonate was added to the reaction mixture, it can be seen that there is 
no maximum absorbance as shown in Figure 66, possibly due to the carbonate (CO3
2-
) 
anions reacting with the alizarin solution. Hence no proportionality between absorbance 
and fluoride concentration was observed. The method could not be used further for this 
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research since most of the detection of fluoride will be in the presence of carbonate 
anions as the eluting agent; as reported in Section 1.8. 
3.2.3 Ion exchange chromatography (IEC) 
Ion Chromatography (IC) is one of the most common detection methods for the 
determination of anions in solution. A series of standard solutions, with [
19
F]fluoride 
concentration between 1 and 40 ppm was injected via an injection loop of the 
instrument, and the area in µs min
-1
 was obtained. Subsequently a calibration graph was 
plotted from which unknown concentrations could be determined. 
Table 19 Values of Area/µs min
-1
 vs concentration of fluoride/ppm. 
Concentration/ 
ppm 
Area /µs min
-
1
(mean n=3) 
1 3.703 
10 7.892 
20 19.149 
30 26.244 
40 32.762 
50 40.375 
 
 
Figure 67 Chromatogram of a 30 ppm [
19
F]fluoride standard showing the retention time for 
[
19
F]fluoride at 2.893 minutes. 
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Figure 68 Calibration graph of area µs min
-1
 vs series of concentrations of fluoride in the range 1-50 
ppm. 
As shown in Figure 68 there is a good linearity with an R
2
= 0.992, so for this reason a 
further investigation to determine the limit of detection was carried out, and the results 
are shown in Figure 69. For further calculation the slope of the graph in Figure 68 was 
used for subsequent studies. A series of standard solutions of fluoride were prepared in 
the range between 1 ppm to 10 ppb. The average of a series of repeated concentrations 
was plotted and the limit of detection calculated using the formula: (equation 9) 
(Limit of detection = (3 x standard errors)/gradient)    Equation 9 
Table 20 Average area/ µs min
-1
 with errors of different concentration of fluoride. 
Concentration / ppm Area1/µs 
min
-1
 
Area2/ 
µs min
-1
 
Area3/µs 
min
-1
 
Mean STD 
0.5 3.079 2.996 3.255 3.11 0.1322 
0.1 1.517 1.456 1.689 1.554 0.1208 
0.01 0.265 0.298 0.369 0.310667 0.0531 
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Figure 69 Determination of the LOD for [
19
F]fluoride using ion chromatography. 
The average standard error was calculated to be 0.102 ppm which gives a limit of 
detection of 0.06 ppm (3.15 x 10
-6
 mol L
-1
). For the purpose of this research this was a 
good starting point for the detection of [
19
F]fluoride since it was very close to the 
concentration of fluoride ions in water after the cyclotron bombardment (6.25 x 10
-7
 
mol L
-1
) as explained previously in Section 1.10. 
The detection method was tested for interferences with carbonate anions. Three 
different experiments were carried out to investigate the minimum amount of carbonate 
that was possible to inject in the IC without affecting the resolution of the other anions 
in particular the fluoride anion. Three different solution were injected into the IC with 
the fluoride amount kept constant at 30 ppm (30 µg / mL
-1
), only the carbonate (K2CO3) 
concentration was varied, 0.1, 0.01 and 0.001 M.  
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Figure 70 Chromatogram showing the effect of the carbonate ions on the resolution of the analytes 
at 0.1 M K2CO3. 
 
Figure 71 Chromatogram showing the effect of the carbonate ions on the resolution of the peaks. 
With 0.01 M K2CO3 the fluoride peak is resolved, but the interference is still present for further 
detection of other ions. 
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Figure 72 Chromatogram showing the effect of the carbonate ions on the resolution of the peaks. 
With 0.001 M K2CO3 fluoride peak and other peaks present in water fully resolved without 
interference of carbonate. 
As can be seen from the chromatogram in Figure 70, in the presence of carbonate anions 
at high concentration (0.1 M) the fluoride peak cannot be resolved. When lower 
concentrations of carbonate were tested (0.01 M) it was possible to observe the fluoride 
peak as shown in Figure. 71, but the area and the height of the fluoride peak was not the 
same as the area observed when the same concentration of fluoride was run without 
carbonate; (Figure 67). Only when the carbonate concentration was lowered to 0.001 M 
the fluoride peak and the other anions were fully resolved. The experiment showed that 
IC could be used as a detection method for fluoride in the presence of carbonate anions 
without use of any buffer. Therefore this detection method seemed to be best suited in 
terms of the detection limit and volume required for analysis particularly when 
compared to the fluoride electrode. 
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In summary a suitable detection method for fluoride ions in solution at low 
concentration and in the microliter range volume was investigated. Three commonly 
used methods were compared; a colourimetric assay, an anion selective electrode and 
ion exchange chromatography. The first one proved not to be suitable for our purpose 
due to the volume required for the measurement (1 mL) and the interferences of other 
anions with the measurement. The second technique featured improved sensitivity (0.20 
-1 ppm) and the time for the measurement but still the volume required was considered 
high for the purpose described herein (200 µL). Ion exchange chromatography proved 
capable to detect fluoride as low as 0.001-1 ppm in a reasonable time same as electrode 
(5 min) with low sample volume required (>25 µL). Table 21 compares the three 
different detection methods in terms of their sensitivity, volume, interferences and time 
required for test. 
Table 21 Summary of the detections method. 
Detection Sensitivity Volume Interferences Time / min 
Colourimetric 1 ppm 1 mL CO3
2- 
 9  
ISE 1ppm 200 µL pH  5  
IEC 0.01 ppm 25 µL High 
concentration 
salt (CO3
2-
) 
 5  
3.3 Initial test of [19F]fluoride trapping off-chip 
Prior to performing on-chip experiments, three different commercially available 
disposable cartridges were employed to ensure that fluoride could be quantitatively 
trapped and eluted. For these experiments, different resin forms were employed as 
described in 2.1.2, featuring chloride, bicarbonate and hydroxide as their counter ions. 
Detection of fluoride was achieved with Ion Exchange Chromatography (IEC), 
[
19
F]fluoride was measured after collection at the outlet of the cartridge and after elution 
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with K2CO3. The first experiments were carried out to determine the minimum amount 
of K2CO3 where no interferences from the CO3
2-
 with the fluoride peak were observed; 
as previously described this was found to be 0.001 M (mol L
-1
). This amount was found 
to be sufficient to release 1 µg of [
19
F]fluoride from the resin. A comparison of the three 
cartridges illustrated the bicarbonate form as being the most suitable resin for further 
experimentation. The hydroxide resin could not quantitatively trap and recover the 
fluoride as shown in Figure 73. Only 80% of fluoride could be trapped over a series of 
four regeneration steps. The chloride resin gave >90 % trapping efficiency over the four 
runs, but a significant amount of chloride ions were detected over the course of the 
experiments even after excessive washing of the resin with NaHCO3. Chloride has been 
reported to compete in the FDG synthesis step by forming 2-chloro-2deoxy-glucose 
(CIDG) hence affecting the final FDG yield [82]. For this reason, the bicarbonate resin 
was chosen for all future experiments. 
 
 
Figure 73 Graph comparing three different resin forms (hydroxide, chloride and bicarbonate) and 
their efficiency over a series of four runs. 
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3.4 [19F]Fluoride elution off-chip on QMA cartridge 
This part of the work was carried out in collaboration with Dr. Victoria Hammond at the 
Chemistry Department, the University of Hull. During her research she investigated the 
on-chip fluorination of propylditosylate and mannose triflate using first a KF mixture, 
containing K2.2.2 : K2CO3 : KF (1.5 : 1.5 : 1) and consequently she assessed the 
activated [
19
F]fluoride solution obtained by the conventional trapping elution method as 
described in Section 2.1. Due to the higher concentrations needed in cold chemistry for 
detection purposes (HPLC-UV or HPLC with electrochemical detection) it was 
necessary to use the Sep-Pak QMA cartridges rather than the packed bed micro-reactors 
for the trapping of [
19
F]fluoride and its elution with K2.2.2 and potassium carbonate 
previously described in Section 2.5.3. When using the KF mixture a particulate 
formation was observed during the reaction, therefore the fluorination step was 
performed with the activated fluoride from the cartridge. 
The [
19
F]fluoride trapping and release were carried out as outlined in Section 2.5.3. The 
[
19
F]fluoride solution was then used in a directly comparable experiment to those 
performed above with the KF mixture, and no fluorination of the expected compound 
was observed. The [
19
F]fluoride production was repeated a number of times (using 
freshly made solutions) and at no point was any fluorination observed. It was believed 
that there may not have been enough carbonate in the [
19
F]fluoride solution to promote 
the fluorination and to render the solution basic enough compared to the micro-reactor, 
as previous experiments have shown that some carbonate is required for efficient  
fluorination. The amount of carbonate was increased (up to 50 equivalents), however no 
fluorination was observed in the micro-reactor.  
At this point it was speculated that there was a problem with the [
19
F]fluoride 
production. This was confirmed by testing the [
19
F]fluoride solutions by IC; it was 
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found that the [
19
F]fluoride was being trapped on the cartridge but not being eluted in 
the K2.2.2 and carbonate solution. It is believed that this was a concentration effect, 
even though the method had been scaled up accordingly. It was thought that the most 
likely problem was the amount of water in the elution solution may not be enough to 
dissolve all the carbonate which is needed to replace the [
19
F]fluoride on the cartridge. It 
is known that when the elution solution uses 100% water as the solvent, all the fluoride 
is eluted off the cartridge, but at the 8% water and 92% acetonitrile currently used 
resulted in no fluoride being eluted. The amount of water was doubled, and still no 
fluorination was observed. A study was then carried out to determine at which 
percentage of acetonitrile (required for the reaction) in the elution solution the fluoride 
stopped eluting from the cartridge. The results can be seen in Figure 74, showing that 
when the acetonitrile percentage rose above 60% the fluoride was no longer fully eluted 
from the cartridge the test was repeated twice in two different experimental days (n=1 
each day) . Any drop in the concentration of fluoride in the final solution would have a 
direct effect on the amount of fluorination that would occur in the micro-reactor, 
meaning it is important to elute as much of the fluoride as possible from the cartridge  
 
 
Figure 74 Percentage of fluoride eluted in respect to the acetonitrile content from 0-85%. 
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An experiment was then conducted to determine whether it was possible to use the 
elution solution (60% acetonitrile, 40% water) directly in the micro-reactor to perform 
the fluorination of the tosylate compounds system set-up used by Dr Victoria Hammond 
is shown in Figure 75. The experiment was done using a residence time of 30 s in the 
micro-reactor, over a temperature range of 60 to 180 °C. There was no fluorination 
observed in any of the samples, and it was also noticed that particles were forming in 
the channels of the micro-reactor. This shows that the elution solution was not suitable 
for direct use in the fluorination reaction and needed to undergo solvent exchange in a 
module between the fluoride production and fluorination reaction module. It should be 
noted that the particles forming could have been due to reactant insolubility in water and 
there may have been too much water present for it to remain in solution. 
 
 
Figure 75 (left) Labtrix ® start system from Chemtrix BV. Temperature range -15ºC to 190 ºC for 
experiments. Pressure set to 15 bar. Also shown the microreactor (supplied with the instrument) in 
a holder that can be placed over the heated element. The tubing goes directly into the holder where 
it connected to the microreactor by `O` rings (made from Perlast®) so no leakage can occur. 
Courtesy of Victoria Hammond. 
3.5 On-chip [19F]fluoride trapping, elution and regeneration 
Optimisation of fluoride detection: The first step involved the calibration of the ion 
exchange chromatography instrument for fluoride detection in the lowest ppm region, 
which was sufficient for the amount of fluoride to be detected. It was found that 
carbonate, which was the eluent used for releasing the fluoride from the on-chip solid 
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phase packing at a concentration of 0.36 M, interfered with the fluoride peak. After the 
first trapping, another peak overlapping with the fluoride was observed and was found 
to be acetate which has a retention time close to that of fluoride, as shown in Figure 76 
(top and middle). These species were probably formed via a reaction between KHCO3 
and acetic acid (present in the polymeric particle packing) during the regeneration step. 
For this reason, the height of the peak was used to determine the amount of fluoride 
trapped, rather than the area under the peak.  
Initial tests on anion-exchange particle beds: Both silica (Sep-Pak Light Plus QMA) and 
polystyrene (PS) (Chromabond PS-HCO3) particles were tested initially to compare 
their performance for the trapping and subsequent release of fluoride. In each case a 
microfluidic chamber was filled with particles as described in Section 2.1 and the 
fluoride standard (1µg mL
-1
) was trapped and subsequently eluted, with no difference in 
performance observed between the two types of anion-exchange particles. However 
during the regeneration steps a significant chloride peak was detected in the eluate from 
the silica-based ion exchange material. This material was originally in the chloride form 
but was rinsed with 2 mL of 1 M KHCO3 solution prior to its use in our experiment as 
previously discussed. The presence of chloride can interfere with the following 
radiofluorination reaction by forming undesired chlorinated by-products, affecting the 
synthesis of FDG [82]. Moreover, the silica particles were found to be difficult to 
remove from the device while the polystyrene particles (PS) could be easily removed by 
treating the chip in a furnace at 500 °C for several hours. For these reasons, the 
Chromabond PS-HCO3 particles in the carbonate form were selected over silica in the 
chloride form for subsequent investigations. 
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Trapping and elution efficiency: The PS particle chip was then tested for the trapping 
and elution of fluoride. 1 µg mL
-1
 fluoride standard was pumped through the chip 
containing the PS particles in the bicarbonate form at a maximum flow of 1500 µL  
min
-1
. Each collected aliquot was analysed for the presence of fluoride. The peak height 
of fluoride was normalised against the peak height of fluoride present in purified water 
and then converted to a percentage to give the amount of trapped fluoride. The fluoride 
was eluted with a 1 mL solution containing 10 mg K2.2.2 in 900 µL acetonitrile and 
100 µL K2CO3 (0.01 M) pumped at 250 µL min
-1
 through the chip. The eluted solution 
was dried and reconstituted with 1 mL water, as acetonitrile is not a suitable solvent for 
ion chromatography, prior to being analysed for the presence of fluoride. This 
experiment was repeated up to 40 times, and it was found that the [
19
F]fluoride could be 
trapped and released in all cases with more than 90 % efficiency.  
 
Figure 76 Chromatograms obtained for the trapping and elution of non-radioactive [
19
F]fluoride 
ions, showing 1µg mL
-1
 fluoride before trapping (bottom), the diminished fluoride peak of waste 
solution collected during trapping (middle) and the full fluoride peak following elution (top). 
3.5.1 Resin breakthrough for [19F]fluoride  
The full capacity of the particle packing with respect to the [
19
F]fluoride ion  was 
investigated by the determination of the breakthrough capacity. 1 mL aliquots of 
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fluoride solutions (1 µg mL
-1
) were consecutively introduced into the chip, at a flow rate 
of 500 µL min
-1
, until fluoride was detected at the outlet; the percentage of fluoride 
trapped versus the mass of fluoride introduced is shown in Figure 79. The amount of 
fluoride trapped was about 90 % over the first ten injections, before gradually 
decreasing down to 40 %, as expected due to the reduced number of binding sites 
present in the particle bed. The trapping capacity determined by breakthrough analysis 
specific for [
19
F]fluoride ion was found to be 11 ± 4 µg of per 20 ± 5 mg of dry particles 
which is equal to 0.55 µg g
-1
 of particles (0.028 meq g
-1
). This was found to be 28 times 
less than the maximum loading capacity provided by the manufacturer (0.80 milli-
equivalents g
-1
) to be noted that the manufactures protocols uses different binding 
molecules and detection method [175]. 
 
 
Figure 77 Breakthrough plot of the anion-exchange chip showing the trapping efficiency versus the 
amount of [
19
F]fluoride ions introduced into the chip. As the mass of fluoride was increased, the 
trapping efficiency decayed linearly as the number of trapping sites on the particles decreased. The 
maximum capacity of the anion exchange particles (Chromabond PS-HCO3) before loss of 
efficiency was determined to be 0.55 µg mg
-1
. 
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3.5.2 [19F]Fluoride trapping and regeneration at maximum flow rate 
The reusability of the resin bed was accomplished by regenerating the particles at the 
end of each trapping and elution by pumping 2 mL of NaHCO3 (1.0 M) at flow rate of 1 
mL min
-1
 and subsequently washing extensively (3-5 mL) with purified water at the 
same flow rate. This would replace the original counter ion present on the resin by 
washing out all the other anions bound to the particles. A total of 40 runs were 
performed on the same resin bed, and no significant decrease in trapping of fluoride was 
observed (>90 % trapping efficiencies in all the runs). After establishing the reusability 
of the chip we investigated the maximum flow rate at which the fluoride could be 
quantitatively trapped. In this experiment the same chip was employed, and the 
detection of fluoride (%) towards different flow rate was plotted the results Figure 80 
show significant decrease in trapping efficiency (< 80 %) at a flow rate 1850 µL min
-1
 
and above. The same chip was used repeatedly for these experiments to confirm that the 
decrease in efficiency was due to the high flow rate rather than the decrease in capacity 
of the resin, to prove this, after the 2000 µL min
-1
 runs a standard fluoride of 1 ppm was 
introduced with flow rate of 700 µL min
-1
 and this resulted in trapping efficiency of 93 
%. 
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Figure 78 Graph showing the efficiency of the fluoride trapping onchip (%) vs flow rate µL min
-1
 
showing a decrease in efficiency of about 15-20 % after flow rate of 1800 µL min
-1
. 
3.5.3 Pressure study on-chip 
As part of a modular system which at the end will constitute an integrated platform for 
the synthesis of radiotracers together with four other modules, pressure testing was 
performed on the chip to ascertain a suitable pressure which the chip could withstand. A 
pressure gauge was employed to measure the back pressure resulting from the packed 
bed (typical set-up described in Section 1.6.1) and was found that the device did not 
leak or cracked at a maximum pressure of 12 Bar (188 psi) in Figure 81 a graph 
showing the relation between the pressure and the flow rate is plotted. 
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Figure 79 Calibration graph of the flow rate µL min
-1
 vs pressure / bar. 
3.5.4  [19F]Fluoride trapping and elution efficiency on-chip 
Next the on-chip elution was investigated, 1 µg of fluoride was trapped on chip at a 
flow rate of 500 µL min
-1
 then the elution solution consisting of 1 mL (900 µl aqueous 
K2CO3 (5%) + 100 µL MeCN (10 mg K2.2.2)) was pumped. 50 µl aliquots were 
collected at different flow rates ranging from 10 to 200 µl min
-1
 and analysed for 
presence of fluoride. The area of the peak was used for quantification and calculated 
with respect to the reference peak area of the starting fluoride solution a graph of the 
results is shown in Figure 80 (n=1). Since it was not possible to exactly match the area 
of the starting fluoride against the sum of the areas of the different aliquots, to make 
sure that the fluoride was completely eluted the experiment was performed until no 
fluoride was measured in the eluent, this value was found constant between the different 
flow rates to be a volume of 250 µl; as shown in Figure 83 no fluoride was measured 
within the 300 µl aliquot. Furthermore, no linear trend or correlation was observed 
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between flow rates and percentage of trapped fluoride eluted, however it can be seen 
that at a higher flow rate fluoride is eluted quickly. 
 
 
Figure 80 Elution of trapped fluoride from PS-HCO3 particles at different flow rates.  In all cases, 
100 % of fluoride was eluted in the first 250 µL collected from the chip, with higher flow rates 
typically affording faster elution times of the total fluoride. 
3.6 On-chip [18F]fluoride trapping and release 
Conditioning and regeneration of the integrated anion-exchange chip: After experiments 
carried out on the trapping procedure with non-radioactive fluoride, the method was 
tested for radioactive [
18
F]fluoride ion as outlined in the experimental section 2.6. The 
possibility of trapping and releasing several aliquots of aqueous [
18
F]fluoride ion was 
investigated. The first aspect to be considered was the set-up of a suitable procedure for 
pre-conditioning of the anion-exchange particle bed. Since the chosen polymer was 
polystyrene based, at the beginning of each experimental day 2 mL of 96% ethanol 
(EtOH) solution was flushed through the chip in order to fully wet the particle bed. 
However, before re-conditioning the counter anion with NaHCO3, an additional rinse of 
the chip with 2 mL of pure water was required, since it was found that passing 
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bicarbonate solution immediately after EtOH caused copious salt precipitation in the 
hardware. After this first EtOH/H2O pre-conditioning step, the system was ready for 
bicarbonate re-conditioning. This was performed by flushing the chip with 2 mL 
NaHCO3 (1M), followed 2 mL H2O and no further EtOH preconditioning cycles were 
required during the same experimental day. The trapping of [
18
F]fluoride ions was 
conducted using 0.5 mL portions withdrawn from a batch of irradiated water, with total 
starting radioactivity ranging from 5 to 7 GBq, and whose volume was adjusted to 4 mL 
with pure water. This process was chosen for conducting as many experiments as 
possible with one batch of irradiated water.  
3.6.1 [18F]Fluoride trapping in the integrated chip 
 [
18
F]fluoride ion trapping in the integrated chip: Radioactivity, as indicated earlier, was 
monitored in three key positions of the hardware; the microfluidic chamber, waste vial 
and collection vial. As shown in Figure 81, complete trapping of the radioactivity was 
always observed in the chip, and during the delivery of [
18
F]fluoride ion into the chip 
there was no radioactivity detected in the waste vial (Figure 81, red line/solid line). 
Experiments were also conducted by trapping the whole 4 mL of target water in order to 
determine whether volume or fluoride mass was detrimental for trapping, whereupon it 
was found that the performance of the chip remained excellent, and there was no escape 
of radioactivity. In this trapping step, as well as in the elution step, it was important to 
dry the system void volume by using 1 mL of air. We also tested flow rates from 50 to 
500 µL min
-1
 to investigate any flow related effects and found that the total radioactivity 
was always trapped on the particles, independent of the applied flow rate. 
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3.6.2 [18F]Fluoride elution in the integrated chip 
[
18
F]fluoride ion elution in the integrated chip: 0.5 mL of K2.2.2 in acetonitrile solution 
containing 5 % K2CO3 (0.36 M) was used for elution of the fluoride complex from the 
anion-exchange particle bed. This volume was sufficient for eluting more than 95 % of 
the radioactive fluoride trapped on the particles. As a matter of fact, by monitoring the 
signal from the radioactivity detector placed on the chip, we noticed that the first 200-
250 µL of eluent already removed all of the radioactivity from the particle bed; the rest 
of the volume and the air served for emptying the tubing up to the collecting vial and 
drying the system. Also in this case, we tested various flow rates from 50 to 500 µL 
min
-1
 and found no decrease in the performance of the elution step. Hence, the 
maximum flow rate was adopted as the optimal working condition, in order to perform 
the fastest possible processing times. 
After elution, 0.5 mL of H2O was used to rinse the system and prepare it for the re-
conditioning cycle, and also to avoid the previously described precipitation problems 
encountered when using concentrated bicarbonate solution. During this stage, a small 
decrease in radioactivity counts was observed in the chip; this was justified by the 
elution of fluoride residuals from the anion-exchange particles. This remaining 
radioactivity was completely recovered in the waste vial during the NaHCO3/H2O 
reconditioning phase, as illustrated in Figure 81. The waste vial counting revealed that 
the amount of [
18
F]fluoride ions that could not be recovered as elution complex with 
this procedure was < 5 % of the total radioactivity. No radioactivity was detected in the 
particle bed at the end of the whole cycle, the on-chip detector always returned to 
background reading. The same chip was used for performing a total of 20 trap and 
release cycles over three experimental days, and the performance of the system was 
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always consistent in recovering >95% of the total radioactivity in the acetonitrile/K2.2.2 
elution phase.  
 
Figure 81 Seven consecutive runs of the trapping and elution of radioactive [
18
F]fluoride ions. 
Counts per second (c.p.s) was measured by three independent radioactivity detectors: on the chip 
(blue / dashed line), in the collection vessel after elution (green/ dotted line), and in the waste vessel 
(red / solid line). 
3.7 [18F]Fluoride labeling reaction 
Labeling reaction: To demonstrate the reactivity of the [
18
F]fluoride ion solution 
produced via this process, its efficiency for labeling was tested in a model aliphatic 
substitution reaction frequently used in our laboratory, namely the fluorine substitution 
of the tosylate group of ethyl ditosylate (EtDT). The concentrated [
18
F]fluoride solution 
eluted from the chip was collected and excess water was removed by azeotropic 
distillation as described in Section 2.4. The dried, activated labeling solution was used 
to perform sequential on-capillary reactions with EtDT precursor solution using a 
commercial Advion “NanoTek” microfluidic module. Briefly, the reactants were 
charged into small-bore PEEK loops of adequate volume and delivered, by pushing pure 
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solvent on the opposite head of the loops into the 2 m long micro capillary (100 µm i.d.) 
housed in a heater (Figure 82(a)). After each run, the system was cleaned with pure 
solvent (the sweep step, (Figure 83 (b)), and a further run performed in a similar 
manner. A sample from each consecutive run was analysed by Radio-HPLC and an 
average incorporation yield of 96 % (Figure 82 top) demonstrated very good chemical 
reactivity and high process stability over repeated runs. 
 
Figure 82 Typical Radio-HPLC profile for the labeling of ethyl ditosylate (EtDT) to yield 
[
18
F]fluoroethyltosylate. The top trace represents the radioactivity , and it shows the percentage of 
unreacted fluoride against the percentage of product formed, while the bottom trace represents the 
UV absorbance at 254 nm showing the unreacted EtDT peak (Rt = 7.3min). 
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Figure 83 Schematic representation of the EtDT labeling reaction process within the Advion 
automated system after drying of excess of water has been performed. The precursor solution was 
pumped into the loop of pump 1 (P1) while the labeling solution was introduced into the sample 
loop of pump 3 (P3). (a) In the reaction step, fluoride complex and precursor solution aliquots were 
delivered into the capillary microreactor (MR) preheated at a temperature 150 °C from the storage 
loops by pushing with pure solvent (acetonitrile); in this phase the fluids moved through the lines 
indicated in bold. (b) In the sweep step, the microreactor system was rinsed with pure solvent 
through the lines indicated in bold and prepared for a further reaction with other aliquots of 
reagents. 
3.7.1 Particle stability 
After successfully demonstrating the reusability and the efficiency of the packed micro-
chamber module with both non-radioactive and radioactive fluoride it was decided to 
see if in any way the particles were affected by the radioactivity or from the 
regeneration steps. A series of SEM pictures of the particles before and after treatment 
with both radioactive and non radioactive fluoride were taken as shown in Figure 84, (a) 
SEM pictures of the resin before any treatment showing the monodispersity of PS-DVB 
beads, (b) SEM picture after a series of trapping of [
19
F]fluoride treatments which 
shows a slight formation of crystals possibly due to the salt washing (NaHCO3) and (c) 
SEM picture of resin after a series of radioactive treatments showing a significant 
crystal formation identified as Na crystals by elemental analysis, due to a non 
extensively washing with water after the regeneration step. 
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Figure 84 (a) SEM picture of PS-DVB particles. (b) SEM picture of PS-DVB particles after several 
treatment with [
19
F]fluoride. (c) SEM picture of PS-DVB particles after a series of treatment with 
18 F fluoride, showing some crystal formation which was identified to be Na by elemental analysis 
due to non sufficient washing after the conditioning and regeneration steps. 
3.8 Summary 
Both radioactive [
18
F] and non-radioactive [
19
F]fluoride ions could be repeatedly 
recovered by employing a chip containing a smaller amount of anion exchange particles 
than conventional cartridges. The entire process required less than 6 min and had a 
trapping efficiency >90%, while the particles could be repeatedly regenerated and 
reused up to 40 times via a multicycle approach, without loss of performance. The 
radioactive solution resulting from this innovative process was highly reactive and 
could be employed in the radiofluorination of EtDT. On this basis, the chip could easily 
be integrated into automated systems to provide highly reactive fluoride complexes for 
the production of fluorinated PET radiotracers in high yields. The ability to regenerate 
the anion-exchange chip would also allow many batches of radiopharmaceuticals to be 
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synthesized without requiring continuous manual interaction of personnel within the 
shielded synthesiser. 
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4 On-chip preconcentration of [18/19F]fluoride via magnetic 
batch approach 
In this chapter, proof-of-principle experiments are described in which plugs of 
positively charged superparamagnetic particles were formed inside a parallel channel 
glass device. Both [
18/19
F]fluoride was trapped on the particles and subsequently eluted  
This initial study has been published in the proceedings of the MicroTAS 2010 
conference [176]. 
4.1 Introduction 
Microparticles are most commonly used as packing materials in microfluidic devices, 
acting as a high surface area solid-support for reactions. Magnetic particles can be 
formed into plugs of particles using simple magnetic set-ups, and this has already been 
demonstrated for many analytical applications [59, 64]. So far, to our knowledge, 
nothing has been reported for such a method for pre-concentration of [
18/19
F]fluoride 
used for radiotracer synthesis that involves the use of magnetic forces. Here, we 
investigate this method. The schematic shown in Figure 85 describes the concept the 
loading of the magnetic particles which, under the influence of the magnetic forces, 
form a plug. Pumping of the fluoride ions in aqueous solution results in trapping via 
exchange reaction onto the magnetic particles and finally, elution can be performed via 
a high ionic strength salt (K2CO3). 
  Chapter 4     bjbk 
143 
 
 
Figure 85 Schematic of the magnetic capture approach. Using an external magnet; fluoride can be 
trapped and subsequently eluted from the particle bed. 
4.2 Off-chip test for [19F]fluoride trapping and elution 
A series of off-chip tests were performed to ensure and quantify the trapping efficiency 
of the magnetic particles for fluoride. The main objective was to determine the number 
of particles needed to trap 1 µg of fluoride. From preliminary results using non 
magnetic particles (Chapter 3) it was known that trapping of fluoride was achieved via 
strong anion exchanger solid support, hence two different commercially available types 
of magnetic particles were employed as described in Section 2.1.3. Firstly the 
manufacturer’s protocols were followed together with the method employed in Chapter 
3 for the on-chip pre-concentration via packed bed. However it was not possible to 
measure any trapping of cold fluoride even with very high number of particles mL
-1
. 
Even at 1 x 10
10 
particles mL
-1
, no significant trapping efficiency could be measured in 
the ion exchange chromatography. A deviation from the manufacturer’s protocol was 
then tested in which the magnetic particles suspension was firstly washed with high 
concentration of HCl in a way that the particles counter ions (in the case of Invitrogen 
SAX and Chemicell SiMAG-Q Chloride counter ion Cl
-
) could be always be present in 
excess. By using 0.1 M of HCl during the last washing step of the stock preparation it 
was possible to observe and measure, trapping of fluoride. The number of particles 
needed to trap 1 µg of fluoride was found to be 1 x 10
7
 particles mL
-1
 of Chemicell 
SiMAG-Q particles. 
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In Figure 86 the set-up for the off-chip experiment shows the magnet one on side and 
the particles attracted to it, and subsequently the supernatant solution is analysed via IC 
for presence of fluoride. 
 
Figure 86 Photo of the off-chip set-up used to determine trapping and elution efficiency of fluoride, 
in this image is shown an Eppendorf tube with the box magnet placed on the side to allow the 
magnetic particles to be trapped on one side so that the supernatant can be analysed for presence of 
fluoride, Particles used in this image are Chemicell SiMAG-Q.  
4.3 Optimisation of chip design  
In parallel to studying the trapping efficiency of the magnetic particles, the formation of 
a magnetic plug in a capillary was investigated; the set-up is shown in Figure 89 and 
described in Section 2.7.1. Using a solution of 1 x 10 
4
 particles mL
-1
, particles were 
successfully trapped within the two magnets. Magnetic plugs were formed in the 
capillary according to the method described in Section 2.1.5, with different flow rates 
investigated. The maximum was found to be 60-120 µL hr
-1 
(1-2.5 mm s
-1
); photographs 
of the plug formed can be seen in Figure 87. 
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Figure 87 Single on capillary formation of plug at 120 µL h
-1
.
 
  
However from the off-chip experiments it was known that the number of particles to 
trap 1 µg of fluoride was not sufficient. So a design with several parallel channels was 
fabricated, first a design consisting of 16 and 32 parallel channels as shown in Figure 
38. The design with 32 parallel channels was tested, 1 x 10
8
 particles were pumped 
through the chip at a flow rate of 350 µL h
-1
 but this caused blocking and clogging of 
the device at several points. Finally a device with 128 parallel channels was used 
(PC128 section 2.2.1). Some sticking of the magnetic particles on the glass surface was 
observed possibly due to the negatively charged silanol groups interacting with the 
positively charged functional groups of the magnetic particles. However, formation of 
plugs on the channels was achieved by placing three box magnets on top of the device. 
Several flow rates were investigated to determine the maximum flow for the formation 
of plug with minimum particles escaping. This was found to be 900 µL h
-1
. At this 
particular flow, most of the particles were trapped on chip, the exact number of particles 
was not possible to determine however as shown in Figure 88 the middle vial represent 
the solution collected at the outlet of the device during the trapping experiment and 
clearly can be seen the clear solution collected with a minimum amount of particles 
demonstrating successful trapping and plugs formation. 
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Figure 88 Magnetic particles suspensions (left) before introducing in chip as very dense 
concentrated solution, (middle) solution collected at the outlet of the 128 paralle channels showing 
the most of the particles have formed magnetic plugs, (right) residual particles at the end of the 
experiment found at the bottom of the syringe. 
 
Figure 89 (top) Set-up of the magnet pairs to form plug, magnet held in place) by a clamp and 
placed on top and bottom of the glass device (at distance of 2 mm from the glass device for 
magnetic field improvement. (bottom) Image of the 16 parallel channels glass device. 
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Figure 90 CAD image of the 128 parallel channels on the left and the formation of plug image 
downstream the magnet. Showing the position of the three magnets, which were always in the top 
middle of the glass device. 
As shown in Figure 90 plugs were successfully formed on chip, even though not in all 
the channels was possible to observe a uniform and constant plug formation. A FEMM 
simulation was performed to model the magnetic field gradient across the parallel 
channels and as shown in Figure. 92. Interestingly was found that plugs formation was 
more readily formed at the edges of the series of magnets where the magnetic field 
gradient is stronger, and leaving some of the central channels with no plug formation as 
shown in Figure 91 (bottom area). 
 
Figure 91 image of the plug formation on chip showing some of inner channels where no plug was 
formed possibly due to the weaker magnetic field gradient suggested using the FEMM simulation. 
In Figure 92 two-dimensional simulation of the magnet flux density, B, over the 128 
parallel channels glass device, as observed from a side-on view. FEMM software was 
used to generate the model. As shown in the simulation, the magnetic field is stronger at 
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the edges of the magnets and weaker in the middle magnet, possibly this explain why 
fewer particles were trapped between the border of the magnets as shown in Figure 90 
between the south pole of one magnet and the north pole of the next magnet less 
particles plug formation is observed. 
  
Figure 92 FEMM simulation of the magnetic flux density of 3 magnets facing opposite poles (10 x 
10 x 5 mm
3
 NdFeB magnets across the microfluidic chamber from a side-on cross-sectional view. 
4.4 [19F]Fluoride trapping and elution on-chip 
After investigating the plug formation we performed an experiment where after forming 
a plug with 1 x 10
7
 particles mL
-1
 at 900 µL h
-1
 (Figure 93) a solution of standard 
fluoride 1 µg mL
-1
 to was pumped to perform the trapping step. Initially the solution 
was pumped at low flow rate of 300 µL h
-1
 and by carefully observing under the 
microscope if any of the plugs were disrupted gradually it was increased up to 700 µL  
h
-1
 where some deformation of the plugs was observed so it was decided to pump all the 
remaining solution using this flow rate. 
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Figure 93 Photographs of magnetic particle plugs formed on chip (a) upstream from the magnet, (c) 
downstream from the magnets, (b) image of the 128 parallel channels device filled with red ink for 
visualization and showing the position and orientation of the NdFeB magnets. 
Subsequently the solution was collected at the outlet and analysed using IEC for 
presence of fluoride. In this case we used the area of the fluoride peak and was found 
that 0.5 µg of fluoride was trapped on the magnetic beads. A significant amount of 
chloride was observed during the analysis, but there was no interference with the 
fluoride peak. In Figure 94 a series of four chromatograms representing the fluoride 
peak in the water background (d), the peak of the fluoride standard (e), the trapping of 
fluoride after passing through the magnetic plugs and finally the release of the fluoride 
with K2CO3 (0.001M) are illustrated. Subsequently, a third step for the release of the 
fluoride was performed, in this case 1 mL of solution of K2CO3 (0.001M) was pumped 
at a flow rate of 500 µL h
-1
 and the solution collected at the outlet was analysed with 
IEC, and as a result 70 % (3.5 µg) of the trapped fluoride was successfully released. 
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Figure 94 (a) Chromatogram of water (background signal), showing the presence of fluoride at 
very low concentration, (b) chromatogram of 1 µg mL
-1
 fluoride solution (reference standard). (c) 
Chromatogram after passing fluoride solution through the magnetic particles plugs, showing a 
small fluoride peak and a large chloride peak (the counter-ion on the resin) (d) Chromatogram of 
eluted fluoride solution featuring the fluoride peak and indicating that 70 % (3.5µg)  of fluoride 
had been released. 
With the proof of principle demonstrating that indeed cold fluoride could be trapped and 
eluted on chip via a formation of magnetic particles plugs, the set-up and experiments 
were transferred on the radioactive trapping and elution of fluoride. 
4.5 [18F]Fluoride trapping off-chip 
This work was carried out in collaboration with Dr Giancarlo Pascali in the radioactive 
facilities of the Institute of Clinical Physiology of National Research Council (IFC-
CNR) in Pisa (Italy). In order to corroborate the experiments carried out in Hull with 
non radioactive fluoride. First off-chip tests were repeated in the same way as described 
in Section 2.7.1. 
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Figure 95(top) set-up of the on-chip trapping and elution of [
18
F]fluoride via plug formation of 
magnetic particles, showing a syringe pump, glass syringe and glass device, through a glass window 
for radioactivity shielding. (bottom) image of the glass device at the end of the experiment showing 
the brownish color given by the particles on the left and the clear side after the magnet on the right. 
100 µL of Chemicell particles (1 x 10 
9
 particles mL
-1
) in 900 µL of solution of HCl in 
water (0.1M) was first prepared in the Eppendorf tube, vortexed for 30 s and the 
supernatant washed away, subsequently an activity of 63.4 mCi of [
18
F]fluoride was 
added to the Eppendorf  tube, with mixing by shaking for about 1 min. The magnet was 
then applied on the side, the supernatant washed away, and the activity was measured 
on the vial which now contained only particles without solution, it was measured as 8.4 
mCi n.d.c, (8.6 d.c.) the washed solution also was measured and found to be 50 mCi 
n.d.c (52.25 d.c.). This procedure was repeated for three times, but no significant 
trapping and elution of activity was measured, the total activity trapped at the end was 
only 3 % of the starting fluoride. It was known from the non radioactive test that off 
chip experiment was not giving great results for fluoride trapping; in the case of the 
radioactive test it may be that the incubation time was not enough for the exchange 
mechanism between F
- 
with Cl
-
. 
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4.6 [18F]Fluoride trapping and elution on-chip 
Despite the unsuccessful results with the off-chip radioactive fluoride the experiments 
was tested on-chip and the setup and procedure are described in Section 2.7.1. This time 
30 µl of Chemicell particles (1 x 10
7 
particles mL
-1
) were loaded in the glass syringe and 
the plug was formed at 20 µL min
-1
 as shown in Figure 95. 500 µL of [
18
F]fluoride with 
activity of 38.3 mCi was pumped through the chip at a flow rate of 15 µL min
-1
, at the 
end of the solution activity was measured first in the syringe and found to be 3.7 mCi as 
well as in the collection vial where was measured at 20.18 mCi which is equal to 45 % 
of radioactive fluoride successfully trapped on the plug. Subsequently a 100 µL solution 
of K2.2.2 + K2CO3 and MeCN was pumped at 10 µL min
-1
 for the elution steps, at the 
end of the solution, activity was measured in the vial, and only 50 % of the fluoride was 
eluted, this steps were repeated again with another 100 µL elution solution where finally 
another 40 % of fluoride was successfully eluted. 
5.0
693.0
0
T
t
eAA     Equation 10 
A0 = Initial Activity 
A = Activity 
T0.5 = half life of [
18
F]fluoride 109.7 min or 6586 s 
t = time elapsed since initial activity 
Since the activity at any given time was measured Equation 10 was rearranged in order 
to solve the initial Activity A0: 
5.0/693.00 Tte
A
A     Equation 11 
Activity of fluoride at the start of the experiments 38.3 mCi at time 0. 
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The amount of fluoride trapped was calculated by subtracting the amount of activity left 
in the empty syringe plus the activity at the outlet minus the starting fluoride activity, 
decay corrected using Equation 11. 
Table 22 Values of the trapping and elution activity during the on-chip experiments. 
 Initial 
activity 
Activity N0 Time / s Efficiency / % 
Glass syringe (A) 3.7 4.55 1980  
Collection vial (B) 13.18 16.23 1980  
Trapped activity D=(C-
(A+B)) 
 17.31 1980 45 
Fluoride elution 1 3.3 4.49 2940 25 
Fluoride elution 2 4 6.2 4200 35 
Fluoride elution 3 2.6 6.33 8460 35 
 
As reported in Table 22 the trapped activity was measured indirectly by difference. 
What has to be noted is first results of this experiment are based on the theoretical decay 
of the fluoride at different time points, especially within such a long experiment (elution 
step was after 141 minutes, 109.7 half life of fluoride) and is not considering any 
possibilities of fluoride sticking on the glass surface which is an issue already reported 
in literature [156]. The experiment was then repeated once more using the same settings 
with the difference being that between the trapping and the elution 200 µL of pure 
MeCN were pumped at 8 µL min
-1
 to actually prove if the fluoride was trapped onto the 
particles, or there was any sticking of fluoride in the tubing. Using this approach 35 % 
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trapping of fluoride and 60 % elution of fluoride, with another 30 % of the trapped 
fluoride being washed away by the MeCN was observed. 
4.7 Summary 
Investigations were performed into trapping and elution of [
18/19
F]fluoride via formation 
of magnetic plug inside a glass micro-device even though the method was not as fast or 
as efficient as the packed bed of micro-particles (Chapter 3). The proof of principle 
showed that an alternative process that uses magnetic forces can be adapted for future 
on-chip systems for pre-concentration of fluoride. However by employing positively 
charged magnetic particles, fluoride could be trapped and eluted; although the efficiency 
and the volume throughput were not as high as expected. Further optimisation of the 
set-up however could have potential for any future dose-on-demand applications [177]. 
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5 On-chip free-flow magnetophoresis: towards a continuous 
method for pre-concentration of [18/19F]fluoride 
The work described in this chapter concerns the determination of laminar flow and 
study of magnetic particle characteristics in a microfluidic device with the ultimate aim 
to develop a continuous method of [
18/19
F]fluoride pre-concentration. 
5.1 Introduction 
As described in Section 1.5, the principle of on-chip free-flow magnetophoresis was 
further developed such that continuous flow trapping and elution of [
18/19
F]fluoride be 
performed on mobile AE magnetic particles. Briefly, laminar flow is generated in the x-
direction across a wide chamber, as in the magnetophoresis device, but with the flow 
now consisting of alternating streams of reagents and buffer solutions (Figure 96). 
Functionalised magnetic particles are then introduced into the chamber and deflected 
sequentially through each of the streams, allowing consecutive reactions to take place 
on the particle surfaces. 
The principle of this method was a modification of a similar process currently under 
investigation in our Research group (Dr. Pamme, The University of Hull), three types of 
applications were investigated: (i) bioassays (by Sally Peyman)[178, 179],(ii) DNA 
hybridisation (by Martin Vojtisek) [180] and (iii) chemical reactions/depositions (by 
Mark D. Tarn) [181-183]. 
Here, a departure from the more bioanalytical assays was investigated, in which fluoride 
pre-concentration could be performed in continuous flow, possibly even combined with 
solvent exchange. One envisaged concept is shown in Figure 96, whereby magnetic 
particles with anion-exchange groups on their surface are deflected through a chamber 
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with several laminar reagent streams. The particles first pass through a fluoride-
containing stream where the fluoride binds to the particle surface. The particles are then 
dragged into a stream which would elute the fluoride, either an aqueous solution of 
carbonate or, alternatively, an acetonitrile based solution containing some carbonate. 
The fluoride on the particle surface will be replaced by the carbonate. The fluoride ions 
will leave the micro-chamber and can be guided to the synthesis step, whereas the 
magnetic particles are further deflected for separate collection. Whilst the previous 
applications were already performed (immunoassays, DNA hybridisation), the capture 
of anions and the pulling of particles through interfaces of different solvents, has not yet 
been studied. 
 
Figure 96 Continuous flow magnetic approach showing the principle of the multi laminar flow 
regime where AE particles are introduced into the reaction chamber and deflected via magnetic 
field (left). The green streams show the trapping while the red stream shows the elution of the 
fluoride. 
5.2 Multilaminar flow approach 
Before performing particle experiments in the multilaminar flow chips, the flow 
regimes were tested to confirm that they were laminar. Previous work by Peyman et 
al.[179] had already established that the diffusion between the laminar streams was not 
sufficient to cause cross-contamination between reagents; however the experiments and 
the set-up were repeated during the work herein, to gain confidence and practicality 
with such a precise and specific process. Figure 99 shows the laminar flow regime of 
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alternating streams of aqueous dye within two different chips designs. The figure clearly 
shows that laminar flow was obtained, with the coloured streams liquids flowing side-
by-side through the microfluidic chamber. During this part of the work the previously 
used hydrodynamic pump described in experimental section 2.3 was replaced by a 
pressure driven pump as described in Section 2.8.1 and shown in Figure 55, where 
instead of having the liquid pumped through the chip by controlling the flow rate, a 
difference in pressures between the inlets and the outlets of the device allows the liquid 
to flow in the y direction. It is due to this pressure drop between inlets and outlets that 
the particles and liquid within the microfluidic chamber can be manoeuvred. 
 
Figure 97 Laminar flow inside the chamber of two different chips design FDL1-FDL2, showing 
stable stream with minimal diffusion. 
Pressure drop  
As a liquid flows through a pipe or channel the pressure decreases from one end of the 
channel (the source of the pressure) to the other due to frictional forces, an effect known 
as the pressure drop. These frictional forces arise from a resistance to the flow exerted 
by a channel based on its dimensions and the viscosity η (N m s-1) of the fluid flowing 
through it [3]. The pressure drop within the device chamber during the experiments was 
achieved by controlling the pressure at the inlets and outlets using the MFCS fluigent 
pump as described in Section 2.8.1. However it can also be calculated theoretically by 
first determining the flow resistance Rϕ (Kg m-4 s-1) as shown in Equation 12:  
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2
2
wd
lfR
R e     Equation 12 
Where l = channel length (m), w = channel width (m), d = channel depth (m), fRe = the 
friction coefficient which is related to the shape of the microchannel (assumed to be 24 
for a microfluidic chamber). The hydrodynamic diameter, δ (in m), can be calculated for 
a rectangular cross-section using Equation 13:  
dw
wd2
    Equation 13 
The pressure drop, Δp (Pa), is then determined from the flow resistance, Rϕ, and the 
applied flow rate, ϕ (m3 s-1), using Equation 14. This can be also be likened to the 
calculation of the voltage, or potential difference (V), from the current (I) and resistance 
(R) in an electronic circuit according to Ohm’s law, (V = I R)  
Rp     Equation 14 
As in an electrical circuit, the flow resistance of multiple channels in a microfluidic chip 
may be treated like electrical resistors, and Kirchhoff’s laws can be applied to find the 
total flow resistance, Rϕ (tot), for the chip and its individual sections. When the 
channels in a microfluidic chip are in a serial arrangement (i.e. one channel follows 
another) the total flow resistance can be calculated using Equation 15, where R1, R2 etc. 
refer to resistance values for individual channels. 
iRRRRR .....321    Equation 15 
When the channels are in a parallel arrangement (i.e. when a single channel splits to 
give two parallel channels) in the case of the magnetophoresis chip the total resistance 
can be calculated by determining the value of 1/R(tot) from each of the parallel channels 
as shown in Equation 16, before taking the inverse of this number to give Rϕ(tot). 
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1
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321
   Equation 16 
The velocity of the laminar flow profile depends on the distance x from the centre of the 
chamber with a depth, d, and the length l, of the chamber. It also depends on the 
pressure drop, Δp, over the chamber and the viscosity, η; of the pumped medium: 
2
2
24
x
d
L
p
v    Equation 17 
As an example, the theoretical flow velocity within the separation chamber was 
calculated for a pressure difference of 50 mbar in each of the 4 inlets of the glass device 
with 4 inlets 4 outlets with a depth of 20 um and a width of 3 mm and a length of 6 mm, 
assuming viscosity of 1.002 N s m
-2 
and x
2
 = 0 at distance x due to the parabolic flow 
velocity. Then the total linear velocity was calculated to be 200 µm s
-1 
by using 
Equation 17 and the theoretical volumetric flow rate was calculated and found to be 43 
µL h
-1
 using Equation 14. The calculated values were compared to the experimental 
results, in fact a different experiment was carried out to be able to determine the speed 
of the liquid inside the chamber, where a calibration of the particles speed against the 
pressure differences were plotted as shown in Figure 100, The particles were forced in 
the y-direction from the inlet pressure that was always kept constant at 200 mbar and 
series of video were recorded of the particles crossing the chamber whilst changing the 
pressure at the outlet from 195-140 mbar. The videos were then analysed by recording 
the time that a particle takes from point a to b and the particles speed was recorded. As 
shown in Figure 100, linearity was observed (n=20) however as expected due to the 
laminar flow profile a significant error especially at high pressure differences within 30-
60 mbar, was observed. 
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Figure 98 Plot of the particles speed µm s
-1
 vs pressur difference between inlets and outlet, particles 
used were Dynabeads M280. 
As shown in Figure 98 at 50 mbar difference in pressure corresponds an average particle 
speed of 460 µm s
-1 
which surprisingly was nearly double the theoretical linear velocity 
calculated previously to be 200 µm s
-1
, a possible explanation of this difference could be 
the fact that the particles anlaysed under the microscope were at a different distance 
within the parabolic flow regime, which means that particles at a different depth within 
the 20 µm structure could have experienced a variations in their velocity up to 50%, 
phenomena that are already reported previously [184]. Nevertheless 50 mbar was then 
used for all the further experiments. 
 
 
 
 
 
  Chapter 5     bjbk 
161 
 
5.3 Off-chip AE particles deflection 
Once the laminar flow within the chamber was determined, an off chip experiment to 
pull particles through a water: acetonitrile interface was carried out (Figure 99). 
However since acetonitrile is a polar solvent and miscible with water, at first it was not 
possible to investigate the transfer of particles through the two interface layer especially 
off chip where mixing happens rapidly, nevertheless using a reported method it was 
possible to separate the two layers by adding excess of high ionic strength salt. In this 
case K2CO3 (3 g in 5 mL solution 80:20 ACN:H2O) was added and the magnetic 
particles transported from the water layer to the acetonitrile layer using a small 
permanent magnet. As clearly shown in Figure 99(a-b) [185]. The experiment suggested 
that the particles can indeed be mobilised through this interface by means of the 
conventional small permanent magnets. 
 
Figure 99 a) Separation of water-acetonitrile layers. b) Pulling of 3 µm particles from water to 
acetonitrile with small permanent magnet. 
5.4 On-chip surface treatment optimisation  
After the laminar flow optimisation and the study of solvent effects on the magnetic 
particles, an experiment with particles inside the device was carried out, as detailed in 
Section 2.7.4. Invitrogen SAX particles were introduced into the microfluidic chamber 
of chip design FDL1 via inlet 1, with a stream of water: MeCN: K222: K2CO3 in inlet 4, 
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and aqueous fluoride solution (1 µg mL
-1
) from inlets 2 and 3. The principle of the 
experiment is shown in Figure 96. However, in initial experiments; the particles simply 
stuck to the surface of the glass upon entering the chamber and would not move 
thereafter as shown in Figure 100. This likely occurred as a result of two factors, the 
first being that the particles have experienced an upwards magnetic force due to the 
NdFeB magnet being placed on top of the chip, which would have drawn the particles 
towards the upper surface of the glass chamber. Secondly, the quaternary ammonium 
particles are positively charged (Figure 22 section 1.9) at pH between 2-14 and 
therefore experienced an electrostatic attraction to the surface of the glass chip which 
possessed a negative charge. Experiments with the magnet placed in-plane with the 
chamber by having a cut out to place the magnet were also carried out which gave 
similar effect without improving adhesion.When silanisation of the chip was performed 
that chip was only used for 1-2 experiments. 
 
Figure 100 Image showing the Invitrogen SAX particles stuck in the glass device with no treatment. 
In an effort to reduce this effect, the glass channels were treated with 
octadecyltrichlorosilane (OTS) as described in section 2.4 to render the chip surfaces 
uncharged, albeit hydrophobic, but no significant improvement was observed. An 
attempt to reduce the sticking was made using trichloro (1H,1H,2H,2H-perfluorooctyl) 
silane (FDTS) to treat the glass surfaces rather than OTS. FDTS features a 
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perfluoroalkyl chain (Table 15) that, when coated onto the glass surfaces, formed 
uncharged and hydrophobic surfaces that prefer to be wetted by fluorinated species. 
Tests to confirm the successful treatment of the hydrophobic coating were done by 
measuring the contact angles between at the air-water interfaces as shown in Figure 101. 
 
Figure 101 (a) Contact angle measurement using water/air interface without silanisation(°44.218), 
(b) after silanisation (°89.518). 
As the chip design used to test the success of the surface treatment was a different 
design previously used for magnetic plug (Chapter 4), the coating method was then 
applied to the newer chip design. On chip contact angle measurements were performed 
via water-air interface, the value before treatment was 45 ° ±5 and after treatment was 
90° ± 5. This proves that after the treatment the channels were hydrophobic, the 
negative charges on the glass surface were replaced by the silanol functional group as 
described in Figure 58. Further attempts to manoeuvre the particles through the chamber 
included a positively charged surface treatments (QAS, quaternary ammonium silane) 
that would actually repel the positively charged particles away from the surface and a 
primary amine such as APTES, however no significant improvement was observed, the 
different surface coating were compared by analysing the average percentage of 
particles sticking within a specific area in the chamber. 
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Table 23 Table showing the compounds name structure and functionality with their relative results 
for the particles sticking. 
Compound name Functionality Adhesion 
Trichloro-(octadecyl)silane Hydrophobic 24% 
Trichloro-(1H,1H,2H,2H-perfluorooctyl)silane Hydrophobic 15% 
(3-Aminopropyl)-triethoxysilane (APTES) Positively charged 22 % 
Quaternary ammonium silane (QAS) Positively charged 29 % 
Poly(allylamine)hydrochloride (PAH) Positively charged 30 % 
 
The different surface treatments as reported in Table 15, were tested using the same 
design chip of 5 inlets and 5 outlets with pressure difference of 15 mbar, the pressure 
was reduced to be able to visualize the particles during the video analysis. Using 1 x 10
6 
particles mL
-1
 of Invitrogen SAX 1 µm, with no surface treatment and no magnet 
present, each individual chip was first treated and then particles pumped through the 
chamber from inlet 1, videos were taken and recorded for 5 min at inlet 1 and particles 
counted, the average particles per minute was recorded to be 120, then images were 
taken at the inlet and at the end of the chamber, with the aid of image J software the 
image of the inlet was subtracted to the outlet so that the difference will be only the 
particles stuck at the outlet, as shown in Figure 102(b) and103(b). Detailed results on 
percentages are reported in Table 23 with the FDTS showing the least number of 
particles stuck within the chamber. 
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Figure 102 Image of the chip of the particles at time 0 showing very little sticking as proved by the 
back ground image (b) where the small black dots represent the particles stuck. 
100µm
Flow
outlets
a) b)
 
Figure 103 image of the video at the outlet of the chamber after 2 minutes showing particles stuck 
at the surface as proved by the background image, then the number of particles was counted before 
and after and percentage of sticking recorded. 
However sticking of the particles was never completely resolved, furthermore what was 
observed was that the number of particles sticking within an experiment was increasing 
during the time, in fact there were approximately 120 particles per minute going 
through the inlet channel at a flow rate of 10-20 µL h
-1
 and in the best case only 15% of 
these were stuck on the glass surface, however during the same experiment after 60 min 
of pumping the solution the number of particles had increased from 15 to 900, as well as 
the number of particles sticking on the surface within the same experiments, it was 
observed that as the number of particles stuck increased, less particles were going 
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through the chamber and exit at the outlet. In fact each individual particle was acting as 
a small magnet sometimes forming cluster of two or more particles. An example of a 
device with particles stuck after 30 min is shown in Figure 104, to be noted the different 
sizes of the dots where the small dot represent one or two particles whilst the big dots 
are cluster of two or more particles.  
50 µm
Big dot
Small dot
Flow
 
Figure 104 Image of a glass device inlet with APTES surface treatment where the different size of 
the dots  represent the small one or two particles and the big dots a cluster of two or more particles 
agglomerate. 
Once the optimum surface treatment was determined to be the FDTS a deflection 
experiment was attempted and to avoid the pulling of the particles towards the top of the 
glass device a chip with a cut out near the top side of the chamber was used as described 
in section 2.8, However with the first box magnet 10 x10 x 5 mm
3
 placed at 1 mm from 
the chamber the particles could not deflect, possibly due to the strong field of the 
magnet, then the distance of the magnet from the chamber was changed, from 1 to 2, 3 
and then 4 mm and in all the cases particles were not deflecting along the chamber, but 
they were stuck on the glass as soon as they enter the chamber. The smaller box magnet 
was tested 4 x 4 x 5 mm
3
 and even when placed in the recess of the device no deflection 
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was observed and the particles were following the flow of the liquid and going out at 
the outlet, also it was placed on top of the chamber however no deflection or particles 
sticking was observed.  
As such, the mechanism behind the sticking of the particles to the surface is not fully 
understood, other than to say that an apparent lack of repulsive forces causes the van der 
Waal’s forces of attraction to dominate. Therefore, this remains an important factor to 
consider regarding the potential of the multilaminar flow system for applications in 
which solvents and charged particles are required, including many types of organic 
synthesis. To overcome this limitation as it is at present, future work should involve a 
rigorous study into the electrostatic, van der Waal’s, hydration, and hydrophobic forces 
at work in the system from a more physical chemistry-based viewpoint. This would 
include characterisation of the particles in different media, the effect of the glass 
surfaces with different treatments (e.g. hydrophilic, charged, and hydrophobic 
silanisation), and the influence of different surfactants at varying concentrations. With 
this type of information, a wider range of practical uses for the multilaminar flow 
technique could become available, with the possibility of tailoring the type of chip 
surface, particle functionalisation, and liquid media to suit specific processes.  
5.5 Particle deflection studies 
A further test was carried out in order to understand if the surface functionality of the 
particles was the main reasons of this sticking issue, or others were the factor to 
consider, so other chromatography particles were tested with different functional 
groups, strong anion exchange particles, weak anion exchange particles, cation 
exchange particles and reversed phase particles specific details are reported in Section 
2.1.2. The experiment was performed with chip design FDL1 with no surface treatment 
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with a pressure difference of 50 mbar without presence of magnet with 1 x 10
7
 particles 
mL
-1
, and as expected it was found that both cation and reversed phase magnetic 
particles could be deflected in some way along the chamber whilst the weak anion could 
be partially deflected, some particles would stop along the deflection trajectory, but they 
will continue their flow when disruption of the capillary was performed. Figure 105 
shows a device with no magnet and a stream of MyOne weak cation exchange particles 
(with a carboxylic functional group, as shown in Table 12 experimental section 2.1.3) 
flowing from inlet towards the outlet with no major sticking observed, a box magnet 10 
x 10 x 5 mm
3
 was placed in the cut out of the glass and as shown in Fig 106 particles 
were deflected even though has to be noted some sticking at the tip of the inlet was 
observed most of which was due to a cluster of particles which observed a stronger 
magnetic field. 
 
Figure 105 Image showing a stream of MyOne weak cation exchange particles flowing with very 
limited sticking from inlet to the outlet without magnet.  
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Figure 106 Image showing MyOne weak cation exchange particles deflected across the chamber 
towards the outlet in presence of a magnet. 
The same experiment was repeated with reversed phase C18 particles, and similar 
deflection was observed. When weak anion particles (primary amine) were tested a 
different behaviour was observed where deflection could only be achieved if capillary 
were flicked at different interval demonstrating the electrostatic interactions between the 
negative glass surface and a partially positive charge of the primary amine was not too 
strong such as particles would stick on to the surface. 
Table 24 Magnetic particles types with their size, showing that deflection was not possible to 
achieve with the strong anion magnetic particles. 
Magnetic particle type Size (µm) Deflection across chamber 
Strong anion (-NH3
+
) 1.0 No (≈ 20% sticking) 
Reversed phase (-C18) 1.0 Yes 
Weak cation (-COO
-
) 1.0 Yes 
Weak anion (-NH3
+
) 2.7 Yes (some sticking) 
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5.6 Summary 
Investigations were performed into deflection of AE superparamagnetic particles with a 
view towards fluoride trapping and elution in continuous flow. However, due to the 
charge of the particles, the charge of the chamber surface itself, and perhaps further as 
yet unknown reasons, deflecting particles across the chamber proved difficult as they 
would stick to the surface, thus preventing them from crossing the reagent stream. 
Different surface treatments were also tested with no major improvement; however a 
more dedicated study would need to be carried on in order to understand the effect of 
variable like magnet size, distance from the chamber and speed of particles. To prove 
that most probably is the interaction between the strongly positive magnetic particles 
and the negatively charge of the wall surface was the reason of the sticking, other 
chromatography magnetic particles were also tested for deflection within the 
microfluidic device results are shown in Table 24.  
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6 Towards Radiotracer purification 
In this chapter a suitable method for removal of Kryptofix as well as an investigation 
into the purification of FECH was investigated using the chip design for performing 
fluoride pre-concentration as described in Chapter 3. 
6.1 Introduction 
The vast majority of all 
18
F-PET-tracers are purified after the reaction by means of 
HPLC or SPE, mostly using C18 reversed phase materials (RP) or ion exchange 
materials (an image of the cartridge used for FDG purification is shown in Figure 107) 
[82]. 
 
Figure 107 Image of an example of cartridge used for FDG purification and on the right the 
materials contained and the type of phase. 
One of the compounds present in many radiotracers that needs to be removed is the 
phase transfer catalyst K2.2.2. In the following pages, two detection methods are 
examined, the first being the colourimetric detection, a modification of the colour spot 
test procedures by Mock et al. [55], the second a more sensitive method which consists 
of a modification of the LC-MS-MS method by Ma et al. [92]. 
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Together with the investigation of Kryptofix removal a method for detection and 
removal of 2-[
18
F]fluoroethyl choline [FECH] was also investigated, one of the few 
examples of ionic radiotracer for PET. The synthesis starts from the production of 
[
18
F]fluoroethyltosylate which reacts with N,N-dimethylamino ethanol (DMAE) in 
presence of MeCN as described in Fig 108. As the FECH product is the only charged 
compound present in the reaction mixture the solution is passed through a cation 
exchange cartridge, where the un-reacted compounds will pass through while the FECH 
is trapped and subsequently eluted with a saline solution. 
 
Figure 108 Synthesis of FECH in two steps reaction first fluoroethyltosylate is produced and then is 
reacted with excess of DMAE to yield the final FECH. 
6.2 Kryptofix detection and removal 
6.2.1  Colourimetric detection 
In the first instance the method of the colour spot test was reproduced as reported by 
Mock et al. In this method however it was only possible to compare the colour of the 
spot between a reference standard and the unknown concentration of Kryptofix and by 
colour comparison determine if the solution was less than 20 µg mL
-1
. This method is 
  Chapter 6     bjbk 
173 
 
based on TLC silica plate as described in Section 2.10.2. What was observed during the 
experiments was that when K2.2.2 in different concentration was reacted with the stock 
iodoplatinate reagent a different colour changes from orange / red colour to blue / purple 
with significant colour change at above 50 µg mL
-1 
was observed as shown in Figure 60.  
It was decided to investigate a semi-quantitative method for the determination of K2.2.2 
by using a spectrophotometer to measure the absorbance. Firstly a quartz cuvette was 
used and investigated the minimum amount of K2.2.2 needed for the reaction with 
iodoplatinate to occur. It was found that 1:1 volume K2.2.2 : iodoplatinate was 
sufficient to obtain a color changes and all the experiment were carried out using 10 µL 
standards kryptofix with 10 µL iodoplatinate reagent made up in 800 µL water. Since 
this is a precipitation reaction the best method was found to be the addition of the 
reagents first, followed by the addition of water. A full spectrum of the different 
concentrations from 1 - 200 µg mL
-1
 was run and it was found that the absorbance 
increased with an increase in concentration of K2.2.2 as shown in Figure 109. Two 
major peaks were observed, at about 600 nm and the other at 365 nm, due to some 
overlapping issue with some standards at 600 nm, 365 nm was chosen to carry out a 
calibration. 
  Chapter 6     bjbk 
174 
 
 
Figure 109 Spectrum range of Kryptofix standards (1 -200 ppm). 
The absorbance was plotted against the log scale of the concentration ranges between 5 
-200 ppm as shown in Figure110 (n=3). Below 5 ppm the method is not sensitive 
enough and the absorbance of the standards interfere with the blank sometimes giving a 
negative value. The method was tested with a real sample of FDG after purification; the 
absorbance value obtained was very close to zero so was not possible to quantify the 
K2.2.2 amount in FDG. 
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Figure 110 Calibration curve of the log scale of the concentration of standard Kryptofix solution 
(10 µL) + acidified iodoplatinate reagent (10 µL) and 800 µL water vs the absorbance measured at λ 
365 nm. 
6.2.2 HPLC-MS detection 
A more sensitive method which uses an HPLC-MS-MS was investigated which would 
enable some quantitative experiments for the purification steps to be performed, such as 
the amount of resin needed to remove the K2.2.2. The method from Ma et al.[92] was 
slightly modified, the use of the ammonium acetate as mobile phase was found to be 
detrimental for the LC pump causing several stalling and blockages so the ammonium 
acetate was substituted with water (50:50 water:ACN), and it was still possible to 
identify the K2.2.2 standards peak. As shown in Figure 111 a typical HPLC mass 
spectrum of K2.2.2 in ACN solution with retention time of 1.46 min, illustrates some 
uncomplexed K2.2.2 and K2.2.2 with sodium. The standards were prepared in ACN 
solution since in the presence of water the two peaks were found to co-elute. Another 
interesting fact is that it could not be possible to see the K2.2.2 + K at 416 m/z even 
after spiking the standard with potassium fluoride; this was of particular interest since it 
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is known that K2.2.2 exhibits particular affinity for potassium ions amongst other alkali 
metal cations [186]. 
 
 
Figure 111 HPLC spectrum showing a typical chromatogram of Kryptofix. 
 
Figure 112 Typical MS spectrum of Kryptofix showing the empty kryptofic at 377 m/z and the 
sodiated Kryptofix at 399 m/z. 
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Once the feasibility of the detection method was established the limit of detection 
(LOD) was determined to be 0.59 µg mL
-1
 by plotting the peak area against the 
concentration of K2.2.2 standards as shown in Figure 113 (n=1) and was calculated 
using the formula: 
LOD = (3.3 * standard deviation of the lowest value)/gradient of the slope) Equation 19 
 
Figure 113 Concentration of kryptofix standards (0.1- 100 ppm) vs peak area measured with 
HPLC-MS. 
Even though the method was not as sensitive as the one previously reported by Ma et. 
al. [92] it is suitable to quantify K2.2.2 below the required level which is 25 µg mL
-1
. 
In Table 25 the two methods for detection of K2.2.2 are compared, and the most 
accurate and specific for our experimentation was found to be the HPLC-MS. 
Table 25 Comparisons between HPLC-MS and spectrophotometric detection 
 HPLC -MS Spectrophotometric 
Run time 2-5 min <2 min 
Preparation time < 2 min 10-30 min 
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Volume required 10 µL (injection) 10 µL  
LOD 0.6 ppm 10 ppm 
User friendliness Commercial system Wet chemistry 
Advantages Accurate  Inexpensive 
Disadvantages Expensive Semi-quantitative 
6.3 Removal of K2.2.2 in FDG 
After establishing that HPLC-MS was the most suitable method for detection of K2.2.2 
it was tested on a real sample of [
19
F]FDG prepared according to Gomzina et al. [22] 
procedures The [
19
F]FDG sample was provided by Dr Victoria Hammond and after the 
product was purified it was analysed for the presence of K2.2.2. Figure 114 shows the 
chromatogram of the peak identified during the run. This shows very low counts for 
K2.2.2 and in the spectrum below, the intensity of the K2.2.2 peak at 377 m/z together 
with some background ions. It was not possible to quantify, but it was concluded to be 
below our detection limit of 0.59 µg mL
-1
. 
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Figure 114. HPLC-MS spectrum of FDG showing very low count intensity for Kryptofix which was 
identified to be less than 100 ng. 
6.4 FECH detection and removal 
The next part of the chapter is focused towards the development of a new purification 
route for the synthesis of FECH. Since the purification of the FDG is already state of the 
art with single cartridges available to trap all the by-products and release only the final 
FDG product, it was decided to investigate a new approach for the FECH compound 
based on the same idea where all the by-products are trapped and the FECH released. 
Table 26 shows the compounds present in the FECH reaction. These include starting 
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materials, by-products and products with the corresponding type of purification 
material, as well as the detection method used for analysis. 
Table 26 Starting materials and products for the FECH synthesis with their solid phase material 
for extraction as well as the detection method. 
Compounds Resin Detection 
Ethyl-di-tosylate (EtdT) C18 HPLC-UV 
18
F-EtOTs C18 HPLC-UV 
DMAE Cation IEC 
diMM Cation IEC 
FECH Cation IEC 
K2.2.2 C18 HPLC-MS / TLC 
TBAHCO3 Cation IEC 
 
The first step was the identification of a suitable detection method for the final product. 
Since the final product is a positively charged compound the IEC instrument previously 
used for fluoride detection was used, with the difference being a switch from anion to 
cation exchange, which involved replacing the column, the mobile phase and suppressor 
to be able to identify cations. The starting material and final compounds were purchased 
from ABX compounds and not synthesized, one of the by-products (diMM) was not 
readily available and for this reason was not analysed. A known amount of both FECH 
(15 ppm) and DMAE (10 ppm) was injected into the IEC and it was possible to separate 
and identify both compounds. However for some reason, when FECH was injected at a 
concentration lower than 5 ppm, no peak was observed. It was proposed that this is due 
to the sensitivity of the instrument, which was unexpected since typically LOD up to 
ppb level can be analysed with the IC in cation mode. However further work to evaluate 
parameters such as temperature of the column, injection volume or trying a gradient 
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elution could help to analyse lower concentration of FECH. Figure 115 shows an 
isocratic run where it was possible to separate DMAE and FECH within the same run.  
 
Figure 115 IC chromatogram of a mixture of DMAE and FECH separated with a CS18 cation 
column, 20 mM methanesulfonic acid 0.25 mL min
-1
. 
It is reported in the literature [96] that sometimes TBAHCO3 is used during synthesis of 
FECH due to it being less toxic than K2.2.2 and easily removed with a cation cartridge. 
TBAHCO3 was purchased from ABX. A mixture of FECH (10ppm) DMAE (10 ppm) 
and TBAHCO3 (10 ppm) was injected in the IEC and surprisingly it was possible to 
separate the three compounds with an isocratic run. As shown in Figure 116, within 8 
min the three compounds were eluted from the cation column. So far separation and 
identification of the three compounds was not reported in the same run. However, 
further studies in the limit of detection and quantification would need to be carried out 
in order to optimize the method to be able to analyse much lower concentration 
commonly obtained during radiotracer synthesis. 
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Figure 116 IC chromatogram of a mixture of DMAE and FECH and TBAHCO3separated with a 
CS18 cation column, 20 mM methanesulfonic acid 0.25 mL min
-1
. 
Once the method for detection of FECH and DMAE was optimised, the chip design 
used for the pre-concentration of fluoride in Chapter 3 was prepared and filled with 
cation exchange particles from the CM cartridge (Waters, UK) describe in Section 2.1.2. 
Approximately 20 mg of dried particles were filled in each chamber of the chip as 
shown in Figure 117. 
 
Figure 117 Image of glass device used for FECH removal showing the two chambers filled with 
approximately 20 mg each of cation exchange particles extracted from a CM cartridge from Waters 
UK 
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Once the device was prepared it was connected to a syringe pump as described in 
section 2.1.7.1. In detail 1 mL of 10 ppm of FECH (10 µg mL
-1
) was pumped through 
the chip at 600 µl min
-
1(n=1). The solution was collected at the outlet and analysed for 
presence of FECH, in order to measure the resin specific capacity for FECH trapping. 
As shown in Figure 118, the percentage of FECH trapped was plotted against the 
number of times that a 1 mL solution was pumped through the chip, which was equal to 
10 µg mL
-1
 per run. 
 
 
Figure 118 Graph showing the % of FECH trapped vs the number of runs which equal to 10 µg 
mL
-1
 per run. 
The maximum trapping capacity where more than 90% FECH was trapped was found to 
be 110 µg of FECH per 20 mg resin, which is equal to 5.5 µg mg
-1
 of resin. Since the 
amount of FECH is much lower that the capacity determined using the method above, it 
would be possible to reduce the amount of resin, and as a consequence the design of the 
microchamber could be much smaller for real FECH purification during the 
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radiosynthesis. The next step was to investigate the possibility to have a single use 
system where different radiotracers could be purified. It has to be noted that in the 
current radiotracer synthesis there is no need of such a system. However many research 
groups are currently working on microfluidic modular platforms, with the final goal to 
be able to produce different doses of different radiotracers at the touch of a button, with 
the final aim to have a versatile, small and fully automated systems. By combining the 
need for such as a system as well as the knowledge that SPE purification of any product 
is basically performed on four different types of chromatography material together with 
the awareness that these materials could be regenerated as proven with the anion 
exchange resin during the pre-concentration of fluoride in Chapter 3. The concept was 
to fill four of the chamber micro-devices with the different materials (Alumina, Cation, 
Anion and Reversed phase resins). Describe in Section 2.1.2 of experimental chapter 
and be able to connect them with the use of tubing valve and T-connector. In this way 
the product could be directed into any of the four chambers, so that a product could be 
purified and collected at the outlet and each individual chamber could be regenerated 
independently; using its own regenerant solution. Figure 119 in more detail shows 
example how crude FDG could go pass through the four chambers for purification and 
be collected at the outlet. Subsequently the individual materials could be regenerated 
independently by introduction of separate solutions; such as, reversed phase with an 
excess of ethanol, cation and anion with an excess of salt/base (NaCl, K2CO3) and 
alumina could be stripped of its un-reacted fluoride by washing with acid. In this way 
the different materials could be ready to be used in the next purification step. In the case 
of FECH, the unpurified mixture could be passed first through the reversed phase where 
starting materials (tosylated by products, DMAE and K2.2.2) could be trapped, 
subsequently FECH will be trapped in the cation resin whilst un-reacted fluoride is 
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retained by the alumina and a final step would be the release of the FECH via chip 2 by 
washing with a saline solution. However, it will be difficult to integrate this system in 
any of the current platforms due to stringent quality requirements, with the possibilities 
of cross contamination. However this approach could not be used in the current 
cartridge approach where all the materials are in direct contact, as shown in Figure 109 
with the FDG base hydrolysis cartridge which contains all the materials in the same 
tube. It would not be possible to pass, for example, a solution of strong acid through an 
anion exchange material or a strong base through the cation exchange materials. 
 
Figure 119 Schematic of four different micro-chambers independently connected where it will be 
possible to redirect the liquid solution in the desired chamber by using a valve or T junction to 
allow multiple radiotracers purification and subsequently the regeneration of each individual 
material. 
The schematic shown in Figure 119 was investigated to prove the concept for FECH 
purification by trapping all the by-products and starting materials except the final 
FECH. This was achieved by connecting three different micro-devices with the three 
materials: i) reversed phase ii) anion resin and iii) alumina as shown in Figure 120. 2 
mL solution containing 40 µg of FECH, 200 µg of K2.2.2. 3 µg 
19
F
-
, 200 µg DMAE 
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was pumped through the chip at a flow rate 600 µl min
-1,
 the solution collected at the 
outlet of the T-valve and analysed for the presence of different compounds. The 
colourimetric method was used to prove that K2.2.2 was present in less than 10 µg, Ion 
selective electrode for fluoride which proved to be less than 0.5 µg, FECH analysed by 
IEC where it shows that more than 90% was released. However, DMAE was not fully 
trapped. Only 30 % was trapped in the chips with 70 % released, possibly there was not 
enough reversed phase resin for both DMAE and K2.2.2. Further work will be the study 
of DMAE and the reversed phase resins capacity. 
 
Figure 120 Image showing the three chips with different chromatography materials integrated and 
connected together used for FECH purification by trapping the byproduct and release the final 
product FECH. 
6.5 Summary 
Investigations were performed into the detection and removal of K2.2.2, with two 
detection methods identified for K2.2.2 analysis. Subsequently the method was applied 
to K2.2.2 in FDG samples to prove the suitability of the method. In addition, a suitable 
detection method for FECH, DMAE and TBAHCO3 was also optimised by development 
of an isocratic IEC method. It was possible to achieve separation of three compounds in 
the same run. Trapping of FECH was also achieved with cation exchange material 
trapped in micro-chamber, and the capacity of the material was also studied and found 
to be 5.5 µg mg
-1
 of resin. Finally a study towards the integration of different micro-
chambers was tested with FECH by integrating three different resin materials to 
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establish an alternative method for purification of FECH where all the by-products are 
trapped and FECH released. However, results of this study showed it was not possible 
to completely purify FECH, and DMAE presence was found in the collected solution in 
high traces (only 30 % was trapped and the rest released together with FECH.) 
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7 Conclusion 
The aim of this work was to develop and implement a microfluidic platform for pre-
concentration of [
18/19
F]fluoride with possibilities to use it for further on-chip solid 
phase extraction purification techniques . In order to achieve this, the research employed 
three different approaches; 1) Anion exchange microparticles packed in micro-
chambers, 2) characterisation of suitable magnetic particles and their optimisation for 
trapping and elution of fluoride in a micro glass device and 3) the investigation of a 
possible continuous flow trapping and elution of fluoride by means of free-flow 
magnetophoresis. In addition, preliminary studies and results on the on-chip removal of 
K2.2.2 as well as a new route for purification of FECH were also investigated. In this 
Chapter the achievements of the work will be summarised and discussed, along with 
considerations for future work on the project. 
7.1  On-chip pre-concentration via packed bed (batch method) 
While pre-concentration of [
18/19
F]fluoride on-chip had been previously and extensively 
investigated one important factor in both the macro a micro scale method had not been 
considered yet, the regeneration of the solid phase extraction of the anion exchange 
material. Both radioactive [
18
F] and non-radioactive [
19
F]fluoride ions could be 
repeatedly recovered by employing a chip containing a reduced amount of anion 
exchange particles than conventional cartridges. The entire process required less than 6 
min and had trapping efficiency > 90 %, while the particles could be regenerated and re-
used up to 40 times via a multicycle approach, without loss of performance. The 
radioactive solution resulting from this innovative process was highly reactive and 
could be employed in the radiofluorination of EtDT. On this basis, the standalone chip 
could easily be integrated into automated systems to provide highly reactive fluoride 
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complexes for the production of fluorinated PET radiotracers in high yields. The ability 
to regenerate the anion-exchange chip would also allow many batches of 
radiopharmaceuticals to be synthesised without requiring continuous user interaction 
within the shielded synthesiser. As a standalone chip, the design and optimisation was 
demonstrated to be a reliable and ready to use module for successful pre-concentration 
of [
18/19
F]fluoride, however future work would need to include the possibility of 
integration with other microfluidic platform systems, where synthesis of radiotracers 
could be achieved in a series of micro-devices including synthesis, hydrolysis and 
purification steps. An effort towards this was currently under investigation by the ROC 
consortium and which preliminary results are shown in Figure 121, where indeed a 
platform was built in which four of the five steps required during the synthesis of FDG 
are integrated, (pre-concentration, solvent exchange, synthesis and hydrolysis) 
significant results were achieved (FDG was synthesised successfully) and they are 
currently been submitted to Proceedings of the National Academy of Sciences Journal 
(PNAS). Figure 121 shows an image of the prototype (http://www.roc-project.eu/site/) 
 
Figure 121 Image of the prototype modular system built by Siemens showing the four modules 
connected together in order the pre-concentration module, followed by the micro-reactor, the 
solvent exchange and the second micro-reactor. 
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7.2 On-chip pre-concentration via magnetic plugs (batch approach) 
Many methods were reported on pre-concentration of fluoride however so far, there is 
no report in the literature for any trapping and elution of [
18/19
F]fluoride via magnetic 
forces. Investigations were performed into trapping and elution of [
18/19
F]fluoride via 
formation of magnetic plug inside a glass micro-device. Even though the method was 
not as fast as efficient as the packed bed of microparticles (Chapter 3) the proof of 
principle showed that an alternative process using magnetic forces can be adapted for 
future on-chip systems for pre-concentration of fluoride. Employing positively charged 
magnetic particles, fluoride could be trapped in yield of >50% and elution achieved 
with approximately 90% recovery of fluoride. However, this proof of principle was 
more labour intensive and time consuming than current methods for trapping and 
elution of fluoride, overall the process took nearly two hours (which includes loading of 
particles trapping of fluoride and elution of fluoride). Future work would therefore 
include optimisation of the number of magnetic particles required for trapping the 
fluoride, as well as a new chip design where number of channels and the depth could be 
increased in order to increase the volume throughput and the speed of the process. It 
also could be considered to investigate more accurate set-up including the magnets and 
the magnetic field. 
7.3 Towards on-chip continuous method for pre-concentration  
To further explore the use of magnetic forces in the pre-concentration of fluoride, a 
continuous method for the trapping and elution of fluoride was investigated, with the 
aim of having pre-concentration and solvent exchange performed on the same chip in 
continuous mode, which so far has not been reported in the literature. A multilaminar 
flow micro-reactor has been investigated and described in which anion magnetic 
particles can be deflected through streams of reagents with the final aim to perform 
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trapping and elution of fluoride in continuous flow. Previously, the platform had been 
applied to proof-of-principle bioassays [181, 187] and DNA hybridisation [180], to 
great effect. Herein, studies were undertaken to determine the possibility to deflect 
anion exchange superparamagnetic particles, with a view towards fluoride trapping and 
elution in continuous flow. However, due to the charge of the particles, the charge of the 
chamber surface itself, and perhaps further as yet not considered phenomena, deflecting 
particles across the chamber proved difficult as they would stick to the surface, thus 
preventing them from crossing the reagent stream. Different surface treatments were 
also tested with no major improvement however a more dedicated study would need to 
be carried on in order to understand the effect of variables such as magnet size, distance 
from the chamber, speed of particles as well as a more in depth study from a Physical 
chemistry point of view to understand the adhesion phenomena.  
7.4 Towards radiotracer purification 
Once the pre-concentration method via packed bed was optimised (Chapter 3), the same 
chip design was investigated for the purification, with the aim to have single 
independent chambers, where the different phase materials are connected, filled with 
different solid phase materials instead of individual cartridges (Figure 107), approach 
which is yet not reported in the literature and which would be beneficial since the 
independent materials could be regenerated and possibly reused for further purification 
experiments. Also an investigation was performed into the detection and removal of 
K2.2.2, with two detection methods identified for K2.2.2 analysis, with detection of 
K2.2.2 in FDG samples used to prove the suitability of the method. As suitable 
detection method for FECH and DMAE and TBAHCO3 was also optimised by 
separation of the three compounds was achieved in the same run with IEC. Trapping of 
FECH was also achieved with cation exchange material trapped in micro-chamber and 
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the capacity of the material was also studied and found to be 5.5 µg mg
-1
 of resin. A 
subsequent study towards the possibilities of integrating different micro-chambers was 
tested with FECH. By integrating three different materials it was proposed that an 
alternative method for purification of FECH could be developed, where all the by-
products are trapped and FECH released. Unfortunately, this study showed that it was 
not possible to completely purify FECH, with DMAE detected in the collected solution, 
with only 30 % trapped and the rest released with the FECH). Future work could 
include the optimisation of the device for removal of K2.2.2 with studies on the 
breakthrough of the reversed phase resin and tests on other radiocompounds rather than 
FDG. A more detailed study would need to be carried out for the purification FECH, 
first by repeating the experiments with a real sample of radioactive [
18
F]FECH and a 
subsequent study on the breakthrough of each individual resin to identify the exact 
amount of solid phase materials required. Finally further work could be explored in 
which the series of micro-chambers could be used to purify different radiotracers. 
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